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Abstract
Abstract
Oscillometric blood pressure (BP) monitors are currently used to diagnose hyper-
tension both in home and clinical settings. These monitors take BP measurements
once every 15 minutes over a 24 hour period and provide a reliable and accurate
system that is minimally invasive. Although intermittent cuff measurements have
proven to be a good indicator of BP, a continuous BP monitor is highly desirable
for the diagnosis of hypertension and other cardiac diseases. However, no such
devices currently exist.
A novel algorithm has been developed based on the Pulse Transit Time (PTT)
method, which would allow non-invasive and continuous BP measurement. PTT
is defined as the time it takes the BP wave to propagate from the heart to a
specified point on the body. After an initial BP measurement, PTT algorithms
can track BP over short periods of time, known as calibration intervals. After this
time has elapsed, a new BP measurement is required to recalibrate the algorithm.
Using the PhysioNet database as a basis, the new algorithm was developed and
tested using 15 patients, each tested 3 times over a period of 30 minutes. The
predicted BP of the algorithm was compared to the arterial BP of each patient.
It has been established that this new algorithm is capable of tracking BP over
12 minutes without the need for recalibration, using the BHS standard, a 100%
improvement over what has been previously identified.
The algorithm was incorporated into a new system based on its requirements and
was tested using three volunteers. The results mirrored those previously observed,
providing accurate BP measurements when a 12 minute calibration interval was
used. This new system provides a significant improvement to the existing method
allowing BP to be monitored continuously and non-invasively, on a beat-to-beat
basis over 24 hours, adding major clinical and diagnostic value.
ix Brian M McCarthy
Publications
Patent Application
B. M. McCarthy. A Non-Invasive Blood Pressure Monitoring System and
Method. filed to U.K. Patent Office, December 2014. Application No.
GB1422667.4
Journals
B. M. McCarthy, C. J. Vaughan, B. O’Flynn, A. Mathewson and C. Ó
Mathúna. A Novel Approach to Accurately Track Blood Pressure based
on the Pulse Transit Time Method. Submitted IEEE Transactions on
Biomedical Engineering, June 2015.
B. M. McCarthy, C. J. Vaughan, B. O’Flynn, A. Mathewson and C. Ó
Mathúna. An Examination of Calibration Intervals Required for Accurately
Tracking Blood Pressure Using Pulse Transit Time Algorithms. J Hum
Hypertens, 27(12):744-750, Dec 2013.
Conferences
B. M. McCarthy, B. O’Flynn and A. Mathewson. An Investigation of
Pulse Transit Time as a Non-Invasive Blood Pressure Measurement Method.
Journal of Physics: Conference Series, 307(1):012060, 2011.
Brian McCarthy, Michael Walsh, Brendan O’Flynn, Alan Mathewson, Tyn-
dall Physiological Health Monitoring System, 34th International Microelec-
tronics and Packaging IMAPS - CPMT, 2010.
Development of a Novel PTT Based
Algorithm
x
Abstract
Glossary
Term Explanation
AAL . . . . . . . . . . . . . Ambient Assisted Living
AAMI . . . . . . . . . . . . . Association for the Advancement of Medical Instrumentation
ABP . . . . . . . . . . . . . Arterial Blood Pressure
ADC . . . . . . . . . . . . . Analogue to Digital Converter
BCG . . . . . . . . . . . . . Ballistocardiograph
BHS . . . . . . . . . . . . . British Hypertension Society
BP . . . . . . . . . . . . . Blood Pressure
CO . . . . . . . . . . . . . Cardiac Output
CVD . . . . . . . . . . . . . Cardiovascular Disease
CWT . . . . . . . . . . . . . Continuous Wavelet Transform
DABP . . . . . . . . . . . . . Diastolic Arterial Blood Pressure
DAC . . . . . . . . . . . . . Digital to Analogue Converter
DBP . . . . . . . . . . . . . Diastolic Blood Pressure
DDS . . . . . . . . . . . . . Direct Digital Synthesis
ECG . . . . . . . . . . . . . Electrocardiograph
EEPROM . . . . . . . . . . . . . Electrically Erasable Programmable Read Only Memory
ESH . . . . . . . . . . . . . European Society of Hypertension
HFC . . . . . . . . . . . . . High Frequency Component
GMR . . . . . . . . . . . . . Giant Magneto Resonance
IC . . . . . . . . . . . . . Integrated Circuit
ICG . . . . . . . . . . . . . Impedance Cardiograph
ICU . . . . . . . . . . . . . Intensive Care Unit
I2C . . . . . . . . . . . . . Inter Integrated Circuit
IMU . . . . . . . . . . . . . Inertial Measurement Unit
LED . . . . . . . . . . . . . Light Emitting Diode
LFC . . . . . . . . . . . . . Low Frequency Component
LVET . . . . . . . . . . . . . Left Ventricle Ejection Time
MLR . . . . . . . . . . . . . Multiple Linear Regression
MAP . . . . . . . . . . . . . Mean Arterial (Blood) Pressure
MMSB . . . . . . . . . . . . . Modulated Magnetic Signature of Blood
NIR . . . . . . . . . . . . . Near Infra-Red
PAC . . . . . . . . . . . . . Pulmonary Arterial Catheter
PAT . . . . . . . . . . . . . Pulse Arrival Time
PCB . . . . . . . . . . . . . Printed Circuit Board
PEP . . . . . . . . . . . . . Pre-Ejection Period
PHAL . . . . . . . . . . . . . Physiological Health for Assisted Living
PO . . . . . . . . . . . . . Pulse Oximeter
PPG . . . . . . . . . . . . . Photoplethysmograph
PTT . . . . . . . . . . . . . Pulse Transit Time
SABP . . . . . . . . . . . . . Systolic Arterial Blood Pressure
SBP . . . . . . . . . . . . . Systolic Blood Pressure
SD . . . . . . . . . . . . . Secure Digital
SPI . . . . . . . . . . . . . Serial Peripheral Interface
SV . . . . . . . . . . . . . Stroke Volume
TFI . . . . . . . . . . . . . Thoracic Fluid Index
VEPT . . . . . . . . . . . . . Volume of Electrically Participating Tissue
WSN . . . . . . . . . . . . . Wireless Sensor Network
xi Brian M McCarthy
Chapter 1
Introduction to Non-Invasive
Blood Pressure Monitoring
1.1 Introduction
The thesis under investigation in this work was to develop a new algorithm that
would continuously track blood pressure (BP) as part of a non-invasive, unob-
trusive and comfortable personal monitoring system that is highly accurate and
reliable. The first section of this chapter provides the motivation for developing
this algorithm, explains why such an algorithm is required and why it is so impor-
tant. The next section of this chapter introduces some basic concepts including a
description of BP and provides an introduction to the electrocardiogram (ECG)
trace that is used throughout the thesis as part of one of the measurement sys-
tems. Some general terms that are used throughout the thesis will be introduced
and the standards that are used to evaluate BP monitors are explained. The final
section of this introductory chapter provides an outline of the thesis, introduces
the subject of each chapter and describes what will be discussed.
1.2 Motivation
BP is a major indicator of the health of a person and is one of the four primary
vital signs. However, unlike other vital signs, abnormal BP can be an indication
of a long term illness and can be used as a predictor of Cardiovascular Disease
(CVD). CVD is the leading cause of death worldwide and accounted for 32.16%
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of all deaths in Ireland in 2013 [1].
There are a number of methods used to measure BP. The most accurate method
to do this is by using invasive intra-arterial pressure transducers (catheters).
However, invasive BP monitors are not usually found outside of the hospital and
rarely outside of the Intensive Care Unit (ICU). Catheters also have many risks
associated with their use, including embolism, arrhythmias, heart attacks and
even mortality [2, 3]. The more practical BP monitors used outside the ICU are
known as non-invasive BP monitors.
The most common non-invasive BP monitor system typically used in a clinical
setting is a sphygmomanometer, which also requires a stethoscope and a trained
clinician. Although this method is considered to be the gold standard for BP
measurement, it has been recognized that there are numerous problems with it
[4, 5, 6]. Furthermore, since it relies on an inflatable cuff it is not a continuous
measurement. It is commonly acknowledged that a non-invasive and continuous
BP measurement device would be preferable to the sphygmomanometer [7] if one
could be found that provides the necessary accuracy and reliability.
Even when BP is measured by an expert in a clinical setting, there are other
known issues which can cause inaccuracies in the reading. Many of these can be
minimised by ensuring that the person who is being tested has not eaten, taken
any BP altering drugs (including caffeine or nicotine), or performed any exercise
prior to the measurement. However, another source of error comes from white
coat hypertension, something which is not easily controllable and which has cast
doubt on many measurements. White coat hypertension is a false reading of an
elevated BP, due to the presence of a clinician [6, 8]. This occurs because the
person that is having their BP read is nervous about having their BP taken and
as a consequence their BP increases temporarily. This means that the clinician
records an abnormally high BP. If the BP is read outside of a clinical setting i.e.
at home or at work, or frequently just by an automated monitor, this effect can
be minimised if not avoided.
It is frequently desirable to measure BP outside of the clinical setting. Usually
if a clinician would like to diagnose a patient for an abnormal BP, the patient
is given an automated BP monitor for 24 hours that takes a measurement once
every 15 to 20 minutes throughout the day and night[6]. This method helps to
reduce the effect of white coat hypertension and has also been shown to give lower
and more accurate readings.
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Another area in which home BP readings are becoming more prevalent and useful
is in the area of Ambient Assisted Living (AAL), which is an area of growing
interest. It is well documented that over the next number of years there will
a demographic shift in the average age of the general population. In fact it is
predicted that by 2050 there will be more people over the age of 65 than people
between the ages of 18 and 64 [9]. This demographic change is already leading
to an increased burden on already strained healthcare systems. In an effort to
combat this strain, there has been a considerable amount of research into the
area of AAL. AAL technologies allow the continuous monitoring of people in the
home and alert healthcare practitioners if the person they are monitoring were
to fall ill. This minimises the need for a live-in healthcare practitioner in many
cases. As BP is one of the vital parameters, being able to measure it continuously
is highly desirable in the area of AAL.
Although there are numerous non-invasive methods available for many other AAL
monitoring applications such as falls, there are many associated shortcomings
with BP monitoring in this area. The most prominent of these is that most
automated BP monitors that are in use today recommend the use an inflatable
cuff to measure BP. This is undesirable for two reasons
• When an inflatable cuff is used, there is an associated inflation and deflation
time and the measurement is not continuous (due to the time required to
inflate and deflate the cuff)
• The inflatable cuff used to prevent flow through the brachial artery and the
BP monitor can be quite uncomfortable to use, especially over extended
periods of time
For these reasons, the need for a continuous, non-invasive, unobtrusive and
comfortable system that is accurate and reliable becomes more apparent. The
specifics of each BP monitoring system and their benefits and shortcomings will
be discussed at length in Chapter 2.
1.2.1 What is Blood Pressure?
Blood pressure is a measurement of the force applied to the walls of the arteries
as the heart pumps blood through the body. This pressure is determined by
the force and amount of blood pumped, as well as the size and flexibility of the
arteries. A contraction of the heart pumps blood into the vascular system which
3 Brian M McCarthy
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leads to an increased BP around the rest of the body. This high pressure is known
as the Systolic Blood Pressure (SBP). While the heart is refilling with blood, the
blood pressure around the body drops to a low pressure known as the Diastolic
Blood Pressure (DBP). The connection between the BP and heart activity is
shown in Figure 1.1.
Figure 1.1: The BP in comparison to the activity of the ventricle of the heart.
Image taken from Braun [10]
1.2.2 The Importance of Blood Pressure
Blood pressure is one of the primary vital signs which indicate the health of a
person. Other primary vital signs include:
• Heart Rate
• Respiration Rate
• Temperature
These vital signs are measured and monitored to determine an individual’s level
of physical health. A normal BP is given as 120/80 mmHg, where the numerator
is the systolic BP and the denominator is the diastolic value. However, along
with the other vital signs, this varies with age, sex, weight, exercise tolerance
and condition. Like the other vital signs above, an abnormal blood pressure can
be a good indicator that there is something physically wrong with an individual.
Although low BP is also of concern, the vast majority of people who have an
abnormal BP are concerned with high blood pressure or hypertension.
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High BP increases the risk of getting heart disease and/or kidney disease, and/or
having a stroke. Anyone, regardless of age, sex and race can have high BP. Once
high BP develops, it usually lasts a lifetime although it can be prevented and
controlled. This is why over a third (36%) of people who are receiving long term
medical treatment in the EU, are doing so because of hypertension.
• High BP (hypertension) killed 54,186 people in the United States in 2004.
It was listed as a primary or contributing cause of death in about 277,000
U.S. deaths in 2004 [9].
• 28% of people with high BP don’t know they have it [9].
• Of all people with high BP, 71.8% are aware of their condition, 61.4% are
under treatment, 35.1% have it under control and 64.9% do not have it
controlled [9].
• The cause of 90-95% of the cases of high BP is unknown; however, high
BP is easily detected and is usually controllable using drug treatment and
exercise [9].
1.2.3 The Electrocardiogram and its Relationship to BP
An electrocardiogram (ECG) is a device that measures the electrical activity of
the heart. Frequently there is confusion over the meaning of each part of the
graph. The most important point to note is that the ECG measures the electrical
activity of the heart. Most of the components of this electrical activity have a
corresponding physiological or mechanical effect, but some components have no
direct mechanical meaning.
The cardiac cycle of the heart is illustrated in Figure 1.2a, where each sequential
contribution is shown separately. The cycle begins with the depolarisation of the
sinoatrial (SA) node. Once the electrical signal leaves the SA node, the atria are
activated and blood flows into them.This wave of depolarisation passing through
the atrial muscle corresponds to the P wave, shown in Figure 1.2b. When the
atria become full of blood, the electrical activity spreads to the left and right
atria, which then contract and push blood into the ventricles.
As blood flows into the ventricles, the electrical activity occurs at the Atrio-
Ventricular (AV) Node. Once the signal passes through the AV node, it continues
to the Bundle of HIS, and separates to the bundle branches. The electrical signal
then flows to Purkinje fibres which corresponds to the Q wave of the ECG signal.
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(a) The components of each electrical signal in the ECG waveform
(b) The sum of each of the components provide the total
signal recoded from an ECG
Figure 1.2: An explanation of the ECG signal. Image taken from [11]
From the Purkinje fibres the electrical signal flows to the ventricle walls. This
causes the ventricle walls to contract, indicated by the large electrical impulse
represented by the R wave. The signal then relaxes as the blood is ejected from the
ventricles around the body, creating a BP wave and the SBP while the electrical
signal falls to the S point. From this point, ventricular re-polarisation begins
and terminates at the T point. A further wave, the U wave is then noted as the
Purkinje fibres re-polarise, however this point is not always observed in people
that have been measured [11, 12, 13].
The most important component of the characteristic ECG wave from the per-
spective of this project, i.e. the measurement of Blood Pressure, is the start of
the R wave or the point at which blood is ejected from the heart and circulated
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1.3 Outline of Thesis
The chapters of this thesis have been divided as follows.
Chapter 2 begins with an introduction to the BP measurement standards that
are used to evaluate each of the methodologies discussed within this thesis. The
State of the Art for BP measurement techniques, starting with the sphygmo-
manometer and progressing through to the Pulse Transit Time (PTT) method
will then be described. The significance and shortcomings of each of these meth-
ods are outlined and discussed in detail. This chapter highlights the need for an
improvement to all existing methods and identifies the PTT method as the area
where a potential improvement could be made.
In Chapter 3, the PTT methodology is discussed in more detail and evaluated.
The chapter begins with the development of the hardware that was required
to measure PTT in conjunction with a description of each component that was
included in the design, as well as the software and middleware that were required
to capture the data. The various rounds of testing where volunteers were used to
record the required signals and the subsequent evaluation of the PTT methods
using algorithms to derive BP from the PTT measurements from both Chen
[14] and Poon [15], who are two of the most referenced authors in the area,
are also described. Using the results of these tests, the specific shortcomings of
the method were clearly identified. This is something which had not previously
been identified in the literature, and, furthermore, potential ways to improve the
system in practice are suggested.
The inclusion of extra parameters that could be included into the PTT method so
that a new and improved algorithm could be developed is described in Chapter 4.
The focus of this chapter is investigating how Stroke Volume (SV) among other
physiological signals can be examined for the development of a new algorithm.
Two methods were investigated which would allow the examination of these sig-
nals. One method used a hardware implementation known as an Impedance
Cardiograph which would require the measurement of data from volunteers. The
second method was to use the PhysioNet Resource, which is a database that con-
tained the required signals that had been previously captured through invasive
techniques. The identification of the most suitable source of validating data as
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well as the test protocol and algorithm evaluation based on results from Chapter
3 will be discussed.
Methods with which a new algorithm could be developed that could include both
the PTT, SV as well as other parameters are discussed in Chapter 5. In this
chapter, the importance of each physiological parameter is identified and Mul-
tiple Linear Regression is investigated as a tool for the development of a new
algorithm. One potential solution identified by this method provided very good
results. However due to some concerns arising from the statistical basis of the
work used in the derivation of this algorithm, an alternative method was sought.
This alternative method used the lessons learned from the equations developed
using Multiple Linear Regression, and helped to derive an algorithm using a com-
bination of existing equations and physical and physiological relationships. This
new algorithm yielded even better, more universally applicable results. The new
algorithm and its results are also compared to current state of the art algorithms
to emphasise its quality, with the results showing a 100% increase in the cal-
ibration intervals provided by Chen’s and Poon’s algorithms. Furthermore, a
description of how the new algorithm could be implemented and integrated into
technology that is currently available to provide a minimally intrusive 24 hour
continuous BP monitor, is described. A preliminary validation of this system
was investigated using a number of volunteers from the test outlined in Chapter
3. The results recorded in this test matched those found when the PhysioNet
database was used and has validated both the system and the algorithm con-
cepts. Although these results appear to only double the calibration intervals of
the existing PTT algorithms of Poon and Chen, the implications of the validation
of the system and algorithm have much more long term consequences. Although
the test contained only three people and a non-invasive BP monitor was used
as a reference, these results indicate that it is now possible to measure BP on
a continuous basis, by non-invasive methods over calibration intervals that are
twice that of previously investigated algorithms, making them practical from the
perspective of both clinicians and users.
The importance of this new algorithm and why its results make the PTT method
useful in a practical sense is described in Chapter 6. Prior to the development of
this algorithm, none of the state of the art algorithms were useful in a practical
setting. However, this new approach has addressed these shortcomings, and this
new algorithm and method provide a valid practical alternative and significant
improvement on existing technologies. Furthermore, this system is the first re-
ported non-invasive and continuous BP monitoring system that does not require
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a continuously inflated or inflating cuff as is required with other state of the art
BP monitors. Instead this novel system only requires one cuff measurement ev-
ery 12 minutes. This chapter also outlines the next steps that are required for
the continuation of this work, including clinical trials, so that its value can be
confirmed in accordance with international standards.
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Chapter 2
State of the Art of Blood
Pressure Measurement
Techniques
2.1 Introduction
As discussed, there are many ways by which Blood Pressure (BP) can be mea-
sured, the most accurate being by invasive methods. However, the focus of this
thesis is measurement of BP by non-invasive methods only and an attempt is
being made to replicate the accuracy of the invasive methods through the use of
non-invasive techniques. In order to facilitate this explanation, it is necessary to
provide a baseline and identify the currently used non-invasive BP measurement
approaches, as well as their respective characteristics and identify ways to im-
prove on these. In this chapter each method will be examined, starting with the
oldest (and still most accurate) method and progressing through the evolution
of this method to incorporate technology. Similarly, other less well known and
implemented technologies and methods are examined and the advantages and dis-
advantages of these methods are highlighted, in terms of accuracy and reliability,
as well as ease of use and practicality from the user and clinician perspectives.
The chapter begins with an introduction to the various BP measurement stan-
dards that are used to evaluate each methodology. The objective of this chapter is
to identify the research opportunity which would allow a continuous BP monitor
to be developed.
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2.2 BP Measurement Standards
There are currently three standards used for evaluating BP monitors. These
are the Association for the Advancement of Medical Instrumentation (AAMI)
Standard (SP-10) [16], the British Hypertension Society (BHS) standard [17] and
the European Society for Hypertension (ESH) protocol [18].
Of these, the AAMI standard is the most straightforward. Using this standard,
85 subjects should be examined and the error between the BP of the measurement
device under test and the gold standard sphygmomanometer should not differ by a
mean of± 5 mmHg or should not have a standard deviation greater than 8 mmHg.
There are few instances in the literature when adherence to the requirement
of 85 subjects is satisfied, due to the practical implementations of such a test.
Essentially this means that if any of these test results were actually submitted
to the AAMI, they would fail. However, applying the standard to any tests with
fewer subjects can give a good indication of performance.
The BHS standard is a little more complex and grades results in terms of their
accuracy. This is presented in Table 2.1. In this standard both a grade A or grade
B is considered a pass while a grade C or D is a fail. For a device to achieve a
grade A, 60% of its measurements, when compared to the gold standard, have to
have a mean error of less than 5 mmHg, 85% of the measurements have to have
an error less than 10 mmHg and 95% of its measurements have to have an error
less than 15mmHg, and so on.
Table 2.1: A summary of the British Hypertension Society (BHS) standard which
uses percentages of total error of values falling within 5, 10 and 15 mmHg, based
on the system for assessing BP measurement accuracy, a rating of “B” is deemed
acceptable, while a rating of “C” is deemed a fail.
Grading % < 5 mmHg % < 10 mmHg % < 15 mmHg
A 60 % 85 % 95%
B 50 % 75 % 90%
C 40 % 65 % 85%
D Worse than C
The final standard is the European Society of Hypertension (ESH) International
Protocol for validation of BP measuring devices. This is the most complex of
the three standards and uses lessons learned from the BHS and AAMI standards.
The aim when creating this standard was to make it more practical for smaller
companies to be able to validate their devices because both the BHS and AAMI
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standards require a large data set to be tested with a large variance of BP across
all the subjects. This makes any new device very expensive to validate.
The ESH standard is very detailed on how the validation should be carried out.
The ESH standard uses a categorisation system similar to the BHS standard to
evaluate the device. However, it is far more detailed about procedures and thus
more complex.
Each of the standards described in this section were developed with intermittent
or cuff measurements in mind and this presents some problems when trying to
evaluate a continuous beat to beat system. Although the AAMI standard and
BHS standard can be applied to a continuous monitoring system, it was felt
that due to the limitations in the ESH standard with regard to its measurement
methodology, and its explicit descriptions of procedure with regard to observers
and subjects, it would not be appropriate for this suite of tests. It should be
noted that Appendix C of the ESH standard [18] recommends that continuous
or beat to beat devices should be compared to intra-arterial measurements but
states that it is not appropriate to use this standard when a new device is being
compared to intra-arterial BP measurements, something which is undertaken in
Chapter 5. A full explanation of the ESH standard is available in Appendix B.
However, it should be noted that the ESH standard was not applied in any of the
tests in this project for reasons also outlined in Appendix B.
2.3 Auscultatory Techniques
In 1905, Nikolai Korotkoff published his thesis regarding measuring BP in animals
using a sphygmomanometer, a stethoscope and a Riva-Rocci sleeve [5] and this
method became known as the “Auscultatory Technique”. This method formed
the basis of a BP monitoring technique that is still used worldwide today and is
considered by many to be the “gold standard” for non-invasive BP measurement
[8]. The technique involves inflating a pressure cuff placed on the brachial artery
to ≈ 30 mmHg above systolic BP, so that the brachial artery becomes occluded.
While the pressure cuff is slowly deflated at a rate of 2 - 3 mmHg per heartbeat
[5] , the operator uses a stethoscope to listen to arterial sounds as the pulsatile
blood flow is re-established. The sounds associated with this measurement have
been classified in one of five phases based on their intensity as follows:
• Phase I: Appearance of clear tapping sounds corresponding to a clear pal-
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pable pulse
• Phase II: Sounds become softer and longer
• Phase III: Sounds become crisper and louder
• Phase IV: Sounds become muﬄed and softer
• Phase V: Sounds disappear completely.
Phase I corresponds to systolic pressure and the pressure at which Phase V occurs
is said to be the diastolic pressure. There is agreement that the systolic pressure as
measured by this method generally underestimates the pressure when compared
to a direct intra-arterial measurement, while the diastolic pressure given by the
“Korotkoff sounds” is generally higher than that of a direct measurement [19].
These phases and the related cuff pressure measurement is shown in Figure 2.1.
Figure 2.1: A graphical representation of the arm while listening for Korotokoff
Sounds using an inflatable cuff [20]
2.3.1 Improvements to the Auscultatory Technique
There have not been any major changes to the Korotkoff principal since its first
proposal in 1905 or in its first use on humans in 1932 by von Bonsdorff. In 1911
the sounds were characterised into the five phases as described above by Goodman
and Howell [21]. However, the sphygmomanometer has been improved since its
first use along with the techniques used for analysis. Mercury sphygmomanome-
ters have always been considered the “gold standard” for BP measurement and
have changed very little in the past 50 years, the major difference being that
those now in use are less likely to spill mercury if dropped. An example of a
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typical mercury sphygmomanometer is shown in Figure 2.2. One of the major
advantages of the mercury sphygmomanometers is that they are of a simple de-
sign and so are less prone to faults. Furthermore, there is negligible difference in
the accuracy between different brands [5].
Figure 2.2: A “gold standard” mercury sphygmomanometer [22].
Other improvements have been implemented since its first use. Among these are
a set of guidelines as to how measurements should be taken [5]. These guidelines
include what size the cuff should be in relation to the arm, where the cuff should
be placed, how the stethoscope should be held and perhaps most significantly
the phase at which the diastolic pressure is measured. Prior to 1988, it had been
recommended that Phase IV sounds should be adopted for the measurement of
diastolic BP. However, since Phase V is more easily identifiable, this is what is
usually used and accepted in literature as the gold standard [6].
Aneroid sphygmomanometers are an alternative to mercury ones; however, they
must be calibrated frequently to avoid errors. Aneroid sphygmomanometers use
a mechanical system of metal bellows that expand as the cuff pressure increases
to register the pressure.
2.3.2 Significant Advances
Electronic sphygmomanometers have been used in some cases. These new ma-
chines use microphones to hear the sounds disappear or an oscilloscope which
senses motion from the occluded artery in order to record BP [23]. These elec-
tronic sphygmomanometers are usually inflated and deflated automatically and
went some way to address the concerns that using a syphgmomanometer with a
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stethoscope is a subjective measurement because it relies on the operator “hearing
sounds” [4] and can vary from clinician to clinician.
2.4 Oscillometric Method
In 1876, a French physiologist, Etienne Jules Marey, first used the oscillometeric
method for non-invasive BP measurement. This method uses the amplitude of
cuff pressure oscillations to measure BP [24].
2.4.1 Origins of the Oscillometric Method
In a similar way to the “Auscultatory method”, the cuff is first inflated to such
a pressure that the artery becomes occluded. As the pressure in the cuff is de-
flated, a sensor registers the onset of oscillations that originate from the blood
starting to flow through the arm again. The amplitude of these oscillations in-
crease steadily until they reach a maximum, when the cuff pressure equals the
Mean Intra-Arterial Pressure. The oscillations begin well above systolic pressure
and continue to well below diastolic pressure so these pressures can only be deter-
mined using specific fractions of the maximum oscillation amplitude and the cuff
pressure. These fractions are known as characteristic ratios. The characteristic
ratios vary between manufacturers and the algorithms used to calculate BP are
not divulged by any of the manufacturers. This causes significant differences in
reading between equipment from different manufacturers [6].
2.4.2 Improvements to the Oscillometric Method
Since the oscillometric technique does not rely on the detection of Korotkoff
sounds, it is much simpler to use this technique to measure BP than the ausculta-
tory method. For this reason, the oscillometric method is the favoured one among
ambulatory and home BP measurement systems. Furthermore, the readings are
taken automatically and do not require subjective judgement or perceptions from
an observer. These home and ambulatory BP measurement systems generally
show good agreement with the auscultatory methods and many have been shown
to adhere to the standards provided by the AAMI and BHS. A comprehensive list
of these systems is available at Dabl Educational [25]. Figure 2.3 shows one of
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the most highly recommended oscillometric BP Monitors from the Dabl database,
the Omron M6.
Figure 2.3: The Omron M6 Oscillometric BP Monitor [26].
2.5 Tonometry
Tonometry is an alternative method for measuring BP compared to the two pre-
vious techniques. Historically, tonometry has been used to measure intra-ocular
pressure. In this application, a sensor is placed on the eye, and the intra-ocular
pressure is determined by the force that is required to flatten a given area or a
measurement of the corneal indentation produced by a given weight loaded rod
[27]. Figure 2.4 shows an example of this type of system where the end of a
small handheld probe is pressed against the eye. The tip of the probe carries
a pressure-sensitive area approximately 1 mm across. If the eye is momentarily
flattened to beyond this sensitive area, the only pressure that will be recorded is
the intra-ocular pressure of the eye [27].
When tonometry is used in the area of BP measurement, it is usually known
as applanation tonometry, radial tonometry or arterial tonometry. Applanation
tonometry has the desirable characteristic of not having an occluding cuff but
does have an inflatable component. In this application, the tonometer comprises
of a small cylinder with an opening on one end. This is the part that will be
in contact with the skin. This opening is covered by a flexible diaphragm and
inside the cylinder there is a saline solution [28].The diaphragm is then placed in
contact with the skin typically over the radial artery as shown in Figure 2.5.
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Figure 2.4: A simplified diagram of the tonometer [27].
(a) Cross Section of the tonometer
before inflation
(b) Side view of the tonometer before in-
flation
(c) Cross Section of the tonometer
when fully inflated
(d) Side view of the tonometer when fully
inflated
Figure 2.5: A cross section a side view of the tonometer before and during occlu-
sion of the artery
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The amount of saline fluid in the cylinder can be controlled using a syringe or
other automated method. The cylinder is divided into small compartments, each
compartment running from the top of the cylinder to the diaphragm and each
compartment has an electrode pair. The volume of saline in the cylinder is mea-
sured by an impedance plethysmograph, which injects a small current between
the electrode pair in that compartment and into the liquid and depending on
the resistance measured, can determine its volume. Since the volume changes
with the deflection in the diaphragm when it is placed over an artery, the vol-
ume change in the artery is reflected in the volume change in the compartment.
A pressure sensor is also present in each compartment to measure the pressure
exerted by the artery on the diaphragm [29].
Once the device is in place, the volume of saline in the cylinder is increased by
injecting more saline into the cylinder, thus compressing the radial artery over
the radial bone to reduce the effects of intervening tissue, damping effects and ar-
terial wall stress. This is the equivalent of compressing the eye with the flattened
surface of the transducer as shown in Figure 2.4 and this procedure is known as
an applanation sweep and is illustrated in Figure 2.6. Just as in oscillometric
cuff measurement, in tonometry the maximum arterial compliance occurs at zero
transmural pressure. This level of artery compression results in maximum pulse
pressure at mean arterial BP. When additional pressure is exerted, the artery
begins to occlude and the signal amplitude is reduced. Since many factors im-
pact the maximum pressure, this pressure needs to be identified using multiple
measurements [30].
Figure 2.6: A representation of the applanation sweep used to detect the arterial
waveform for BP measurement [31].
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2.5.1 Current State of the Art Tonometers
One persistent feature and shortcoming of tonometers that has been observed is
that it can be quite difficult to align the sensor exactly with the artery when
using only a single transducer. Therefore, multiple compartments are used in
an attempt to guarantee that at least one of the transducers will be positioned
correctly [32].
In general, tonometers have shown good agreement to arterial BP. Kemmotsu et
al [32], with support from Colin Electronics Company, used an intra-arterial line
and compared the results from this to the Colin CBM-3000 tonometer using 28
patients under anaesthesia. The results showed good results and good correlations
between the two devices for systolic ( r = 0.78, r2 = 0.61), mean ( r = 0.81, r2 =
0.66) and diastolic pressures ( r = 0.70, r2 = 0.49), although there is no mention
of compliance with standards in their publication.
Nair et al [33] tested 89 subjects in line with the ESH, and AAMI standards,
outlined in section 2.2. The tonometer used was a HealthSTATS BPro and the
readings from this was compared with a sphygmomanomter and an oscillometric
cuff, (the HealthSTATS MC3000), in line with the ESH standard. The results
showed that this device met the accuracy criteria for both the ESH and AAMI
standards.
Dueck et al [30] investigated the TL-200, a third generation tonometer from
Tensys using 19 subjects. The TL-200 has the advantage of being able to auto-
matically adjust its pressure sensor to the optimal position to achieve maximal
pulsation. The recorded data was then compared to measurements taken by an
intra-arterial catheter. The results showed good correlation between the two de-
vices with Systolic BP ( r = 0.93, r2 = 0.86), Mean BP ( r = 0.93, r2 = 0.86) and
Diastolic BP ( r = 0.89, r2 = 0.80). This study also showed that the TL200 would
pass the AAMI standard for each of systolic ( 2.3 ± 7.8 mmHg), diastolic ( 1.7 ±
6.2 mmHg) and mean ( 2.3 ± 5.9 mmHg) BPs, when the AAMI standard was ap-
plied, but that it continuously failed the BHS standard for all three analysed BPs.
Dueck noted that the number of subjects that they used needed to be increased
in line with the standards, vasoactive drugs should be introduced to the study
and a greater range of pressures need to be examined. However, he states that
the device can be recommended as a non-invasive beat-to-beat device for hemo-
dynamically unstable patients during general anaesthesia and surgery based on
the results obtained in this study. However, Dueck does state in the “conflict of
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interest” section of this paper that he had received funding from Tensys Medical
Inc for this study.
Weiss et al [34] found considerably different results when comparing the Colin
SA-250 tonometer to a radial artery catheter using 22 high risk surgical patients.
During the same investigation an oscillometric BP monitor, BP-508, was also
compared to the catheter. The results showed a good correlation between both
the catheter and tonometer and catheter and cuff, but the correlations for the cuff
were found to be better than the tonometer. Using the oscillometer the following
correlations were found: Systolic BP r = 0.83 (r2 = 0.69), Diastolic BP r = 0.90
(r2 = 0.81), Mean BP r = 0.92 (r2 = 0.85). Using the tonometer the following
correlations were found: Systolic BP( r = 0.80, r2 = 0.64), Diastolic BP (r = 0.77,
r2 = 0.59) , Mean BP (r = 0.84, r2 = 0.71). The conclusions of this study were
that, compared to a catheter, intermittent measurements using a oscillometric
BP meter provided more accurate arterial pressure monitoring measurements,
whereas the tonometer offered a reliable trend indicator of pressure. It should
be noted that the subjects in this study were high risk surgical patients and this
may have affected the results.
The Vasotrac system is a modified tonometer and does not require the frequent
calibrations needed by other tonometers. However, it does not provide beat to
beat BP with arterial waveform display. It has been compared with both a non-
invasive (oscillometeric) meter and an arterial catheter with good results. In their
paper Belani et al [31] tested the Vasotrac system using these devices to analyse
the accuracy of the device using 54 volunteers. Out of these 54, 11 were given
vasoactive drugs to alter their BP to test the accuracy and ability of the device
to track induced BP changes. In the 43 volunteers who were not given drugs, the
results showed that the Vasotrac measurements were highly correlated with the
Systolic BP (r = 0.94, r2 = 0.89), Diastolic BP (r = 0.94, r2 = 0.88) and Mean BP
(r = 0.97, r2 = 0.94). These results also showed that 90% of the recorded errors
were less than 5mmHg. In the remaining 11 volunteers similar results were found
compared to the other 43 volunteers with high correlations again of Systolic BP
(r = 0.91, r2 = 0.82), Diastolic BP (r = 0.94, r2 = 0.89) and Mean BP (r = 0.98,
r2 = 0.96).
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2.6 Vascular Unloading Technique
The vascular unloading method is another method that has evolved from Marey’s
work in 1876 [2]. This method was first specified by Shirer [35] and can be
explained as follows: changes in the volume of blood vessels that arise due to intra-
arterial pressure can be countered by an external pressure to maintain a constant
pressure in an unloaded state. This can occur because tissue can be assumed
to be essentially incompressible and therefore an externally applied pressure is
transmitted directly onto the underlying vessels where it results in an altered
transmural (external minus internal) pressure. If the external pressure exceeds
the internal pressure, the vessel collapses. When the external pressure equals the
internal pressure, the vessel is said to be in an unloaded state. This allows the
indirect measurement of the intra-arterial pressure [36].
Using this concept in 1973, Jan Peñáz, a Czech physiologist proposed a non-
invasive BP monitoring method [37]. His technique involved the use of a trans-
parent finger cuff, a photoelectric plethysmogram and pressure controller. The
photoelectric plethysmogram (PPG) measures blood volume changes in the fin-
ger. As the BP increases, the volume of blood in the finger increases and therefore
the output of the PPG also increases linearly. The PPG controls the pressure
controller at the base of the finger using a measurement and feedback system. As
the volume of blood in the finger increases, the PPG responds by increasing the
external pressure to counter these volume changes through adjustments of the
pressure controller. By repeating this procedure rapidly at a rate of 40-60Hz, the
vessels are kept in a constantly unloaded state and the pressure measured in the
cuff corresponds directly to the intra-arterial pressure.
2.6.1 Finapres
In 1985, van Wesseling first commercialised the Peñáz method using the name
Finapres (FINger Arterial PRESsure) [38]. The value of this system was quickly
recognised because it was the first system to provide a reliable measurement of
the beat-to-beat BP measurement in a non-invasive manner [39]. The major
changes implemented from the original Peñáz method were: the Finapres PPG
light sensor was mounted directly onto the skin, whereas the Peñáz method had
the light sensor mounted in such a way that the light had to pass through the
inflatable cuff as well as the skin. This resulted in the motion artifacts being
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greatly reduced.
The original design also had an electro-pneumatic transducer which consisted of
an electrically controlled valve which controlled the amount of air shunted to the
finger cuff. This was a severely restricting factor in the operation of the instru-
ment because it limited the speed with which the cuff could be inflated. The
Finapres used a dynamic compressor which consisted of an air bellows controlled
by a linear motor. This allows pressure changes to be introduced by an order
of magnitude faster than the original. As the Finapres became increasingly ac-
cepted, a substantial number of studies were carried out in an attempt to verify
its accuracy and precision. One of the first of these studies was by Kurki in 1987
[40] who studied 50 men during surgical operations and found that the device
had a high accuracy when compared to intra-arterial methods. These studies
continued and by 1998 the accuracy of the Finapres was broadly acknowledged
[41].
The Finapres, has subsequently been replaced by a newer device known as the
Finometer. The differences between the two include: the signal from the Fi-
nometer is digitally filtered, to reconstruct the brachial artery waveform and;
a correction algorithm is applied to compensate for the pressure gradient along
the arm arteries [42]. Although very accurate and reliable, the Finometer differs
from other BP monitors described in this chapter, as it is quite big and is more
comparable to a bedside monitor rather than the smaller devices that have been
previously discussed. However, the Finometer’s sister product, the Portapres,
shares both the technology and reliability of the Finometer, but is a portable and
more appropriate device for comparison.
2.6.2 Portapres
The Portapres was introduced to the market in 1991 as a portable version of the
successful Finapres product, described above. Additional functionality was added
to enable the device to become portable. Systems were added to record signals
on tape, a second finger cuff and additional circuitry was added to correct for the
hydrostatic height of the hand. The Portapres is also operated from a battery
[43]. The second finger cuff, which is shown in Figure 2.7, is an attempt to reduce
venous congestion and the two cuffs are used alternately for 30 minute periods
throughout the measurement time.
The Portapres has been shown to be valuable since its introduction due to its
Development of a Novel PTT Based
Algorithm
22
2.6 Vascular Unloading Technique
Figure 2.7: The Portapres device from Finapres with the associated finger cuffs,
their servo controller and 5kg belt. Image taken from [44]
portability and has been used in many studies to monitor sleep apnoea. It has also
been compared favourably with the Finapres and has shown good results when
compared with an intra-arterial BP monitor. The Portapres is also recommended
for 24 hour BP monitoring [45]; however, it has been observed to be quite heavy,
weighing 5 kg and cumbersome, as shown in Figure 2.7. Given its size, the
Portapres is unsuitable for most home monitoring and AAL situations but is a
very useful research tool.
2.6.3 Other Peñáz Implementations
The Nexfin monitor [46] is another system which implements the Peñáz method
to measure BP and bears a lot of similarities to the Finometer line of devices. It
has been suggested that the Nexfin is an evolution of the Finometer; however, the
Nexfin monitor does not require a cuff monitor for recalibration [46]. The Nexfin
has also been widely recognised as being accurate and numerous tests have shown
that the monitor has an acceptable error [47] and is within the standards across
various implementations [48, 49, 50]. It should be noted however, that although
Schattenkerk et al [49] claim that the Nexfin monitor is within the standards in
their paper, the results that are presented in the paper indicate that, without
some adjustments, the Nexfin monitor is outside the AAMI standards. Although
these required adjustments are clearly detailed within the paper, all presented
data within the paper that do not have these adjustments exceed that AAMI
standard. However, in the other studies outlined here, it has been shown that
the Nexfin monitor is within the AAMI standards, although it has been shown
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not to pass the ESH standards in a pregnant population [51].
Tatara [52] has also developed an “in ear” Peñáz based BP measurement system.
The ear was chosen as the arterial location for two reasons:
• The height above the heart remains relatively constant, especially in con-
trast to the arms where the height is unpredictable and is the typical loca-
tion of the sensor
• The temperature in the ear reflects changes in the core body temperature
more closely than the arms
Evaluating the device on 7 test subjects it was found that the mean error and
standard deviation was 3.4 ± 9.9 mmHg which is outside the AAMI standard.
2.7 Pulse Transit Time
Since the beginning of the 20th century, there have been many attempts to relate
the pulse to blood pressure. During cardiac systole, blood is pumped into the
circulatory system and a pressure wave is propagated away from the heart. The
velocity of the propagation is dependent on numerous factors, one of which is
the arterial wall stiffness which affects the speed of the wave. Pulse Transit
Time (PTT) is defined as the time it takes the wave to propagate from the heart
to a specified point on the body, typically the finger. This time is related to
the propagation velocity of the pulse wave [53]. PTT is also sometimes referred
to as Pulse Arrival Time (PAT), but these are different parameters which are
unfortunately used interchangeably, depending on whose work is being reported.
The difference between the two parameters is the PAT takes account of the Pre-
Ejection Period (PEP), which represents the isovolumetric contraction time of the
heart, i.e. the time it takes for the myocardium to raise enough pressure to open
the aortic valve and start pushing blood out of the ventricle [54]. Conversely,
PTT generally does not account for the PEP or anything else which may affect
the signal.
There have been many investigations that attempt to relate PTT directly to BP
[55, 56, 57, 58], and many authors have found that there is a relatively high
correlation between PTT and BP, usually r > 0.7 although this can vary by
a significant amount depending on how PTT is defined, as shown by Hennig’s
PTT review, where a difference in correlation coefficients of up to ∆r = 0.23
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Figure 2.8: The various PTT definitions and other characteristic points defined
in this review.
Table 2.2: A brief explanation of the characteristic points shown in Figure 2.8
Point of Interest Name
1 Foot / Onset of Wave
2 Point of Inflection
3 Peak
4 50% of Peak
5 23 Pulse Width
6 Relative Amplitude Second Peak
7 Width of 12 Pulse Width
8 Point of Maximum Inclination
9 Systolic Upstroke Time
10 Diastolic Time
has been reported between authors [53]. The general definition states the PTT
as the time for the pulse wave to reach a second arterial location i.e. the finger.
However, how/when this arrival is defined is the subject of a considerable amount
of debate. When the finger, ear or toe is used as the second arterial location, the
photoplethysmograph is normally used to detect the arrival of the pulse wave.
Table 2.2 provides the name for each of these points and Table 2.4 provides a
full explanation of each point and a summary of some the authors, discussed
here, who use each. Perhaps the easiest location in this signal to use is the peak
(Point 3 in Figure 2.8), because it is the most easily defined. Another favoured
part of the curve is the foot of the PPG wave (Point 1 in Figure 2.8). Many
authors have reported that using this provides a better correlation between PTT
and BP [57]. Other points that are used are the point of maximum inflection
[56] (Point 2), the systolic time and diastolic time [56, 59] (Points 9 and 10),
the point of maximal slope, derived from a continuous wavelet transform, [58]
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(Point 8) and various widths of the wave [60, 56, 59], all of which provide varying
levels of success and correlations. During these studies it was also common for
both systolic and diastolic BPs to be investigated and each value correlated to
PTT and these studies have established that SBP and DBP each show strong
correlations to different locations on the PPG wave.
Masé [61] used a linear regression technique on each individual studied to relate
BP to PTT. Using this technique Masé found inverse correlation values of r2 =0.89
and 0.78 for systolic and diastolic BP respectively using 33 different individuals.
The period of the test lasted 30 minutes and included 5 minutes of rest followed
by 3 minutes of cycling followed by two minutes of rest, repeated 4 times, followed
by 5 minutes of rest. PTT was recorded during the two minute rest periods, while
the subject sat on the exercise bike.
Hassan [62] also used a linear regression technique on 10 individuals, each test
lasting 45 seconds across 3 different conditions: rest, exercise and recovery. Has-
san found the maximum recorded value for the mean and standard deviation
between the cuff and PTT method was 5.72 ± 8.90 mmHg from these 10 indi-
viduals. However, most individuals provided lower valued means and standard
deviations than these maximum values. Although this result is quite promising,
more subjects need to be recorded with a wider range of BPs for the technique
to be confirmed according to the standards.
Although the specific definition of PTT is open to debate, a related parameter,
Pulse Wave Velocity (PWV), measured in m/s, is better defined and it forms
the basis for all PTT methods, regardless of how the PTT is actually measured.
Moens and Korteweg in 1878 [21, 63] first derived a mathematical equation which
related PWV to the elasticity of the artery E (Young’s modulus) [m−1kgs−2], its
diameter d[m], the thickness of the wall t[m] and the density of the blood ρ
[kg/m3], given below by equation 2.1.
PWV =
√
tE
ρd
(2.1)
Using some simplification, substitution and manipulation, as can be found in
Sorvoja [21], PWV can be expressed as:
PWV = K
PTT
=
√
tE0eγP
ρd
(2.2)
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Where E0 is the elastic modulus of the artery at zero pressure [m−1kgs−2], P is
the BP (mmHg), γ is a coefficient ranging from 1.6×10−2 to 1.8×10−2 [mmHg−1]
and K is a proportionality coefficient [m], indicating the specific distance for the
pulse wave to transit within time t[s] at velocity v[m/s], according to Chen [14].
This equation is the basis for all work that has been performed with regard to
PTT or PWV in respect of BP. Most authors who have developed PTT based
algorithms have manipulated this equation further and these modified equations
and the reasons for using each of them will be outlined in the next section.
Shriram et al [64] used the Moens Korteweg equation directly as presented in
equation 2.2 in their investigation into the use of the PTT method to monitor
BP. They found a correlation of r = 0.983 between the PTT method and both
the automatic BP measurement machine that they used (which was not specified)
and the sphygmomanometer, measured from 23 healthy volunteers. The mean
and standard deviation between the PTT method and the automatic machine
was found to be 0.52 ± 3.3 mmHg, which is well inside the AAMI standard.
However, it is unclear whether the use of calibration intervals was investigated
and the duration of the these examinations is not specified either.
More recently, there has been a considerable investigation into the measurement
of PTT via ECG and Modulated Magnetic Signature of Blood (MMSB) which
is detected using Giant Magneto Resonance (GMR) sensors. MMSB is the term
applied to the method of blood pulse and flow monitoring where a uniform mag-
netic field is applied to the skin in close proximity to a major blood vessel. The
uniform magnetic field from a permanent magnet will create a magnetic field that
encompasses skin, fabric and blood vessels. If there is no change in any of these
parameters, a DC magnetic field will be received by the nearby GMR sensor.
However, due to the pulsatile nature of the blood flow in the arteries, the uni-
form magnetic field is disturbed which is then detected by the GMR sensor [65].
This waveform can be then used, in conjunction with an ECG sensor, to measure
PTT, in place of a regular PPG sensor [66]. The advantage of this system is that
it is a planar device and thus can be placed near any major blood vessel. Phua
has investigated using the MMSB system in place of a PPG sensor to measure
PTT for BP acquisition [67]. BP was recorded from 10 individuals and then com-
pared to the estimated BP derived from the system and an adaptation of Fung’s
algorithm [58]. The exact procedure that is followed is unclear but Phua claims
that the measurement of MAP provided by their system has errors of less than
8% when compared to a traditional oscillometric BP monitor.
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Another device, known as a Ballistocardiograph (BCG), has also been investi-
gated to be used as part of a PTT system. A BCG measures the body’s mechan-
ical reaction to the blood ejected during the systole and can be measured using
either a low friction bed [68] or an accelerometer placed on the head [69]. Using
a BCG with an ECG, it has been suggested that it is possible to measure PEP
[70], however most studies have investigated using the BCG and PPG to measure
PTT [71, 72]. Chen’s paper in 2013 [72] uses a BCG and PPG to measure PTT
and, by developing a linear regression model, have produced an algorithm which
allows measurement of DBP within the AAMI standards. However, using this
technique, the SBP was outside the AAMI standard. It is also unclear how many
volunteers were used, but these results seem to be based on five measurements.
2.7.1 Chen’s Significant Contribution to the PTT method
Since the original concept by Moens-Korteweg, many researchers have investi-
gated both the relationship between pulse wave velocity, human arterial extensi-
bility and the relationship between PWV and BP. During the period between the
1960’s and the 1980’s, researchers found statistically significant relationships be-
tween PTT and either systolic BP, diastolic BP or Mean Arterial Pressure (MAP)
[73]. However, the breakthrough came in 2000, when Chen [14] et al proposed
a method based on measuring the beat-to-beat time interval between the QRS
apex in the ECG signal and the onset of photoplethysmogram in an oximeter
sensor placed on the finger tip.
Chen simplified the relationship between BP and PTT to the following:
Pe = Pb − 2
γPTTb
∆PTT (2.3)
Where Pe is the estimated BP, Pb [mmHg] is the base BP measured at the begin-
ning of the measurement and PTTb [s] is the value of the PTT at the beginning
of the measurement and ∆PTT [s] is the change in the PTT. This can then be
further simplified and explained as:
Pe = Pb + ∆P (2.4)
If the changes in the wall thickness (t) and the diameter of the vessel with respect
to BP are negligible, and if the change in the arterial wall tonus (E0) is slow
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enough, the first term on the right hand side above can be regarded as constant
as long as the change in vessel elasticity in negligible, over a short period. This
means that over a short period of time, PTT can be linearly related to the change
in BP. Where Pb is the base BP level, and ∆P is the change over the base level.
Using this theory as a basis for their method, Chen developed his algorithm, which
uses two components, a High Frequency Component (HFC) and a Low Frequency
Component (LFC). During testing, Chen found that a linear relationship existed
between SBP and PTT if the data was filtered using a bandpass filter between
5.3 × 10−4 Hz and 4 × 10−3 Hz, varying with the calibration interval that is
used. Therefore, when a PTT measurement is recorded it is filtered and is known
as the high-frequency component. It should be noted that no other authors
reviewed have reported this relationship to be true and neither its derivation
nor the motivation for using it was explained in the original work. The lower-
frequency component (LFC) is derived from BP cuff measurements. The time
between these measurements was also the calibration interval. Using a linear
lookup table these measurements were interpolated at 1 Hz to form the LFC. At
each calibration point, the estimation was corrected and between the calibration
points, a combination of the higher-frequency component and LFC were used to
track changes in BP. Using this method, Chen obtained an accuracy of 0.97 ±
0.02 mmHg for SBP using 5 min calibration intervals.This result indicated that
BP changes could be tracked using PTT as long as the calibration measurements
were performed regularly and the elasticity of the vessels remained constant.
2.7.2 Significant Advances to the PTT Method
Since the initial work by Chen, the team of Zhang from the Chinese University of
Hong Kong has explored the topic extensively [59, 74, 75, 76]. Others outside of
this group have also worked on calculating BP from the PWV/PTT methods and
calculations, but Zhang’s group have followed Chen’s original work more closely.
Since Chen’s original paper, many researchers have examined the use of PTT
in an attempt to further his concepts. However, there are many inconsistencies
in the studies in this area. The most prominent of these is how to define and
measure PTT itself, as previously discussed.
There are also ongoing debates about whether the Pre-Ejection Period (PEP)
should be included as part of a PTT measurement. Payne et al [77] have reported
that the inclusion of PEP in the measurement of PTT makes the BP measurement
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unreliable; however, others have found good correlations by including PEP in the
measurement of PTT [57].
Ahlstrom [57] used an ECG, a PPG and a phonocardiogram to measure three
different transit times associated with the heart: PEP, VTT (time from first heart
sound to onset of peripheral pulse) and PTT. In this study, PTT was measured
from the peak of the ECG R-wave to the foot of the PPG signal. BP was recorded
using either an oscillometric cuff or via a catheter. Partial correlation analysis
was used to clarify the correlation between the transit times and BP. The best
correlation coefficients were found between SBP and PTT with r = 0.80 ± 0.06.
Although Ahlstrom used a phonocardiogram in an attempt to measure PEP, he
warned that it may not have been accurate because of the difficulty associated
with detecting the signal.
While basing her work on that of Chen, Poon [75], used an alternative method
to calculate SBP [mmHg] and DBP [mmHg]. Poon used a slightly different per-
spective when using Young’s modulus. Poon equated the rate of change of stress
to the difference between SBP and DBP in the arterial system. Substituting this
definition into the Moens-Korteweg equation shows that the difference in SBP
and DBP is inversely proportional to the square of PTT. Poon stated that mean
BP is often approximated as a third of SBP plus two thirds of DBP [78], SBP
and DBP can be estimated as:
DBP = SBP03 +
2DBP0
3 + A ln
PTTW0
PTTW
− (SBP0 −DBP0)3
PTTW0
2
PTTW
2 (2.5)
SBP = DBP + (SBP0 −DBP0)PTTW0
2
PTTW
2 (2.6)
This approach led to an accuracy of 0.6 ± 9.8mmHg for SBP and 0.9 ± 5.6mmHg
for DBP. The BP measurements were recorded using a Colin BP-8800, which
adheres to the AAMI requirements for BP measurements. The standard deviation
of the SBP in this review is slightly outside the recommended AAMI requirement
(8mmHg) but the standard deviation of the DBP of 5mmHg is better than the
AAMI requirement. In order to improve these results, it was suggested that the
equations should incorporate other factors which affect BP recordings while using
PTT, such as ambient temperature, contact force between the sensor and the skin
and arterial vascular properties. It should be noted that neither the measurement
Development of a Novel PTT Based
Algorithm
30
2.7 Pulse Transit Time
nor definition of PTT is included in the paper.
In 2008, Poon [74], investigated how the relationship between BP and PTT chan-
ges over time, in particular the number of heartbeats where the BP-PTT rela-
tionship with constant A (Equation 2.8) and B (Equation 2.9) will hold on a
subject. The investigation was based on the equation derived by Chen from the
Moens-Korteweg equation:
BP = A ln(PTT ) +B = A · PTTln +B (2.7)
Where A and B are subject dependent coefficients (both measured in [mmHg])
namely:
A = −2
γ
(2.8)
and
B = 1
γ
[ln(ρdK
2
tE0
)] (2.9)
The results of Poon’s study showed that beat to beat logarithmic PTT values
(PTTln) and SBP were highly correlated over a short period but the correlation
coefficient decreased as the number of heart beats increased. In fact, for the
data collected, it was found that this method needs to be recalibrated as often as
every 60 beats in order for 95 % of the cases to have a standard deviation within
9.4mmHg, if the optimum pair of A and B coefficients can be obtained for each
subject.
In the work of Yoon [56], ECG, PPG and BP was recorded from five subjects.
Eighteen seconds of data at the middle of the 60 second measurement were anal-
ysed in order to match the actual BP measurement time. These measurements
were recorded simultaneously with the subjects in a seated position after they
had rested for at least 5 minutes. Immediately after 100 step-climbing exercise
(each step was 21 cm high), more measurements were recorded as post-exercise
data in the same seated position. This measurement trial was repeated three
times during the same day. Each trial had at least 20 minutes rest to avoid
the exhaustion of the subject. The experiments were repeated for 5 days with
the same subjects. Five different parameters were measured from the ECG and
PPG signals. These were PTT from the ECG R peak to the PPG wave onset
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(PTT_foot), PTT from the ECG R peak to the maximum derivative point of
the PPG wave (PTT_dp), systolic upstroke time, diastolic time and the width
of 2/3 pulse amplitude (Points 1, 2, 8, 9 and 6 respectively of Figure 2.8). Linear
regression analysis was set up for the systolic and diastolic BP. The results of
this work shows that the PTT to a maximum first derivative point (PTT_dp) is
highly correlated with SBP (-0.712) and that the diastolic time had the highest
correlation with DBP (-0.764).
Gu et al [76] (who are part of the same group as Poon above) have also examined
the PTT / BP relationship. In their research study, they measured PTT during
rest periods and after periods of exercise and included a new parameter known
as the Relative Amplitude of Secondary peak of PPG (RAS), Points 5 of Figure
2.8. As with many of the other studies described in this review, the duration
of the examinations was not specified exactly but the method was shown to be
accurate, even after exercise with a mean error and standard deviation of -0.4 ±
5.3 mmHg.
McCombie [79] used a modified version of the PTT system that has been pre-
sented previously. In this system, Peripheral PTT was examined. In Peripheral
PTT the system consisted of two PPG sensors; one placed on the wrist; the other
placed on the little finger, thus giving the two arterial locations required for PTT
measurements. By examining hydrostatic pressure (defined to be the height at
which the pressure is measured relative to the heart [80]) along with PTT, Mc-
Combie developed a novel calibration method using the hydrostatic measurement
and an adaptive signal processing algorithm. Although only 7 subjects were used
in this investigation, the calibration constant derived using the hydrostatic pres-
sure almost matched that derived from the Finapres which was used as a gold
standard in his experiments.
Teng [59] examined four features of the PPG wave in an attempt to further the
PTT-BP relationship using 15 subjects. Teng however had some difficulty iden-
tifying the foot of the PPG wave and thus used a Continuous Wave Transform
(CWT) on the PPG wave to clarify this position. Using the results of this, Teng
examined the use of the width of 23 pulse amplitude, the width of
1
2 pulse ampli-
tude, systolic upstroke time and diastolic time (Points 4, 6, 8 and 9 respectively
of Figure 2.8). Correlation analysis was then performed and it was found that
the highest correlation was achieved when the diastolic time was used. Using this
feature, the PTT was calculated giving a prediction of 0.21 ± 7.32 mmHg for
SBP and 0.02 ± 4.39 mmHg for DBP.
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Lin et al [60] investigated the use of 3 different measurements based on the PPG
waveform as an alternative to the more usual PTT definition. The three mea-
surements were the duration from the ECG R wave to 50% of the PPG wave,
TR_50(i), the pulse width TW (i) (Points 2 and 6 respectively of Figure 2.8) and
the normalised pulse width TW (i)
TR_50(i)
. Using these measurements to calculate PTT,
Lin used linear regression on each PTT measurement and intra-arterial BP on
9 subjects and found the correlation between the results, each providing a mean
correlation value in excess of r = 0.73. A combination of these parameters and the
correlation results were then combined to create a new parameter SBPcombining.
This was found to be a good predictor of SBP when compared to the intra-arterial
measurement with a correlation r = 0.82. However, as noted in his paper, the
regression coefficients are needed and since these were calculated using the Arte-
rial BP, this means that this method cannot be classified as a non-invasive BP
measurement in its present form.
Muehlsteff et al [81] examined 18 volunteers in their 2006 paper which described
their investigations into the inclusion of PEP in the PTT measurement. PEP
was measured with a NICCOMO patient monitor and BP was measured using
an oscillometric monitor. Posture was also recorded using a 3 axis accelerometer.
PAT was measured from the peak of the ECG R wave and the foot of the PPG
wave (which was determined using a tangent to the uprising pulse) and PTT
was defined as PTT = PAT - PEP. Each subject was tested at rest, during
exercise and during recovery after exercise and the Moens-Korteweg equation
was used to relate PTT/PAT to BP. The results showed that when the SBP
changes due to exercise, the PEP has a higher influence on PAT measurements
than PTT. This shows the importance of PEP and how it dominates PTT in
short term stress tests. However, because of the Moens-Korteweg derivation
and its associated assumptions PEP cannot be excluded from the measurement.
Furthermore, because the true PWV is not available, a linear calibration function
was designed (based on the PWV) which gave a good estimation of SBP. This
calibration function included the length of the subjects arm and is defined as:
SBP = A · L
PAT
+B (2.10)
measured in mmHg and where A and B are defined in the Moens-Korteweg equa-
tion and L is the length of the subjects arm. When A and B are calibrated for
each individual, a mean RMS error of 3.9mmHg was found whereas if A was
averaged over all subjects and B was individually calibrated, an RMS error of
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6.9 mmHg was found. In the first case, it was found that it was possible to
achieve a better (lower) RMS error of 2.7 mmHg if a quadratic equation was
used, but this involved a more complex calibration procedure and was therefore
not implemented.
In 2008, Muehlsteff et al [82] repeated their experiment with a focus on the
effect that posture has on changes on PAT. Left Ventricle Ejection Time was
also monitored in this test, which complemented the measurement of PEP. A
further test outside of the lab was also performed using a wireless body sensor
network system, but in this test no BP was recorded. Results from these tests
show that posture changes have a significant subject-dependent effect on PAT
even at constant SBP and DBP. Specifically, it was found that if subjects rose
from lying to sitting or standing , their PTT increased and vice versa. It is noted
that for any PAT based BP measurement system, the effect of posture must be
taken into account. During stationary lab tests, each test subject should have
the same posture. It is also noted that hydrostatic effects should be accounted
for in any BP measurements.
2.8 Discussion
A variety of non-invasive BP measurement techniques has been presented in this
chapter. Although each technique has its advantages, three techniques provide
results which are superior to the others for long term 24 hour BP monitoring.
These are the Peñáz / Vascular Unloading method, the tonometric method and
the PTT method. These techniques are favoured due to their ability to monitor
BP without the need for an inflatable arm/wrist cuff. This feature is particularly
desirable in the area of BP monitoring for ambient assisted living, because an
unobtrusive nature and comfort to the subject have a major impact on the use-
fulness of any given system. Another valuable trait is that each of these systems
can be used to monitor short term changes in BP, something which the other
techniques cannot do [83].
Although the tonometric method also has the highly desirable feature of provid-
ing an arterial waveform, it has been noted that it is critical to the successful
measurement that the sensor is placed precisely over the radial artery. A few
steps have been taken to improve this, namely the use of multiple compartments
and the automatic adjustment of the sensors. However, this method is very sus-
ceptible to movement artifacts. The Tensys TL200 [30] is capable of eliminating
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many of these issues. However, in an attempt to compensate for these, the sen-
sor has become quite large and could be considered obtrusive, as can be seen in
Figure 2.9.
Figure 2.9: The TL200 tonometric BP monitor is capable of optimising the signal
quality but at the cost of its size and bulkiness. Image taken from [30].
While the vascular unloading method has been shown to be very accurate and
reliable and its comfort is much greater than previous methods, a number of
disadvantages remain associated with its use in AAL. The most obvious of these
is the size associated with the products that are most well known, used and
proven to be reliable i.e. the Finometer/Portapres. It is worth noting that the
Portapres name indicates portability rather than that the system is wearable. In
fact from Figure 2.10 it becomes apparent that the system is far from wearable and
could only be considered portable by the young and not by an ageing population.
Pickering et al [6] noted that the Portapres is “not suited to clinical use because
of its cost, inconvenience, and relative inaccuracy for measuring absolute values
of BP” and that “its greatest value is for research studies” Another concern when
using either the Finometer or Portapres is misapplication of the cuff, which can
lead to underestimation of MAP in the case of tight finger cuffs, or overestimation
in the case of loose finger cuffs [84]. Again, although both devices are known for
their reliability and accuracy, even the Portapres, shown in Figure 2.10, is quite
obtrusive and heavy and not practical for many applications where such monitors
are required i.e. in the area of ambulatory monitoring.
Shaltis et al are working on a system, based on the Peñáz method that can be
implemented and worn on the finger similar to a ring [86]. This ring sensor, and
indeed the Peñáz method in general, still requires an inflatable pressure cuff to
be worn on the finger. Although this ring based system would be much more
comfortable than previous implementations, the use of a pressure cuff, no matter
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Figure 2.10: The Portapres Device being worn during an exercise test with the
associated finger cuffs, their servo controller and 5kg belt. Image taken from
Finapres website [85].
how small, is undesirable. Another concern is that an inflatable cuff on the finger
may cause other medical problems if the cuff is worn over a long period.
It thus becomes evident that the most suitable BP monitoring technique is that
of the PTT method. Using this method, no inflatable cuff is required. In a
similar way to the work of Shaltis, the PTT system can be implemented on a
ring type sensor and an ECG worn on the chest. The PPG sensor can also be
redesigned to work at other arterial locations such as the ear. It is also possible
to use peripheral PTT measurements so that an ECG does not have to be worn.
Table 2.3, based on Peter’s paper [87], gives a good summary of the characteristics
of each of the BP measurement methods discussed in this chapter. Most of this
table is self-explanatory, but some points need to be expanded. The first of
these is with regards to the auscultatory method. This is described as being not
wearable, the reason being that although the sensor is wearable, since a doctor or
clinician is still required, it is not suitable as a wearable system when no doctor
or clinician is present. The wearability of the Peñáz method in this table is also
described as being questionable. The basis for this is that the system is quite large
and bulky as has been previously described and as is shown in Figure 2.10. There
are also questions about the accuracy and wearability of the tonometer in this
table. The inaccuracy is highlighted in Peter’s paper, where it has been noted
that as the duration of use of the tonometer increases, its accuracy decreases.
In a similar way, it is questionable if the tonometer can be described as being
wearable because it is prone to motion artifacts, potentially making it unsuitable
as a wearable device. Finally, it can be seen that the PTT method ticks the most
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boxes in this table, meaning it has the most potential to be the most suitable BP
measurement method. The only question marks that remain concern its accuracy.
Thus far, some PTT methods and algorithms have been found to be accurate but
these have not been independently validated. However, if it were possible to
either prove these methods to be accurate or if a new method was developed,
that was proven to be accurate, the PTT method would provide the best BP
monitoring solution. This table also highlights why the oscillometric method is
currently the most desirable and why it is the most used technique method by
doctors and clinicians.
Table 2.3: A summary of all the BP monitoring methods discussed in this chapter
Technique Continuous Accurate Wearable Cheap
Auscultatory X X
Oscillometric X X X
Peñáz X X ?
Tonometry X ? ? X
Pulse Transit Time X ? X X
The PTT method is still in its infancy though and there are a number of out-
standing issues associated with it. Among these issues is the major problem of
determining exactly how the PTT is measured and what the start and end points
of the PTT are. Throughout this review, a number of different approaches have
been used to define the PTT, including the distance between the peak of the R
wave and the peak of the PPG wave [88] and the R wave to the foot of the PPG
wave [89] among others summarised in Table 2.4 and Figure 2.8. There has also
been discussion as to whether or not the PEP should be included in the mea-
surement of PTT, with various authors saying it should [81] and others arguing
against it [77]. Another characteristic of the PTT method is that regular cali-
bration is required, as reported by Poon [74]. Ma [90] has also noted that “PTT
is influenced by multi-factors, such as Cardiac Output...and other cardiovascular
variables”. Regardless, BP as measured by PTT shows the most promise as a non
invasive, unobtrusive BP monitoring technique given the results published thus
far.
Although there have been many investigations into using the PTT method and
indeed, many authors have derived their own algorithms, most authors have not
stated the calibration intervals that are required. Furthermore, in some cases
neither the duration of the tests nor the duration of the recording of PTT was
provided. This makes comparisons between reported results difficult to perform
and evaluations of the practicalities such as those that have been examined here,
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Table 2.4: A summary of all the PTT definitions and other characteristic points,
that have been reported in this chapter
Point of
Interest
Name rSBP rDBP Author
1 Trough
0.88 0.77 [57]
0.65 0.25 [56]
[54], [89], [59]
2 Point of Inflection 0.71 0.42 [56][76], [61], [54],
[74]
3 Peak [14], [62], [54],
[63]
4 50% of Peak 0.79 [60]
5 23 Pulse Width
0.32 0.38 [56]
[59]
6 Relative Amplitude
Second Peak
[76]
7 Width of
1
2 Pulse
Width
0.73 [60]
[59]
8 Point of Maximum
Inclination
[58]
9 Systolic UpstrokeTime
0.60 0.66 [56]
[59]
10 Diastolic Time 0.60 0.76 [56][59]
also are quite difficult. However, since most authors admit that the PTT method
is only accurate over short periods, a similar outcome to that of this thesis can
be expected and it is suggested that other cardiac parameters may need to be
included to extend the calibration intervals that would allow for accurate tracking
of BP over extended periods of time.
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Chapter 3
Evaluation of the Pulse Transit
Time Method
3.1 Introduction
In this chapter the evaluation of the Pulse Transit Time (PTT) method and
how it has been implemented in this work is discussed. The chapter begins with
a discussion of the Tyndall 25mm Development Platform. This platform was
used as a basis of the system that was required to make PTT measurements,
starting with the hardware and then progressing from there to the middle-ware
and software for data acquisition.
The next section discusses the development of the PTT acquisition algorithm and
the steps that were necessary to implement it. This begins with an analysis of the
electrocardiograph (ECG) waveform and the relevant characteristic points of each
of its components for this project. These points were extracted and incorporated
into the PTT calculation as necessary. A similar approach was taken with respect
to the PPG waveform and using this, the PTT was measured.
The third section details the novel evaluation of the PTT method which would
establish the maximum calibration interval that was required for the PTT method
to remain accurate. Previous examinations of various algorithms typically only
tested the PTT method after certain short periods e.g 1 minute. However, this
examination evaluated the PTT methods across numerous intervals in an attempt
to evaluate the maximum period for which the PTT remained accurate or, in other
words, what was the maximum calibration interval possible from each algorithm
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that would allow that algorithm to remain accurate. First an evaluation of the
Moens-Korteweg equation is described followed by an evaluation of the two state
of the art PTT algorithms that are used to estimate Blood Pressure (BP), which
have been previously described. These algorithms were examined in an attempt
to identify the key parameters and the relationships which were most important
in relating BP and PTT which could later be used to establish a new algorithm.
Finally, the last section of this chapter identifies the shortcomings and limita-
tions of the algorithms that have been developed by other authors, from both
theoretical and practical perspectives.
3.2 The Tyndall 25mm Development Platform
Much of the hardware and middle-ware developed in this project are based on the
Tyndall 25mm development platform [91, 92]. This platform has been designed
for use as part of a Wireless Sensor Network (WSN) prototyping system and has
been used in a variety of different applications, from environmental monitoring
[93] to energy harvesting [94] and healthcare management [95]. An important
feature of this platform is its modular design which allows the rapid development
of specific systems for new application areas or research topics. Each node of this
platform generally consists of a wireless communicating layer, a microcontroller,
an energy source and a sensor, which are stacked on top of each other. Each layer
is designed as a 25mm × 25mm printed circuit board and layers are connected via
high density connectors. Therefore, if a new research topic is being investigated,
the design of only one such layer is usually required as the sensing layer.
Another benefit of the modular nature of the platform is that an extensive soft-
ware library is available along with the wide range of sensors. When a new layer
is designed, this software library can be modified, if necessary, to accommodate
the features of the new layer. However, due to the large number of devices that
have already been implemented, only minor modifications of code are usually
needed when a new system is designed and this allows rapid turnaround of the
prototype system. Once a prototype system has been implemented and evaluated
using the modular development protocol, a custom miniaturised and optimised
planar system can be developed for each specific application.
Development of a Novel PTT Based
Algorithm
40
3.3 The Development of a Pulse Transit Time Measurement System
3.3 The Development of a Pulse Transit Time
Measurement System
The following sections describe the system that was developed and used in the
measurement of PTT in this work. The hardware developed comprises of two
main components: the Physiological Health for Assisted Living (PHAL) board
(which contributes the ECG system) and the Pulse Oximeter, which was used
to detect the arrival of the pressure wave at the secondary location. The PHAL
board was developed as part of this project and has a number of sensors, most
importantly, from the perspective of this work, an ECG, to measure the initiation
of the PTT measurement. The Pulse Oximeter was a part of a system developed
in the WSN group and was part of the Tyndall 25mm platform family of sensor
systems, and both of the BP Monitors used in this work were commercial off the
shelf sensors which were purchased for this project for calibration and validation
of the tests that were carried out.
3.4 Development of the Physiological Health for
Assisted Living Board
The “Physiological Health for Assisted Living Board” or “PHAL Board” was
designed to be used as a system dedicated to monitoring the ECG signals that
were required for this project but would also allow it to be used as part of a BP
monitoring system. One requirement of the system was that it should be as small
as possible so that it could be worn unobtrusively. There are two reasons for this
• Comfort If a device is uncomfortable, a user will not wear it
• Social Perception It is important that any system which monitors some-
one’s health should be invisible and seen by the user as an enabler of well
being. Otherwise, it can be perceived as an identifier of someone who is
frail or sick [96].
Since this had been an issue with other previous assisted living systems, it was
also desirable that the system be wireless and have a long lasting battery life.
Although long battery life was a concern and it was necessary to pick the most
power efficient components possible, it was felt that the biggest gains for long
battery life could be achieved via duty cycling and other optimisations at a later
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stage if necessary.
3.4.1 Design Specification
Although the primary focus of this board was to be used in a PTT detection
system, an activity monitor was also included in the design which could also be
used to identify motion artifacts. The choices for an ECG system in this type
of application are discussed in detail in section 3.4.1.1. Two other components
were also crucial to the build and these were the communications interface and
the on board data storage facility. The requirement for communications is clear:
once the data has been recorded it is important that it be transmitted so those
monitoring the subject in an assisted living setting know that the subject is safe
and well. The second component is the on board storage facility. This is also
important in the case where live transmission of data is not possible and by having
a data storage facility, no data is lost.
3.4.1.1 Electrocardiograph
The ECG sensor was identified as the key component of the PHAL board. Due
to the wearable and unobtrusive requirements of the application, the minimum
number of electrodes that could be used for the ECG system that would retain the
accuracy and reliability would be the most desirable. The most accurate systems,
which allow a clinician to diagnose cardiac problems from ECG waveforms are the
twelve lead systems that are employed in hospitals. Although there are a number
of systems which employ a two electrode ECG approach, it has been found that
many authors recommend a three electrode system, because this allows greater
accuracy. The original design of the ECG circuitry, which is shown in Figure 3.1,
was based on the Tyndall designs outlined by O’Donoghue [97] and datasheets
such as the Analog Devices AD620 [98], which is an instrumentation amplifier,
which is commonly used as a basis for ECG systems.
One other specification that was identified by clinicians advising the project was
the specification of the physical dimensions of the board. Due to the wearable
nature of the board it was desirable that the board be as small as possible. Using
an existing ECG system, it was found that it was possible to record an ECG signal
if the patches were placed in the usual configuration, as specified by Einthoven’s
Triangle [12] and each electrode was at least 50 mm from each other. It was
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therefore decided that the minimum dimensions of the board should be at least
50 mm× 50 mm. This would allow each electrode to be directly attached to the
board and satisfy the 50mm requirement. The reason for this was that it had been
noted that other ECG systems had been designed as a single patch/bandage type
system. If it were possible to attach each of the three electrodes to the board and
manufacture the board with a flexible PCB, a similar system to that of IMEC’s
[99] could be presented. It was found that by increasing the size of the board to
a 50 mm× 80 mm, or a credit card sized board, the three electrodes could be
attached to the board without interfering with each other, as shown in Figure
3.2, with the studs/attachments of the electrodes being placed 5mm in from the
edge of the board.
Figure 3.2: By increasing the board to 50 mm× 80 mm, the three electrodes (in
white) could be attached to the board (green), using the studs on the electrodes
(grey) without interfering with each other or need for modification
3.4.1.2 Communications
There are many choices when it comes to implementing wireless communications
for this type of application. One of the most frequently used systems are the
Zigbee or IEEE 802.15.4 based systems, because of their low power consumption
and high data rate of communication. These have been used extensively for
various applications developed using Tyndall 25mm system and are the most
frequently used in similar body area network projects. Each of these systems
is available in the library and each one exists as a stand-alone layer. By using
these existing layers, design time and space required in the new system could
be minimised. Other choices for communication are Bluetooth, which shares the
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Table 3.1: Some of the Bluetooth options that were considered for this board
CSR Bluecore 5 RN 21/22 RN 41 WML C46 [102] LMX 9838 [103]
Version v3.0 v2.1 v2.1 v2.0 v2.0
Data Rate 300Kbps 3Mbps 1.3Mbps 704kbps
Range 100m 100m
Min. Supply Voltage 1.5V 3.0V 3.0V 2.8V 1.8V
UART Interface X X X X X
USB Interface X X X X X
SPI Interface X X X X X
I2C Interface X X X X X
Transmission Current 45mA 65mA 65mA 70mA 65mA
Receive Current 45mA 35mA 35mA 70mA 65mA
Module X X X X X
same frequency as Zigbee and IEEE 802.15.4 or another lower frequency, such as
433MHz or 868MHz, which would have greater range and be less susceptible to
detrimental RF effects associated with the body. The trade off of using a lower
frequency is that the data rate is much less.
However, the major advantage of using Bluetooth in this system is that it would
allow it to communicate directly to a mobile phone, most of which are now Blue-
tooth enabled. The primary advantage of this is that it would allow the system
to indirectly broadcast its data to a GP or send an alert in times of emergency.
With some modification, it could also potentially allow any signal manipulation
i.e. filtering, to be performed on the phone instead of onboard the system. With
this in mind a number of Bluetooth chips were considered as shown in Table 3.1.
It is clear from this table that the best system would be the CSR Bluecore 5
because it had the latest version of Bluetooth at the time and provided the
lowest transmission current. However, since it was not available as a module, it
is far less desirable, because this would require the design and manufacture of an
additional, custom antenna. The alternatives then were either the RN-21 [100]
or RN-41 [101] because these provided the newer Bluetooth versions, had the
next lowest transmission current consumption, the lowest overall receive current
consumptions as well as an antenna built in to the module. Therefore, it was
decided that the newer of the chips would be chosen i.e. the Roving Networks
RN-41 Bluetooth module.
3.4.1.3 Microcontroller Choice
The choice for the Microcontroller followed much the same procedure as that of
the Bluetooth module. Four microcontrollers were shortlisted after an extensive
review as can be seen in Table 3.2. Two microcontrollers, the Atmel Mega 128
[104] and 1281 [105] were considered because they had been previously imple-
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Table 3.2: Some of the Microcontroller options that were considered for this board
Atmel 128 Atmel 1281 MSP430 [109] XMega A1 [110]
Pin Count 64 64 100 100
Flash 128KB 128KB 128KB 128KB
ADC Resolution 10 bit 10bit 12 bit 12 bit
Min. Supply Voltage 2.7V 1.8V 1.8V 1.6V
Sleep Current 2.5 µA 0.1 µA 1.7 µ A 0.1 µ A
Operating Current 50 µA 10 µA 200 µ A 50 µ A
Size 16mm × 16mm 16mm × 16mm 16mm × 16mm 16mm × 16mm
Available Libraries X X X X
mented in designs using the Tyndall platform, the 1281 being an updated version
of the 128. The other two microcontrollers were considered because they were two
of the best microcontrollers that were used in similar systems and other embedded
systems that had been researched [106, 107, 108]. Each of the microcontrollers
had similar basic specifications although the XMega had many more features
than the others. However, in a similar manner to the Bluetooth choice, it was
decided that the Mega 1281 should be used for ease of compatibility with other
layers in the Tyndall 25mm collection of motes and since the software libraries
had already been developed and verified.
3.4.1.4 Activity Monitor
The original specification of the PHALs board was to include an activity monitor
to allow the system to be incorporated into an ambient assisted living systems.
This activity monitor could then be used as an activity monitor, a falls monitor
and could also be used to identify any potential motion artifacts. From reading
Noury [111] and Bourke [112] it became apparent that at the very least a three
axis accelerometer and a three axis gyroscope would be necessary to accurately
identify a fall. Therefore, an Inertial Measurement Unit (IMU) was incorporated
into the design that satisfied the specifications of Noury and Bourke, but also
that were in accordance to other work that was also concurrent in the group [113].
Using these three sources an accelerometer from Analog Devices (the ADXL345
[114]), two gyroscopes from Invensense (the IDG650 [115] and the ISZ650 [116])
and a tri-axis digital magnetometer from Honeywell (the HMC5843 [117]) were
implemented in the design, to be used as an activity monitor.
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3.4.1.5 Other Features
The PHAL Board has also incorporated the connectors available on the Tyn-
dall mote, which would allow additional sensors and communication layers to be
attached. Using the extra modules provided by the Tyndall Mote, the system
is also capable of transmitting data wirelessly and incorporating different sen-
sors depending on a given application. This allows a variety of possible wireless
transceiver systems (operating in the 433MHz, 868/915MHz and 2.4GHz ISM
Band) with embedded protocol software, depending on the requirements of the
user.
Peripheral components
• Storage There were two main options for storage of the data: either an SD
card or flash storage. Although flash storage has a number of advantages
with respect to size and power consumption it was decided that a Secure
Digital (SD) card would be preferable, because it is easier to read data from
it, without needing specialised equipment.
• Analogue to Digital Converter (ADC) The requirements for the Ana-
logue to Digital Converter were: at least 12 bits of resolution, 7 inputs (for
the gyroscope’s outputs: 3 for the 2000 deg/s outputs, 3 for the 440 deg/s
and 1 for the temperature sensor output [115, 116] ) and 1Mbps throughput
rate to follow the previous configurations. The ADC (AD7490) [118] from
Analog Devices was selected for use in the project. When all the necessary
connections had been made, it was found that there were an additional 5
ADC pins that were not required for any onboard sensors. It was therefore
decided to connect these extra pins to holes at the edge of the board that
could be used to add new sensors at a later stage if required.
• EEPROM An EEPROM was added in order to separately calibrate each
part of the IMU and store the corresponding calibration data. The 24AA128
from Microchip [119] was selected for this purpose because it exhibits low
power consumption, has a broad voltage range and comes in a variety of
package types. The chip communicates via an I2C interface.
3.4.2 Pulse Oximeter Board
The Pulse Oximeter used in this project had originally been developed for the
National Access Program [97]. The design of the Pulse Oximeter is well docu-
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Figure 3.4: The Manufactured PHAL Board.
mented, as outlined by Allen [120]. A Pulse Oximeter is used to measure the
amount of saturated oxygen in the blood. In general, two Light Emitting Diodes
(LED’s) are mounted within a finger cuff, one a Red LED with a wavelength about
660nm and the other a Near Infra-Red (NIR) LED with a wavelength of 940nm.
Depending on the design, a photodiode can either be mounted on the same side
as the LEDs (Reflective Design) or on the opposite side of the LEDs (Refractive
Design). These wavelengths were chosen because deoxygenated hemoglobin ex-
hibits higher absorption at 660 nm, whereas oxygenated hemoglobin exhibits a
peak absorption at 940 nm. Once the absorption levels are detected from each,
it is possible to determine the ratio of the absorption between the deoxygenated
and oxygenated hemoglobin.
There are two components to this measurement: the DC component and the AC
component. The DC component is comprised of the absorbance due to the tissue
and bone and non-pulsatile arterial blood which remain constant. It is only the
change of the amount of blood in the finger that contributes to the AC component
and thus the amplitude of the signal will indicate the amount of blood within the
finger. The waveform is gathered from both frequencies for both the AC and DC
components and the ratio is defined as follows:
R =
(
ACRED
DCRED
)
(
ACNIR
DCNIR
) (3.1)
This ratio is then used in a calibration curve based on studies of healthy individ-
uals to determine the Sp02.
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In this particular application though, it is not necessary to measure the ratio, as
the sensor is only being used to detect when the BP wave arrives at the finger.
Therefore, the system could be simplified and only one LED was necessary. From
a practical point of view it was decided that the Red LED would be used, since
it would be easier to ensure that this LED was operational during testing of
individuals.
Figure 3.5: The Pulse Oximeter which had been developed as part of the Tyndall
system .
3.5 Software
The software section of this chapter discusses all the software used in this project.
Here the term “software” is employed in its most general sense and is used in a
wide encompassing manner. The first part of this section discusses the embed-
ded C code that is used to enable and control the hardware as described in the
previous section. The next part describes the software that was used to enable
the recording of the data. The software used for this data recording is National
Instruments LabView [121] which was written specifically for this application so
that the data could be recorded reliably without loss, while enabling the highest
data rate possible. The final section discusses how the data was then exported to
the data analysis software and why Matlab [122] was chosen as the post-processing
tool.
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3.5.1 Embedded C Code
As outlined in section 3.2, much of the code and the software libraries were part
of the Tyndall WSN modular system. However, there was still some development
work required to get all the sensors in this implementation to work coherently.
This began by mapping all the pins of the microcontroller to each of its respec-
tive connections and writing an initialisation protocol for the board and each pin.
This procedure ensured that the minimum power was used and sensors were only
enabled as they were needed. From this, the enabling software for each sensor
was developed and optimised so the data from each sensor could be recorded indi-
vidually or all the data from every sensor data could be recorded simultaneously
at a high enough sampling rate to ensure the quality of the data was not affected.
3.5.2 Data Recording / LabView
A preliminary investigation was undertaken to measure the PTT and to derive
the BP from this signal. This initial investigation used data recorded from both
the ECG board and Pulse Oximeter board via an oscilloscope. Given the nature
of this setup, it was only possible to record the signals over a period of 20 seconds
but the principle was shown to work well.
All the signals that were recorded by the oscilloscope at a 1 kHz sampling rate
were saved to a .csv file which was then exported to an Excel spreadsheet for
processing. The results of this process can be seen in Figure 3.6. Once the
principle had been proven with the oscilloscope method, it was necessary to devise
a more practical method of recording the data.
The initial setup included adding a Zigbee layer, from the Tyndall suite of motes,
to both the PHAL board and the Pulse Oximeter board and transmitting the
data recorded by both of these devices to a third Zigbee device which would act
as a base station. The reason for using Zigbee, rather than Bluetooth, was that
existing protocols and libraries existed for transmitting data from two nodes to
a base station using Zigbee, whereas this had not been previously done using
Bluetooth within the WSN Team and this setup was more complex to implement
using Bluetooth.
However, there were concerns that by using wireless communications of any kind,
the data could be susceptible to small delays due to synchronisation errors. Given
the small times associated with the PTT measurement of approximately 150 -
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Figure 3.6: The data recorded from the oscilloscope was analysed and plotted
using Excel.
200 ms, and the possible effect that slight delays could have on the outcome,
this could have a significant impact on the results. Since this investigation was
focused on evaluating the PTT method and its associated algorithms, rather than
the evaluation of the PTT method as part of a WSN, it was felt that any potential
sources of error, from anything other than the algorithms should be removed and
so a wired serial communication method was used as it is the most reliable and
accurate communications method for this type of application. To enable this
methodology, a wire was connected from the output of the Pulse Oximeter to one
of the extra ADC inputs of the AD7490 that was used on the PHAL board. Since
the ECG was also sampled using this ADC, this meant both signals were digitized
in exactly the same way, removing any possible delay errors. The PHAL board
was then connected directly to a PC via a USB cable. Although this ensured no
loss of data due to synchronisation errors, there were still a number of issues to
be addressed for reliable data recording, as will be explained in the next section.
The next step in the process was to decide how the data would be recorded into a
file that could be used to process the data at a later stage. One possible solution
was to use LabView to record the data. Due to the serial connection between
the sensors and the PC it would also be possible to display the data as it was
being recorded, ensuring any errors could be flagged and addressed immediately.
LabView can also be used to record data into Microsoft Excel files with relative
ease and since some preliminary work had already been done in Excel including
some post-processing of data, it was decided to record the data to an Excel file
while maintaining a high sampling rate.
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3.5.2.1 Data Pre-Processing
Once it had been established that LabView could be used to write data to Excel
sheets, the data from both ECG and PPG sensors were written to an Excel
sheet and reconstructed for post processing. During this post-processing it was
observed that parts of the signals seemed to be missing when the signals were
reconstructed. In an attempt to verify that data was actually missing, a counter
was implemented on the micro-controller that would continuously count up and
down for the duration of the test. The result of this count function was then
plotted and, provided no data was being lost, a perfectly periodic triangular wave
should appear. If data was lost, it would then be obvious and easy to identify
where this loss took place. An analysis of these triangular waveforms revealed
that data was indeed being lost, even when only two minutes of data was being
recorded. Figure 3.7 shows an example of this. At every point where there is a
sudden jump in data values, if there is a gap or if there is any place on the graph
that does not show an evenly rising or falling line, data has been lost.
Figure 3.7: A counter was used to identify locations of data loss in the recorded
signals. Anywhere that the graph is uneven or if there are gaps in the data, some
data has been lost.
After examining the data, it was found that the data was being lost in a semi-
periodic manner. The hardware was investigated first and data was transmitted
to a PC, without using LabView and plotted but no data loss was observed.
It was therefore evident that the problem was associated with LabView and its
recording process. Investigations showed that this was a known issue when trying
to write large amounts of data at a high sampling rate. Due to the high sampling
rate of the hardware, it was found that the buffer in LabView which was used to
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write the data to a spreadsheet, would periodically fill up, and dump the excess
data and then start recording fresh data again.
The solution of this was to write to a .csv file (a comma separated value file), since
it contained less overhead than an Excel file, but the same issue was found. Al-
ternative formats were examined and it was established that if data was recorded
to a binary file, no data loss occurred and it was also possible to record at an
even higher sampling rate of up to 650 samples per second from each of the two
sensors, although it had been estimated a sampling rate of 400 samples per sec-
ond would have been adequate. Once all the data had been recorded to a binary
file, a second LabView program translated the data from the binary format and
wrote the data to a .csv for data processing.
3.5.3 Post-Processing and Matlab Code Development
From the literature it is evident that much of the signal quality attributed to
ECGs are due to the incorporation of hardware [123] and software filters. By
using tools such as Matlab [122] and Mathematica [124], it is possible to achieve
a similar signal quality as those found in commercial solutions. Using either of
these tools, the data that was required for this application could be processed
much faster than the tools available in Excel. It was also found that both tools
had extensive filters that could be used to smooth the signals in an adaptive
manner rather than by using predetermined filters in an hardware application.
An example of a moving average filter defined in Matlab can be seen in Figure
3.8. Of these tools, it was found that Matlab was generally faster and seemed
to have a lot more useful functions and was therefore chosen as the tool that
would be used for all post-processing. It was also discovered at a much later date
that Matlab could have been used to directly record the data. However, since
so much data had been recorded using the LabView method and the subsequent
testing of this data had taken place and was published, there was a concern about
consistency of test protocols. It was felt that by changing the testing procedures,
subsequent tests may have some influence on the data and this new data could
not be directly compared to those previous tests.
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Figure 3.8: A Moving Average Filter of 31 terms (red) implemented in Matlab
on a noisy ECG Signal (blue)
3.6 Pulse Transit Time Calculation
As reported in Chapter 2, many authors have reported different methods for
measuring and defining PTT. However, there is a general consensus that the
peak of the R wave of the ECG should be used as the initiation point for the
measurement. The difference in the definition of PTT relates to the PPG wave.
Most authors have defined the PTT as being measured from one of three locations
on the PPG wave: the peak, the onset of the PPG wave, or the point of maximum
inflection. The following subsections describe the steps necessary to identify each
of these locations, using code written and developed using Matlab.
3.6.1 ECG R Wave Detection
One of the most critical points that needs to be identified as part of a PTT
measurement is the peak of the R wave. The first stage in detecting R waves from
the ECG signal is to implement a DC rejection filter as can be seen in Figure 3.9.
This DC rejection filter removes the baseline wander (a known occurrence where
a DC component is introduced to the ECG signal over time) and some other
artifacts that are of an ECG signal. Although baseline wander is responsible for
some of the distortion of the ECG signal, much of the amplitude variation of the
QRS waves in Figure 3.9 is compounded by motion artifacts from the volunteer
(seen here as saturation of the signal). The filtered signal removes and minimises
the effect of both but also causes a reduction in the amplitude of the signal.
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As is apparent from Figure 3.9, a simple threshold based algorithm would not
be sufficient to detect R waves, even if a DC rejection filter has already been
implemented. The red line here represents the minimum height that would be
required to detect all R peaks in this window. If this threshold was used, many
other peaks in the ECG signal could also be misidentified as being R peaks.
Therefore a more detailed algorithm is required to detect the R peaks.
Figure 3.9: The result of a DC rejection filter (in green) on the raw ECG signal
seen in blue. It is also apparent that a simple threshold based algorithm would
not be sufficient to detect R peaks.
One of the characteristics of the ECG R wave is that, following the R wave, the
signal has a quick transition from its value to the S peak, milliseconds later. This
characteristic is rarely observed elsewhere in the signal even in the presence of
motion artifacts as illustrated by Figure 3.10 which focuses on the filtered signal
from Figure 3.9. To detect an R wave the following procedure was applied
• All peaks above a certain threshold (green line) were identified and charac-
terised as being potential R peaks (green stars)
• All troughs below a certain threshold (blue line) were identified and char-
acterised as being potential S “peaks” (blue stars)
• If there was a rapid enough transition between a potential R peak and a
potential S “peak”, the potential R peak was determined to be an R peak
(black stars)
• Once an R peak had been identified, all other potential R peaks were ignored
over a certain window, or exclusion zone, to ensure artifacts could not be
misidentified as being R peaks
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The window/exclusion zone described above is shown in Figure 3.10 as the black
dotted line, and was identified by assuming no volunteers had a resting heart rate
higher than 150 beats per minute or one beat every 60150 = 0.40 seconds. Therefore,
once an R wave had been identified, no other peaks were examined for the next
0.40 seconds i.e. in Figure 3.10, none of the potential R (or S) peaks in the
89-90 second exclusion zone were examined once the R wave had been identified.
Using this procedure, the motion artefact in Figure 3.10 is not identified as an
R peak because, although it is outside the exclusion window, the transition from
potential R peak to S peak is too large.
Figure 3.10: The various thresholds, windows and other components used to
detect an ECG R wave.
3.6.2 PPG Wave Characteristic Points Detection
For the evaluation of the PTT methods, PTT was measured from the peak of
the ECG R Wave to the peak of the PPG signal, because it was found to be
the easiest to identify and provided the most reliable measurement, especially
in the presence of noise and artifacts. It was found that by using a threshold
based system of the PPG signal, the peak of the PPG signals could be correctly
identified and therefore used as in the measurement of PTT. This threshold based
system used a percentage of the maximum height to identify all major peaks of
the signal (since no baseline drift was observed in this signal) and the same
minimum distance between peaks that had been used in the ECG R detection
algorithms was specified so only the peaks of PPG signals would be used in the
PTT measurement, in a way that is similar to the exclusion zone seen in Figure
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3.10 in relation to the ECG wave and R peak detection. An example of this can
be seen in Figure 3.11.
Figure 3.11: The use of a minimum threshold and an exclusion window was found
to be sufficient to detect a PPG Peak.
3.7 Testing the Pulse Transit Time Method
3.7.1 Introduction: Preliminary Testing
Prior to the commencement of the evaluation tests of the PTT method, it was
necessary to ensure that all the signals were sufficiently noise - and artefact - free
and the characteristic points of all signals were easily identifiable. This would
ensure that the methodology would provide representative results and give an
accurate evaluation of the technique. The first part of this process was to ensure
that both the ECG and Pulse Oximeter sensors gave signals of sufficient quality
across a number of individuals. Three individuals agreed to provide 5 minutes of
sample data each before the full test would be undertaken.
3.7.2 Sensor Optimisation
3.7.2.1 Pulse Oximeter
During the preliminary research for this round of testing, it was found that a
number of precautions were identified as being necessary to acquire a good signal
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from the Pulse Oximeter/PPG sensor. One of the most critical of these was to
ensure that no one who was being tested was wearing nail polish during the test as
it would distort the signal and introduce errors due to distortion of the reflected
signal. It was also noted that the PPG sensor is very susceptible to motion and
light artifacts. Therefore, it was important that all people under test would keep
their hand still throughout the test and that there was no chance of light shining
into the sensor during measurement
3.7.2.2 ECG Testing - Electrode Placement
While testing the ECG system during the preliminary testing it was found that
in some volunteers, using the traditional electrode placement i.e. Einthoven’s
Triangle, as outlined by Bernston [12], gave a signal, where the T wave was much
larger than the R wave. After consulting with the clinical advisory team, it was
found that this was not an unknown or unusual problem, the solution to which
was to move the electrodes. After some experimentation it was found that by
moving one of the electrodes it was possible to recover the typical ECG signal as
can be seen in figure 3.12. This is also known as Modified Central Lead (MCL1)
[125].
Figure 3.12: An example of the traditional and modified ECG electrode placement
used throughout testing
3.8 Evaluating the PTT Method - Round 1 of
Testing
Once the experimental set up as described in the previous sections had been put
in place, it was possible to begin the first round of testing and evaluating the PTT
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method. This round of testing was an attempt to recreate some of the results
that had been seen in literature and to test the validity of the concept using a
simple BP monitor: the Sanitas SBM30. The testing methodology was defined
using Pickerings recommendations [6] as a basis for BP measurement. The exact
procedure that was followed for this test and all subsequent tests is outlined in
Appendix D. Six volunteers were chosen for the test. This was validated by the
advisory team who recommended using four male and two female subjects. Each
volunteer was then subjected to the same test, under the same conditions where
possible. The test setup and procedure was as follows:
• Each subject rested for 5 minutes prior to each test
• The ECG electrodes were placed in accordance with Einthoven’s Triangle
where possible: One under each collarbone and one on the right hand side
as seen in Figure 3.12a)
• The Pulse Oximeter was placed on the middle finger of the left hand
• The inflatable cuff was placed on the upper left arm, 2 -3 cm above the
bend in the elbow
• A BP measurement from the Sanitas device was taken every 5 minutes (this
was the minimum allowed time from its manual)
• This BP reading was used as an initiation point or a calibration point for
the PTT method
• The ECG ad PPG was continuously recorded for the duration of the test
which was 15 minutes.
Due to assumptions made by Moens-Korteweg in relating PTT to BP, the re-
lationship is only said to be valid over short periods of time, after which a re-
calibration is required i.e. a new cuff measurement has to be taken to realign
or recalibrate the PTT method. This was discussed as being one of the major
limitations of the state of the art. One of the most critical features, therefore,
that should be examined when evaluating the PTT method is the calibration
interval which is defined as the time between the initial BP measurement (de-
fined as SBP0 or DBP0 by Poon [75] or Pb by Chen [14]) and the subsequent
BP measurement that is required to recalibrate the PTT method. In this case,
because of the limitation of the BP monitor the minimum calibration interval
was 5 minutes i.e. an initial BP cuff measurement was taken, the PTT was used
to track changes of BP for 5 minutes, after which another BP cuff measurement
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was used to recalibrate the PTT and continue this cycle. However, if the method
was found to be accurate, a longer calibration interval could be used, meaning
less cuff measurements would be required. Therefore, the usefulness of the PTT
method should not only be defined by the ability of the method to track BP
but how long is required between subsequent BP measurements that allow the
method to remain accurate.
Although six volunteers were initially measured, only five managed to complete
the test, as one had a panic attack during their test. It was also discovered that
one of the other volunteers was a diabetic and hypotensive, although this did
not adversely affect the results for this volunteer. Finally, one other patient was
found to have a high T-wave which caused some problems for the algorithm to
distinguish between it and the R wave of this patient. Upon inspection of the data
files for each volunteer, it was found that the algorithm that had been developed
had failed to detect a number of ECG and PPG peaks which resulted in poor
results. Also due to the small number of tests performed it was difficult to draw
any definitive conclusions with regards the value of the PTT method. However,
each of these highlighted issues identified valuable information that would be
required for future testing.
3.8.1 Required Improvements for Subsequent Testing
A number of lessons were learned from the testing in “Round 1” which meant
optimisation of the experimental protocol were required for “Round 2”. A more
detailed list of the required improvements is discussed in Appendix D.
The first change was to choose 6 Volunteers who would be able to complete
the testing and they should undergo an initial trial to test for any ECG signal
abnormalities. Under this process, one volunteer was eliminated due to the fact
that they had a very small R wave. The testing procedure was adjusted so that
a second female was added to the group.
Further changes included each volunteer being tested for half an hour and each of
the sensors was also packaged prior to the testing. Most importantly, the Sanitas
BP Monitor was replaced by a top of the range BP monitor, the Omron M6. This
is shown in Figure 3.13 and was used because of its compliance with the standards
[126] and could be considered a gold standard for comparative purposes.
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Figure 3.13: The Omron M6 Oscillometric BP Monitor [26].
3.9 Evaluating the PTT Method - Round 2 of
Testing
During this round of testing, PTT was directly evaluated using Chen’s inter-
pretation of the Moens-Korteweg equations to relate PTT directly to BP only.
Six volunteers were chosen for this test, four males and two females all between
24 and 28 years old. ECG data was recorded from the PHAL board and Pulse
Oximeter data was recorded from the device directly to the PC, as described in
section 3.4.2. PTT was defined as the time between the ECG R wave and the
peak of the Pulse Oximeter wave. Each test was recorded for 30 minutes between
the times of 2.00 PM and 4.30PM in a quiet environment at 20°C. The volunteers
were asked to refrain from smoking and ingesting caffeine or any other BP alter-
ing drugs in the hours prior to the test, as per the recommendations for all BP
measurements [6]. The Omron M6 was worn on the upper left arm and was used
to recalibrate the estimated BP at five minute intervals. The Pulse Oximeter was
worn on the index finger of the right hand, so as to be unaffected by the inflation
and deflation of the cuff. The data was then post-processed using Matlab, which
filtered and extracted the points and data of interest according to the algorithms
developed and described in section 3.6.
The results of this test can be seen in Table 3.3 [127]. The PTT method was
evaluated using the AAMI standard. When using a 5 minute calibration interval
i.e. one BP reading every 5 minutes with each measurement also being used to
evaluate the prediction, the PTT method was found to be accurate for every
volunteer and adhered to the AAMI standards. As can be seen in Table 3.3, it
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Table 3.3: The results of “Round 2” testing to evaluate the PTT method
Volunteer Estimated Error of Systolic BP (mmHg)
1 1.81 ± 4.39
2 -0.82 ± 3.69
3 -1.34 ± 7.93
4 -1.44 ± 5.71
5 -2.57 ± 6.23
6 -0.53 ± 3.70
is apparent that some volunteers provided a lower mean and standard deviation
than others, indicating that the PTT suits some people more than others. The
reason for this seemed obvious for at least one volunteer, volunteer 3 who had been
found to be diabetic and hypotensive in “Round 1”, who was included to provide
a greater range of people tested. It was also noted that Volunteers 4 and 5 had a
noisy signal with respect to the results recorded from the Pulse Oximeter due to
motion artifacts. By using Matlab it was possible to remove some of these artifacts
but it was not possible to remove them entirely. Therefore, given the similar age,
fitness and general health of the remaining volunteers it was unclear what were
the reasons for the discrepancies of the results between individuals, although the
low number of volunteers could be the problem. However, since there are so
many factors which can affect blood pressure, there are only so many precautions
that can be undertaken prior to a BP reading being recorded, especially when
volunteers are being used, rather than patients who can be controlled or people
who are being paid. For example, although the tests were recorded in a noise free
and temperature controlled environment, it is not possible to evaluate a person’s
mental state during these tests.
Although, each of the volunteers claimed good general health and that they had
refrained from blood pressure altering activities prior to the tests but none of
these claims could be substantiated without employing a more rigorous controlled
environment, something which was not feasible for these tests.
Although these results were promising because they all adhered to the AAMI
standards having a mean less than 5 mmHg and standard deviation less than
8 mmHg, it was clear that a more thorough investigation was required. The
first decision was that in order to minimise the impact of the variability of the
subjects a larger number of subjects should be examined. Also each subject
should be tested numerous times and perhaps each test should have a longer
duration. Furthermore, the granularity of the investigation should be increased
by measuring the BP more frequently to find the point at which the PTT first
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failed or exceeded the AAMI standards. It was also decided that instead of solely
examining the PTT, other algorithms which related PTT to BP should be studied.
These algorithms are described in literature and have been widely published but
the calibration intervals that are required for them to remain accurate or their
ability to track BP has never been established to date. Although many authors
report that their methods and algorithms show a strong relationship between
BP and PTT, most have only been evaluated over very short periods of time,
typically less than 2 minute intervals and frequently with a few minutes between
PTT measurements. In these cases, a break in testing occurred so the patient
could exercise before the test resumed and the impact of exercise on BP and
PTT could be observed [56, 61, 62]. Although well intentioned and valuable to a
degree, it meant that a non-continuous measurement of PTT and BP was recorded
and the duration of accuracy or the role of the calibration interval was never
investigated. Therefore, it was decided to test two of the most cited algorithms,
to evaluate which provided the best results, in terms of tracking BP and also for
which algorithm allowed for the longest calibration interval.
3.10 Evaluating the PTT Method Using Two
Different PTT Algorithms - Round 3 of
Testing
From section 3.9, it became apparent that a larger number of volunteers was
required for testing the PTT method so as to ensure that any results would
be statistically significant. The number of volunteers was originally increased
from six to ten (this was subsequently further increased to fifteen based on the
recommendations of the reviewers of the paper that was published based on the
results of these tests [128]). Two algorithms were identified in the literature as
discussed in section 2.7, namely Chen’s algorithm [14] and Poon’s algorithm [75],
for an evaluation of the PTT method rather than examining the Moens-Korteweg
equation. These two algorithms were chosen because they are two of the most
cited works in the PTT area. Finally, it was decided that each algorithm would be
evaluated at two minute intervals, so that a more precise calibration interval could
be determined. The figure of two minutes was chosen as a function of the Omron
M6 BP monitor, which under normal circumstances would take 45 seconds to
take a measurement, but occasionally would need a second inflation which could
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double the measurement time to one and a half minutes. The occurrence of
these incidents is rare, however, since a test to identify the calibration intervals
over which various PTT algorithms remain accurate had never been previously
investigated, testing using one BP measurement every two minutes over the 30
minute test was deemed to be satisfactory, even if it was found to cause some
discomfort for some of the volunteers at this interval due to the constant inflation
and deflation of the cuff. The second part of evaluation of these algorithms was
to investigate how well each one was able to track the BP i.e. if a large change
in BP was found during the tests, would either algorithm be able to track this
change. Both of these criteria will be discussed in the following sections.
Another statistical analysis tool was also used in this round of testing, the Bland
Altman graph [129], which presents results in a graphical manner and allows the
data to be presented in line with other works in the area. A Bland Altman graph
is used to compare the measurement and accuracy of experimental measurements
from the two methods, neither of which are the gold standard. This graphing
technique is common in the area of BP monitor evaluations. In a Bland Altman
graph the difference, or error, between the two methods is plotted against the
mean result obtained of the two methods. An example of a Bland Altman graph
used to assess the BP derived from PTT algorithms against a BP monitor is
shown in Figure 3.14a and shows good agreement between the two methods. The
red lines of this graph show the mean error, the black lines show the error ±
the standard deviation and the green lines show the 90% confidence intervals.
The close agreement between the two methods can be determined in Figure 3.14a
because the error is small when compared to the mean. More specifically, for
the area of BP monitoring, the good agreement can be seen since most of the
errors are less than 5 mmHg, a key figure in both the AAMI standard and BHS
standard. The standard deviation in this graph is also seen to be less than
4 mmHg, which is well within the 8 mmHg specified by the AAMI standard.
Finally, all the errors displayed here are less than 10 mmHg indicating a very
good agreement from the perspective of the BHS standard. This is emphasised
by the 95% confidence intervals being less than 8 mmHg, but these lines are not
always displayed. Although there is a large spread of values across the x-axis, this
is due to the fact that the results from three different individuals are shown in this
example, each individual having a different mean BP. The individual breakdown
can be seen in Figure 3.14b.
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(a) The Bland Altman Graph of three different individuals, without
being distinguished
(b) The Bland Altman Graph specifying which data points are
from each individual
Figure 3.14: An example of the Bland Altman Graph used in the analysis of the
accuracy of the PTT method
3.10.1 Evaluating Chen’s Algorithm
Chen’s method was evaluated using the system described in section 3.3 to confirm
his findings and to establish the maximum calibration interval that could be used
for his method to remain reliable and accurate.
Table 3.4 shows the results of using Chen’s algorithm to track BP over each
calibration interval, presented in the format used in the AAMI standard. This
determines that the test “device” (PTT) must not differ from the standard (the
Omron M6) by a mean difference of less than 5 mmHg or a standard deviation
greater than or equal to 8 mmHg. The last row presents the accumulated results
Development of a Novel PTT Based
Algorithm
66
3.10 Evaluating the PTT Method Using Two Different PTT Algorithms - Round 3 of Testing
Table 3.4: A summary of the results from testing Chen’s algorithm from each
volunteer. Each result represents the mean error ± the standard deviation of
error between the Estimated BP, given by the PTT method, and Measured BP
given by the Omron M6
Volunteer 2 Minute
Interval
4 Minute
Interval
6 Minute
Interval
8 Minute
Interval
10
Minute
Interval
12
Minute
Interval
1 0.59±0.89 0.03±0.09 1.13±0.78 6.79±3.94 4.19±9.88 −47.32±9.31
2 0.62±0.73 0.02±0.02 1.02±0.55 6.73±4.15 5.99±6.14 −46.09±13.08
3 1.02±2.16 0.04±0.07 1.05±1.01 5.39±4.93 5.54±10.06 −31.92±26.24
4 0.68±1.83 0.03±0.05 0.06±0.92 4.88±6.25 10.25±7.96 −3.47±35.02
5 0.69±2.26 0.04±0.14 0.89±1.21 3.61±4.84 2.08±17.07 −20.24±32.07
6 0.51±0.64 0.04±0.05 0.85±0.82 5.41±3.64 5.14±10.24 −34.18±31.86
7 0.79±0.16 0.05±0.11 1.19±1.13 5.48±4.95 −0.87±20.65 −33.97±20.99
8 0.94±2.68 0.04±0.09 2.17±8.31 7.30±10.64 4.59±11.28 −26.04±25.21
9 0.40±0.27 0.02±0.02 0.92±0.39 6.74±3.07 7.29±4.27 −45.96±6.38
10 0.31±0.58 0.03±0.04 0.68±1.78 4.60±5.74 8.88±4.12 −16.33±40.61
11 0.54±0.54 0.03±0.03 1.03±1.12 8.97±11.49 11.77±7.99 −34.68±30.43
12 0.45±0.45 0.02±0.02 0.82±0.38 5.85±4.92 9.17±4.58 −35.50±18.23
13 0.38±0.44 0.03±0.04 0.51±0.66 5.61±4.05 12.97±10.78 −10.27±36.92
14 0.68±1.55 0.03±0.07 0.94±0.76 6.72±6.71 8.79±8.44 −43.05±22.29
15 1.03±3.02 0.04±0.07 1.10±0.87 6.31±4.14 5.19±9.77 −45.48±13.65
Overall 0.64±1.55 0.03±0.07 0.99±2.35 6.02±6.12 6.81±10.85 −3.42±29.22
across all volunteers.
Table 3.4 shows the results of using Chen’s algorithm to track BP over each
calibration interval, presented in the format used in the AAMI standard. This
determines that the test “device” (PTT) must not differ from the standard (the
Omron M6) by a mean difference of less than 5 mmHg or a standard deviation
greater than or equal to 8 mmHg. The last row presents the accumulated results
across all volunteers.
Examining the last row of Table 3.4 it can be seen the algorithm exceeds the stan-
dard after the 6 minute calibration interval. Looking at the calibration intervals
greater than 8 minutes it can be seen that the results degrade rapidly after this
point. The reason for this degradation lies with the filter associated with High
Frequency Component (HFC) of Chen’s method, which employs a bandpass filter
(between 5.3×10−4 Hz and 4×10−3 Hz, using a 5 minute calibration interval, but
the lower value (FL) varies depending on what calibration interval that is used,
defined by FL = 12pi × (CalibrationInterval)) on all the PTT data recorded.
In Chen’s paper, a 5 minute calibration interval is used. Chen found that when
the filter that is described in his paper is applied to the PTT using this calibration
interval, there is a direct linear relationship between this filtered PTT and BP.
However, the origin of this filter is unclear. In Table 3.4 it can be seen that when a
4 minute calibration interval is applied, the algorithm performs exceedingly well.
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One possible reason for this performance is that the filter is tuned specifically for
performance at 5 minutes and as the calibration interval approaches 5 minutes,
its performance is enhanced.
Over the first two/three intervals, the effect of the bandpass filter has a minor
role in the results and the Low Frequency Component (LFC) was the major
contributor to the results. When the PTT data is filtered, the resulting HFC
component becomes what is essentially a straight, horizontal line with a variation
of less than 3mmHg over the course of the test. In the case of the 4 minute
interval, this variation is even further reduced to approximately 0.15 mmHg,
because of its proximity to the linear relationship that had been established using
a 5 minute calibration interval. However, as the calibration interval grows and
the appropriate changes were accordingly made to the filter i.e as FL was updated
per calibration interval, the effect of the filter on the data changed significantly.
At the times when the calibration interval was shorter, the filter caused the data
to change only by 1 - 3 mmHg over the interval, up to and including when the 6
minute calibration interval is applied.
When a calibration interval of greater than 6 minutes is used, the filter causes an
even greater change over the course of the test and this is reflected in the results
in Table 3.4 and in the Bland Altman graphs Figure 3.15, d) - f). A similar
degradation can be seen in the data from examining the BHS standard in Table
3.5. Using the BHS standard, it is in many ways easier to see how the effect of
the filter changes, with 100% of the results being less than 5mmHg when using
a 2 minute calibration interval, while in the 8 minute calibration interval, this
has fallen to 29.04%. During the 6 minute calibration, where Chen’s algorithm
passes both standards, a linear relationship has been found with r = 0.96 and an
r2 = 0.98.
Although these results show that Chen’s method is very good at tracking BP up
to 6 minutes, there are some concerns with relation to this method. These are
explained as follows:
It has been noted when using Chen’s method, that due to the filtering, the esti-
mated BP doesn’t change much from the initial BP measurement, when using a
small calibration interval, (i.e. when a calibration interval of less than 6 minutes
is used), the filtered PTT data (or the HFC) is essentially a straight, horizon-
tal line. Indeed, it can be seen that no matter what change is recorded using
the cuff, the shape of the Chen’s estimation remains constant, as illustrated in
Figure 3.16a where a six minute calibration interval is used. In this figure the
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(a) 2 Minute Calibration Interval (b) 4 Minute Calibration Interval
(c) 6 Minute Calibration Interval (d) 8 Minute Calibration Interval
(e) 10 Minute Calibration Interval (f) 12 Minute Calibration Interval
Figure 3.15: Using the Bland Altman graphs and Table 3.4 to analyse Chen’s
algorithm, a deterioration of the results in each subsequent calibration interval
can be seen by the growing error and standard deviation (black).
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Table 3.5: A summary of the results using percentage predicted values falling
within 5, 10 and 15 mmHg, based on the BHS system for assessing BP mea-
surement accuracy. Each calibration interval is assessed using this method and
the associated BHS standard is provided in the last column. A rating of “B” is
deemed acceptable, while a rating of “C” is deemed a fail.
Volunteer 2 Minute Interval 4 Minute Interval 6 Minute Interval
5 mmHg 10 mmHg 15 mmHg Grade 5 mmHg 10 mmHg 15 mmHg Grade 5 mmHg 10 mmHg 15 mmHg Grade
1 97.67 % 100 % 100 % A 100 % 100 % 100 % A 97.30 % 100 % 100 % A
2 100 % 100 % 100 % A 100 % 100 % 100 % A 100 % 100 % 100 % A
3 93.75 % 97.92 % 100 % A 100 % 100 % 100 % A 97.62 % 100 % 100 % A
4 95.83 % 97.92 % 100 % A 100 % 100 % 100 % A 100 % 100 % 100 % A
5 97.92 % 97.92 % 97.92 % A 100 % 100 % 100 % A 100 % 100 % 100 % A
6 100 % 100 % 100 % A 100 % 100 % 100 % A 100 % 100 % 100 % A
7 97.73 % 100 % 100 % A 100 % 100 % 100 % A 100 % 100 % 100 % A
8 95.83 % 97.92 % 97.92 % A 100 % 100 % 100 % A 95.24 % 97.62 % 97.62 % A
9 100 % 100 % 100 % A 100 % 100 % 100 % A 100 % 100 % 100 % A
10 100 % 100 % 100 % A 100 % 100 % 100 % A 100 % 100 % 100 % A
11 100 % 100 % 100 % A 100 % 100 % 100 % A 97.62 % 97.62 % 100 % A
12 100 % 100 % 100 % A 100 % 100 % 100 % A 97.62 % 100 % 100 % A
13 100 % 100 % 100 % A 100 % 100 % 100 % A 100 % 100 % 100 % A
14 97.92 % 97.92 % 100 % A 100 % 100 % 100 % A 100 % 100 % 100 % A
15 97.87 % 97.87 % 97.87 % A 100 % 100 % 100 % A 100 % 100 % 100 % A
All 98.31 % 99.15 % 99.58 % A 100 % 100 % 100 % A 99.03 % 99.68 % 99.84 % A
Volunteer 8 Minute Interval 10 Minute Interval 12 Minute Interval
5 mmHg 10 mmHg 15 mmHg Grade 5 mmHg 10 mmHg 15 mmHg Grade 5 mmHg 10 mmHg 15 mmHg Grade
1 3.03 % 100 % 100 % D 6.45 % 83.87 % 96.77 % D 3.57 % 3.57 % 3.57 % D
2 5.00 % 97.50 % 100 % D 11.11 % 72.22 % 100 % D 0.00 % 3.03 % 3.03 % D
3 23.08 % 97.44 % 97.44 % D 19.44 % 50.00 % 91.67 % D 0.00 % 9.09 % 18.18 % D
4 58.97 % 97.44 % 97.44 % D 8.33 % 27.78 % 94.44 % D 30.30 % 33.33 % 51.52 % D
5 46.15 % 100 % 100 % C 11.11 % 66.67 % 88.89 % D 3.03 % 3.03 % 15.15 % D
6 35.90 % 94.87 % 97.44 % D 27.78 % 55.56 % 91.67 % D 15.15 % 18.18 % 21.21 % D
7 34.29 % 94.29 % 97.14 % D 25.00 % 43.75 % 78.13 % D 17.24 % 20.69 % 20.69 % D
8 46.15 % 87.18 % 89.74 % C 47.22 % 75.00 % 94.44 % C 36.36 % 42.42 % 42.42 % D
9 12.82 % 100 % 100 % D 22.22 % 72.22 % 100 % D 0.00 % 0.00 % 0.00 % D
10 48.72 % 94.87 % 94.87 % C 13.89 % 36.11 % 86.11 % D 12.12 % 21.21 % 27.27 % D
11 58.97 % 97.44 % 97.44 % B 22.22 % 52.78 % 97.22 % D 3.03 % 6.06 % 21.21 % D
12 20.51 % 84.62 % 89.74 % D 5.56 % 50.00 % 88.89 % D 6.06 % 12.12 % 15.15 % D
13 15.38 % 97.44 % 97.44 % D 2.78 % 61.11 % 100 % D 12.12 % 18.18 % 21.21 % D
14 10.26 % 87.18 % 94.87 % D 2.78 % 61.11 % 86.11 % D 0.00 % 6.06 % 9.09 % D
15 13.16 % 97.37 % 100 % D 17.14 % 77.14 % 97.14 % D 0.00 % 0.00 % 3.13 % D
All 29.04 % 95.13 % 96.87 % D 16.23 % 58.87 % 92.83 % D 9.28 % 13.20 % 18.35 % D
solid line shows the PTT data after it has been filtered i.e. by the HFC. Despite
large changes being observed in the cuff measurements (the circular points), the
shape of HFC remains almost exactly the same. The LFC interpolates the values
between the cuff measurements and a combination of the LFC and HFC is used
as the final estimation of Chen’s algorithm. This is presented in Figure 3.16b.
Since use of the filter results in only small changes in the data and the LFC
essentially connects one cuff measurement to the other, the overall estimation is
very accurate and the effect is that the errors, if any, are minute. From what has
been observed, it seems that the filter is tuned such that if a 5 minute calibration
interval had been examined, the HFC or filtered PTT, would be reduced to a
perfectly straight, horizontal line. The results of the 4 minute calibration interval
support this, since the variation at this interval have been observed to be less
than 0.15 mmHg. By combining an almost perfectly straight, horizontal line at
4 minutes, with a variation of less than 0.15 mmHg provided by the HFC and a
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(a) The filtered PTT and the LFC, shown separately at
the 6 minute calibration interval
(b) Chen’s prediction at the 6 minute calibration interval
when the two components are added
(c) The filtered PTT and the LFC, shown separately at
the 8 minute calibration interval
(d) Chen’s prediction at the 8 minute calibration interval
when the two components are added
Figure 3.16: The shortcoming of Chen’s algorithm can be seen by comparing the
filtered PTT in the 6 minute calibration to the 8 minute calibration interval
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linear interpolation between the initial BP measurement and test or calibration
BP measurement, it is no surprise that the associated error is so low, since the
only variation from the test point is due to the variation of the HFC. In line
with other filters, it has been found that the algorithm performs much better at
intervals less than the 5 minute interval, the algorithm improves as it approaches
5 minutes and then degrades once the calibration interval exceeds this.
Furthermore, because a healthy person’s BP at rest doesn’t vary substantially
over short intervals, by keeping the amplitude of the estimation (the HFC) low,
the estimate can remain within the 5mmHg limit that is defined by the AAMI
and BHS standards
Therefore, since Chen’s HFC provides a straight line that doesn’t vary by more
than ≈ 3mmHg throughout the entire 6 minutes of the test and relies on the LFC
to correct any errors, it complies with the standards. Due to the requirement for
the LFC to correct the errors, the data is also not provided in real time but with a
lag period which is equal to the duration of the calibration interval. However, as
outlined previously, at 8 minutes the filter introduces a large change in the data
over the calibration interval and becomes the dominant factor in the results, as
can be seen in Figure 3.16c. In this case, the amplitude of the HFC is much larger
(usually in the order of greater than 5mmHg), so when the LFC and the HFC
are added together, the LFC component becomes incapable of compensating by
a large enough degree. This is as shown in Figure 3.16d and thus causing the
failure of the algorithm to meet the standards.
3.10.2 Evaluating Poon’s Algorithm
Tables 3.6 and 3.7 present the results of evaluating Poon’s algorithm described in
2.7. While analysing this algorithm, it was noted that, on occasion, large spikes
in BP occurred during some tests. These spikes exceeded 1000 mmHg and as a
consequence adversely affect the standard deviation of the data. These values,
clearly being errors, were removed and were replaced by a value that was a mean
of the previous ten results. A total of fourteen of these anomalous points occur
in this data set. These spikes are due to motion artifacts in the data where the
patient either moved their body causing a motion artefact in the ECG signal or
moved their hand or finger causing a motion artefact in the PPG signal. These
motion artifacts caused the peak detection algorithms to misidentify them as
points of interest meaning that the changes in PTT were excessively short, and
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Table 3.6: Evaluation of Poon’s algorithm with respect to the AAMI standard.
Each result represents the mean error± the standard deviation of error between
the Estimated BP, given by the PTT method, and Measured BP, given by the
Omron M6.
Volunteer 2 Minute
Interval
4 Minute
Interval
6 Minute
Interval
8 Minute
Interval
10
Minute
Interval
12
Minute
Interval
1 1.16±7.34 1.16±6.45 0.58±8.40 −0.79±6.38 −0.56±8.16 0.34±6.72
2 0.01±6.48 −0.23±6.80 0.08±8.02 0.45±6.98 −0.13±7.65 0.01±8.07
3 0.75±11.11 0.37±8.34 0.47±10.25 −1.06±8.85 −0.48±9.96 −0.68±8.00
4 2.39±13.05 1.26±12.34 3.41±14.24 1.89±13.20 2.13±12.75 1.07±13.13
5 0.21±5.50 0.11±5.30 0.07±6.48 −0.37±6.68 −0.20±5.76 −0.86±6.27
6 0.30±8.25 −0.50±9.52 −0.35±9.36 −0.51±9.35 0.59±8.48 −0.14±10.62
7 −0.88±9.80 −1.39±10.08 −1.77±9.66 −1.41±10.74 −1.53±11.04 −0.94±9.56
8 4.44±10.41 4.44±10.80 4.91±8.91 4.65±9.75 5.38±10.35 5.33±8.46
9 0.18±6.70 0.21±7.07 −0.46±8.30 0.04±7.74 0.57±6.56 1.38±6.53
10 4.36±12.35 6.17±13.39 6.34±10.14 4.95±10.58 4.07±11.12 5.43±11.07
11 2.25±11.85 1.39±11.20 0.82±12.16 1.10±11.86 0.22±9.82 0.10±10.73
12 0.33±7.43 −0.13±6.88 −0.72±5.91 −0.72±7.18 −0.41±6.34 0.68±7.49
13 9.65±15.97 6.09±17.46 6.78±15.59 5.71±10.62 5.23±12.98 4.62±13.22
14 1.21±11.49 1.20±10.03 0.34±10.69 0.00±10.64 −0.12±10.67 0.05±9.50
15 0.23±10.35 0.07±11.32 −1.45±11.47 −0.49±9.16 0.16±9.49 0.01±8.97
Overall 1.79±10.50 1.40±10.48 1.40±10.59 1.08±9.74 1.15±9.84 1.24±9.74
because of the inverse relationship between PTTW and BP in Poon’s algorithm,
a small error in the measurement of PTT will result in a large error in BP.
The Bland Altman graphs in Figure 3.17, a - f, show a slight deterioration of
results and the cluster also grows slightly from the 2 minute calibration interval
to the 12 minute calibration interval, and the number of outliers also increases.
The reason for the similarities and only slight deterioration is because each of
the tests fail by a similar amount when each standard is applied regardless of
the calibration interval. There are also a large number of outliers (errors) that
can be found in each of the Bland Altman graphs, and these are the primary
reason for the large standard deviation and consequent poor performance of the
algorithm. Examining the Bland Altman graphs also reveal that there is a range
of 100 mmHg to 135 mmHg where the algorithm is accurate. Below 100 mmHg,
it appears that the algorithm underestimates the actual BP whereas above 135
mmHg the algorithm overestimates the actual BP. Therefore, it could be said
that Poon’s algorithm is accurate for people whose BP is within this range and
if the tests were repeated and volunteers were chosen whose BP was within this
range, the algorithm could have much better performance.
The reason for this linear relationship in the Bland Altman graphs i.e. the under-
estimation of low BPs, the accuracy of the “middle” range, and the overestimation
of higher BPs, is unclear. One observation that could be made is that there are
very few BP measurements in excess of 130 mmHg and more data would be re-
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Table 3.7: A summary of the results of Poon’s algorithm when the BHS standard
is applied.
Volunteer 2 Minute Interval 4 Minute Interval 6 Minute Interval
5 mmHg 10 mmHg 15 mmHg Grade 5 mmHg 10 mmHg 15 mmHg Grade 5 mmHg 10 mmHg 15 mmHg Grade
1 53.33 % 86.67 % 93.33 % B 61.90 % 85.71 % 97.62 % A 56.41 % 79.49 % 89.74 % C
2 62.50 % 89.58 % 97.92 % A 53.33 % 84.44 % 97.78 % B 50.00 % 76.19 % 90.48 % B
3 47.92 % 70.83 % 83.33 % D 46.67 % 77.78 % 93.33 % C 28.57 % 73.81 % 92.86 % D
4 33.33 % 64.58 % 77.08 % D 26.67 % 60.00 % 82.22 % D 23.81 % 54.76 % 73.81 % D
5 68.75 % 91.67 % 97.92 % A 62.22 % 93.33 % 100 % A 54.76 % 85.71 % 97.62 % B
6 45.83 % 81.25 % 89.58 % C 35.56 % 77.78 % 86.67 % D 40.48 % 69.05 % 92.86 % C
7 45.45 % 77.27 % 88.64 % C 36.59 % 63.41 % 92.68 % D 39.47 % 71.05 % 89.47 % D
8 37.50 % 64.58 % 81.25 % D 31.11 % 55.56 % 84.44 % D 42.86 % 69.05 % 80.95 % D
9 60.42 % 87.50 % 95.83 % A 51.11 % 91.11 % 95.56 % B 59.52 % 85.71 % 95.24 % B
10 37.50 % 52.08 % 58.33 % D 35.42 % 47.92 % 60.42 % D 39.58 % 56.25 % 72.92 % D
11 50.00 % 70.83 % 81.25 % C 35.42 % 60.42 % 77.08 % D 50.00 % 70.83 % 83.33 % D
12 35.42 % 60.42 % 77.08 % D 39.58 % 60.42 % 81.25 % D 45.83 % 58.33 % 77.08 % D
13 58.33 % 87.50 % 97.92 % B 56.25 % 83.33 % 95.83 % B 62.50 % 89.58 % 100 % A
14 47.92 % 81.25 % 89.58 % C 56.25 % 75.00 % 87.50 % C 50.00 % 79.17 % 87.50 % C
15 42.55 % 70.21 % 89.36 % C 40.43 % 68.09 % 85.11 % C 38.30 % 63.83 % 82.98 % D
All 48.46 % 75.70 % 86.52 % C 44.53 % 72.12 % 87.59 % C 45.59 % 72.04 % 86.93 % C
Volunteer 8 Minute Interval 10 Minute Interval 12 Minute Interval
5 mmHg 10 mmHg 15 mmHg Grade 5 mmHg 10 mmHg 15 mmHg Grade 5 mmHg 10 mmHg 15 mmHg Grade
1 72.22 % 91.67 % 97.22 % A 60.61 % 81.82 % 90.91 % B 70.00 % 90.00 % 96.67 % A
2 64.10 % 87.18 % 97.44 % A 61.11 % 83.33 % 88.89 % C 48.48 % 75.76 % 90.91 % C
3 33.33 % 66.67 % 97.44 % D 38.89 % 72.22 % 91.67 % D 45.45 % 78.79 % 93.94 % C
4 28.21 % 51.28 % 71.79 % D 33.33 % 66.67 % 77.78 % D 24.24 % 63.64 % 84.85 % D
5 43.59 % 89.74 % 97.44 % C 52.78 % 94.44 % 100 % B 42.42 % 93.94 % 100 % C
6 46.15 % 71.79 % 92.31 % C 44.44 % 77.78 % 88.89 % C 51.52 % 81.82 % 87.88 % C
7 51.43 % 71.43 % 80.00 % D 43.75 % 65.63 % 87.50 % C 48.28 % 68.97 % 89.66 % C
8 38.46 % 74.36 % 87.18 % D 30.56 % 63.89 % 80.56 % D 45.45 % 72.73 % 84.85 % D
9 61.54 % 94.87 % 94.87 % A 47.22 % 91.67 % 97.22 % C 63.64 % 90.91 % 96.97 % A
10 41.67 % 60.42 % 77.08 % D 50.00 % 62.50 % 75.00 % D 58.33 % 62.50 % 68.75 % D
11 52.08 % 64.58 % 79.17 % D 54.17 % 68.75 % 79.17 % D 54.17 % 72.92 % 81.25 % D
12 43.75 % 64.58 % 79.17 % D 52.08 % 75.00 % 89.58 % C 47.92 % 66.67 % 81.25 % D
13 60.42 % 87.50 % 93.75 % A 66.67 % 87.50 % 95.83 % A 75.00 % 81.25 % 91.67 % B
14 56.25 % 81.25 % 89.58 % C 52.08 % 72.92 % 89.58 % C 56.25 % 81.25 % 91.67 % B
15 57.45 % 76.60 % 85.11 % C 55.32 % 78.72 % 87.23 % C 53.19 % 82.98 % 93.62 % B
All 50.08 % 75.28 % 87.64 % C 50.17 % 75.99 % 87.75 % C 53.03 % 77.12 % 88.21 % C
quired in this range to confirm that the algorithm always overestimates BPs in
this range. This may just be a feature of one particular volunteer, to whom the
algorithm is not suited. A similar argument could also be made for the range of
measurements below 100 mmHg. Analysing the Bland Altman graphs provided
by Poon in her paper would support this to some degree since no linear relation-
ship is observed in these graphs, and a much larger number of BP measurements
in excess of 135 mmHg are available.
Using Poon’s algorithm, it was found that calibration is required before the two
minute calibration interval, even when the large artifacts are removed. The ma-
jority of mean errors recorded were within the acceptable limits i.e. 5mmHg, but
the standard deviation is always greater than 8mmHg.
Poon’s algorithm showed a failure even when using a 2 minute calibration inter-
val against the standards. This is in line with the results that Poon reported.
However, on examination of the algorithm, it appears that it tracks the changes
in BP over some intervals e.g. over the first three intervals Poon’s algorithm is
capable of tracking the large decrease and increase in BP given by the cuff, as
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Figure 3.17: The Bland Altman graphs of Poon’s algorithm for each of the six
intervals (a - f). These Bland Altman graphs represent a visualisation of the last
row of Table 3.6, and show the mean error (red) and the mean ± the standard
deviation (black) of the results.
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can be seen in Figure 3.18. The ability to track changes in BP is also apparent
over the fifth to seventh intervals and again over the tenth to fourteenth inter-
vals. Although this is not sufficient or satisfactory, and a drastic improvement is
clearly required, it does indicate that the PTT could be used to track changes
in BP if an improvement could be made. Although it was necessary to remove
some spikes due to motion artifacts, Poon’s algorithm seems to be much better at
tracking BP than Chen’s method. However, this can be quite difficult to qualify
because of the high magnitude of “noise” associated with it. If this “noise” could
be eliminated or diminished, Poon’s algorithm would be the better method of the
two to use for tracking BP.
Figure 3.18: Poon’s algorithm (in green) and its ability to track measured BP (in
red)
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3.11 Conclusions
The purpose of the work described in this chapter was to evaluate the state of
the art of the PTT algorithms that have been published in the last few years.
In order to perform this evaluation, a number of steps were required so the PTT
could first be measured.
The first section of this was the development of the PHALs Board, which would
provide an ECG wave to measure the initiation of the PTT. A Bluetooth module
was also included to allow wireless communication and allow maximum compati-
bility with other electronic devices which may be common in peoples’ households,
although it was not used during the subsequent tests.
The hardware component that was necessary to measure PTT consisted of the
Pulse Oximeter device which measures the arrival of the pulse wave at the sec-
ondary location. However, for the evaluation of the PTT method, some modifi-
cation was required to allow both devices to record data at a high sampling rate
to Excel via LabView without loss of data.
Once the data was recorded to a satisfactory standard, the use of post-processing
of the data to improve signal quality and extract the various characteristic points
was investigated. The extraction of the characteristic points to measure PTT is
explained in section 3.6 which enabled the evaluation of the various PTT algo-
rithms.
The first evaluation of the PTT method ,“Round 1 of testing”, used the Moens -
Korteweg equation as a basis for an investigation into the usefulness of the PTT
method, and the calibration intervals required for accurate tracking of BP. This
test used a Sanitas SMB30 BP monitor and 5 minute calibration intervals and
data was recorded from 5 volunteers for 15 minutes each. The results of this test
showed that a number of refinements were necessary, including a requirement for
a better BP monitor for testing and that it would be better to test each of the
volunteers over a longer duration.
“Round 2” testing was undertaken with the lessons learned in “Round 1” be-
ing taken into account. The most important difference between the two rounds
was the new BP monitor. The tests used 6 volunteers, 4 males and 2 females,
each tested over 30 minutes and using 5 minute calibration intervals. The PTT
method was evaluated using the Moens-Kortewegg equation as a basis. The re-
sults of this test showed that a 5 minute calibration interval was necessary, with
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longer calibration intervals failing the AAMI standard [127]. To identify a more
precise calibration interval, it was decided that another round of testing should
be undertaken, using a more frequent calibration interval of 2 minutes and using
more volunteers. It was also decided to evaluate the state of the art algorithms
for their ability to calculate BP from PTT in this test.
The final test, “Round 3 Testing”, described in this chapter was the evaluation
of the state of the art algorithms to track BP using PTT. The two algorithms
that were tested were the two most cited works in the area: Chen’s and Poon’s
algorithms. For these tests 15 volunteers were examined, 30 minutes of data was
recorded per sitting, with three sittings per volunteer i.e. each volunteer provided
a total of 90 minutes of data. BP was once again measured using the Omron M6
cuff at two minute intervals.
Chen’s algorithm was found to be statistically accurate when using a 6 minute
calibration interval, which was a slight improvement over Round 2 testing which
only used the Moens-Korteweg equation. However, throughout this work there
were significant concerns raised over the usefulness of the method due to the use
of the LFC and the filter. It was found that at short calibration intervals the LFC
kept the method accurate. For longer calibration intervals the filter was found to
have a much larger effect and the effect of the LFC was reduced.
Poon’s algorithm provided contrasting results, failing even when a two minute cal-
ibration interval was used. The standard deviation of 11mmHg that was achieved
was far greater than the allowed 8mHg from the AAMI standard. This was pri-
marily due to large spikes in the data which affected the mean and standard
deviation. However, an examination of the estimation of the BP provided by
Poon’s algorithm showed that it was capable of tracking changes in BP to some
extent rather than Chen’s algorithm whose prediction was dominated by the filter,
and thus bore no resemblance to either changes in PTT or BP.
Although Chen’s algorithm was shown to be accurate when using a 6 minute cal-
ibration interval, neither of the two algorithms tested were deemed good enough
for practical or clinical use. These results indicate that the PTT alone may not be
sufficient to track BP non-invasively and this conclusion along with these results
was published in the Journal of Human Hypertension [128]. Other authors have
also concluded that other parameters, the most prevalent of which is Pre-Ejection
Period or the time it takes the valve on the ventricle to open completely after
the R wave may need to be included in any such estimation in the future. Other
parameters that have been suggested include heart rate, stroke volume and a
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product of the two, Cardiac Output. The measurement of these parameters and
subsequent data recording will be discussed in the next chapter.
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Chapter 4
Measuring Stroke Volume and
Other Parameters
4.1 Introduction
As discussed in the previous chapter, there is a clear need for improvement in the
existing PTT algorithms, so that the PTT method can have a useful and practical
calibration interval as part of a continuous BP monitoring system. By examining
the results provided by these existing algorithms and studying the literature, a
number of parameters have been identified that could provide an improvement to
these algorithms if they were to be included in the calculation. The most critical
of these parameters include, but are not limited to, Cardiac Output (CO) [7, 81],
Stroke Volume (SV) and Pre-Ejection Period (PEP) [130].
In this chapter the methodology that was used to acquire these important pa-
rameters is discussed. Two methods were identified by which these parameters
could be acquired, either by using an Impedance Cardiograph (ICG) [131] or by
using the PhysioNet Resource. Each method has its own advantages and dis-
advantages and a two pronged approach was taken to investigate which method
would be most beneficial. Once the advantages and disadvantages were identified
for the PhysioNet Resource, they were also established for the ICG.
The first section discusses the use of the PhysioNet Resource [132], which is one
potential method that could be used to acquire the required parameters. This is a
large database of medical signals that have been measured from patients that have
been treated or have been in hospitals over extended periods of time, for a variety
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of reasons and who have had direct measurements of the parameters performed
through invasive means. The use of this database has its own difficulties, such as
identifying appropriate data, but also it eased some other concerns with reference
to clinical approval.
The next section discusses the evaluation of the ICG; this is a system that has
been used in the past to measure SV and CO, but is not a widely used tech-
nique. However, due to the number of parameters that can be measured by this
system, which also include PEP, it is the ideal tool to use because it could also
be incorporated into an existing PTT device, because both are wearable systems.
However, due to the limited information about the system, the lack of reference
material and design notes available, the issues associated with constructing such
a system were soon established.
Section 4.4 summarises the benefits and shortcomings of each method. The Phy-
sioNet Resource was chosen as the tool to acquire the parameters of interest. The
main disadvantage of using the PhysioNet Resource was that it was not possible
to measure PEP, but this database had one major advantage, namely the inclu-
sion of Arterial BP (ABP) data. Unlike the intermittent cuff measurements that
were used to evaluate the PTT algorithms in the previous chapter, the use of
ABP allowed a much better evaluation on a beat to beat and continuous basis of
these algorithms and any other that would be derived.
Finally, in section 4.5 Chen [14] and Poon [75] are re-examined using the Phys-
ioNet database, both as confirmation of the results of the previous chapter and
as an assurance of the value of the database.
4.2 PhysioNet Database
The PhysioNet Resource [132] is intended to stimulate current research and new
investigations in the study of complex biomedical and physiological signals. It
has three closely interdependent components:
• PhysioBank is a large archive and collection of 50 databases containing
biological and physiological signals for use by the biomedical community.
Some of the records within these databases are signals taken from healthy
people as well as from people suffering from a number of conditions includ-
ing, but not limited to, congestive heart failure, sleep apnoea and ageing.
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• PhysioToolkit is a growing collection of software applications for physio-
logical signal processing, detection of various events and analysis of signals.
• PhysioNet is the name of the resource and also the name of the website.
The website exists so that the signals and software available on it can be
freely distributed to allow the exchange of open source software and evalu-
ation of new algorithms.
The data within PhysioBank was the primary interest for this project. Phys-
ioBank itself contains 50 databases and among these databases 36,000 records
of annotated and digitized signals and time series data. Many of the databases
were developed in MIT and at Boston’s Beth Israel Hospital (now the Beth Israel
Deaconess Medical Center). Each of these records can be downloaded using the
software provided by PhysioToolkit. Further software from this resource is also
available to convert the downloaded records into a usable format that could be
interpreted by Matlab.
Depending on which database is used, any number of physiological signals may be
available. These are divided into two major categories described as being continu-
ous and non-continuous. For example in the Apnoea-ECG database, the primary
continuous signals monitored are various ECG signals and respiratory signals
whereas in the MIMIC II database, continuous signals recorded include ECG
Lead I, ECG Lead II, ECG Lead III, ECG Lead IV, ECG Lead V, Respiratory,
Plethysmography, Arterial BP and Pulmonary Arterial Pressure, among others.
Non-continuous measurements include systolic, diastolic, and mean blood pres-
sures, non-invasive arterial BP, cardiac output, carbon dioxide and heart rate,
among others. Throughout this database, “continuous” refers to signals that
have been sampled at a relatively high sampling rate (typically 125 Hz), whereas
“non-continuous” data is typically sampled only at approximately 1 Hz. A typical
example of the continuous signals available from the PhysioNet website can be
seen in Figure 4.1
It should be noted that regardless of the database, some records may only have
a selection of these signals whereas other records may contain all of them. For
this application the signals required were:
• An ECG signal that contained an easily recognisable R wave
• A plethysmograph (PPG) signal
• A BP measurement, preferably Arterial Blood Pressure (ABP)
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Figure 4.1: A typical chart of signals available from the PhysioNet website. [133].
• A Cardiac Output (CO) measurement
Both ECG and PPG signals are required to measure PTT. Since ABP seemed to
be almost as common as ECG in the records that also contained the PPG signal,
it was chosen to be another crucial signal. By including ABP as opposed to a
non-invasive or non-continuous BP measurement, it would be possible to compare
the prediction from the new algorithm to the actual BP on a beat-to-beat basis,
eliminating any errors that may occur due to point measurements from the non-
invasive BP measurement that may be a misrepresentation of the actual data ( i.e.
a BP measurement taken during an artefact). This was particularly important
because many of the records were from patients with various ailments that may
include cardiac arrhythmias for example, although information of this kind was
not always available.
The final critical signal was CO. Although it had been initially hoped that a con-
tinuous CO or SV signal would be available, the only CO measurements available
were non-continuous ones, typically taken at intervals of 1 minute. It was found
83 Brian M McCarthy
4. Measuring Stroke Volume and Other Parameters
that there were a number of different methods that could be used to derive CO
and SV from non-continuous records and the use of an ABP signal. All of these
methods are summarised and evaluated in the work of Sun [134]. The results of
this paper showed that the Liljestrand non-linear compliance method proved to
be the best at predicting CO on a beat to beat basis as opposed to the other
methods evaluated. The PhysioNet Resource also recommends this paper as the
best way to estimate CO from non-continuous measurements.
Although nearly every record examined had an associated ECG signal, finding
records that contained each of the four signals needed proved to be more difficult.
In fact, the most limiting signal was that of CO. Of the 50 databases that were
available, only 3 were found to have CO. One of these databases, the MIMIC II
database had to be omitted because while measuring the PTT, it was noted that
the PTT had a periodic repetitiveness, as can be seen in Figure 4.2. This meant
the PTT was found to have an almost sinusoidal waveform in this particular
database, something which had not been observed in any previous tests or in
other databases on the PhysioNet Resource. In an attempt to overcome this
issue, various different PTT definitions were used:
• Measuring the PTT as the time from the ECG R Wave to the peak of the
PPG wave
• Measuring the PTT as the time from the ECG R Wave to the foot of the
PPG wave
• Measuring the PTT as the time from the ECG R Wave to the point of
maximum inflection of the PPG wave
Examining the signal more closely, it was found that, regardless of which def-
inition was used, the periodic nature of the wave was apparent throughout, as
can be seen in Figure 4.2. It was also found that the sinusoidal nature of the
waveform corresponded to the sampling frequency and so it was felt, because of
concerns with regard to data reliability that this particular database should be
ignored.
The two remaining databases, which contained all the required signals, were the
MIMIC database [135] and the database from the 2009 Challenge [136], as de-
scribed below.
The MIMIC database has 72 complete records, most of which contain both ECG
and PPG records but only 38 were found to contain CO measurements. Of these
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Figure 4.2: The Periodic nature of the PTT measurement was apparent no matter
which of the three definitions were used.
38, only 14 records contained each of the four necessary signals.
The other database was the Challenge Set A and B from 2009. PhysioNet annu-
ally hosts a challenge, inviting participants to tackle clinically interesting prob-
lems. In 2009, the goal of the challenge was to predict which patients in the chal-
lenge dataset would experience an acute hypotensive episode beginning within a
certain forecast window. Each participant to the challenge is given access to a
limited number of records from an otherwise restricted database. These databases
are known as the challenge set databases and are used to create and test any al-
gorithm that the user can derive to predict, which patient would experience this
episode. Once each of the participants has submitted their algorithm, their al-
gorithms would be then tested on another database to check their effectiveness.
Using two of these Challenge Sets, Challenge Sets A and B, 27 of the records from
these databases reportedly had CO measurements; however, only 2 were found
to have CO, PPG, ABP and ECG signals.
A further limitation can be seen when Figure 4.3 is examined and compared to
its description in the database. In this database, CVP is listed as being available
throughout but in this particular window of 10 seconds, the signal is not present.
Unfortunately, this feature can be seen throughout all of the databases. In many
cases, signals may be available only for a matter of seconds or minutes. However,
in some records these signals may not be present at all. In the more typical case,
where the data becomes unavailable for a small period of time, this becomes a
large limitation when either developing or analysing algorithms. Ideally, each
85 Brian M McCarthy
4. Measuring Stroke Volume and Other Parameters
signal should be present for a matter of hours, over each record. This would
allow any algorithm that was developed to be analysed over the same timeline.
However, if there is a break in any of the signals, even for a few seconds, a beat
to beat analysis, such as the one being developed in this work, is not possible in
that window. Figure 4.3 shows the ABP signal disappearing and not reappearing
in this particular window (of 1 minute) as an example.
Figure 4.3: An example showing the ABP signal disappearing during a measure-
ment. It reappears a few minutes later [137]. It is also worth noting that although
being listed as available, CVP is not available in the window shown
There are many possible reasons why these gaps appear. Three suggested reasons
for this behaviour are:
• The patient was disconnected from the monitor for some period (perhaps
for a scan or to replace electrodes)
• The data collection system or the network over which the data was trans-
mitted crashed
• The data that was collected was corrupted and conversion was not possible
It was also not unusual for only one of the four signals to disappear for a few
seconds before reappearing.
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4.3 The Impedance Cardiograph
Impedance Cardiography, Transthoracic Bioimpedance or Impedance Plethys-
mography is a non-invasive tool used for the measurement of Stroke Volume (SV)
and Cardiac Output (CO). Other cardiac parameters such as PEP and Left Ven-
tricle Ejection Time (LVET), which are important parameters for the diagnosis
of cardiac illnesses can also be derived from the use of an ICG. The concept
of ICG was first developed by Kubicek in 1966 [138] for NASA, which resulted
in the Minnesota Impedance Cardiograph [139]. Since then, there have been a
number of commercially available devices developed, but the invasive method of
thermodilution remains the gold standard in Cardiac Output estimation. Ther-
modilution uses a Pulmonary Artery Catheter (PAC) to estimate cardiac output
but has associated risks such as infection, sepsis and mortality and it is therefore
only used for critically ill patients [140]. The main attraction of ICG is that it is
non-invasive, easy to use, inexpensive and provides real-time data [141]. However,
its main disadvantage is that it is very susceptible to motion artifacts.
4.3.1 Impedance Cardiography Instrumentation
The ICG method involves the application of an alternating current of less than
4mA at a frequency of 20 - 100kHz into the body through a set of outer thoracic
electrodes and recording the associated voltage drop across another inner set
of electrodes as shown in Figure 4.5. Although direct current could present a
medical hazard, the 4 mA alternating current in the frequency range of 20 -
100kHz does not [131]. If no inductive or capacitive elements are contained in
the system, the impedance measured is equal to the resistance. Human tissue is
known to be mainly resistive in this frequency range [142]. Due to Ohms Law,
the recorded voltage will vary inversely with the resistivity of the thoracic current
path. The body components with the lowest resistivity are blood and plasma,
so the measured thoracic impedance is highly sensitive to changes in the cardiac
and aortic distribution and flow of blood in the cardiac cycle [143].
The electrode placement shown in Figure 4.4 is the most common arrangement
and most widely accepted [144]. The inner (red) set of electrodes shown in the
diagram, are used to record the impedance changes within the thorax [12]. This
measured signal is known as the impedance or ∆Z waveform but contains no
information and is not directly used to calculate any of the parameters. The
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Figure 4.4: A representation of a typical ICG electrode system, the blue dots
representing the current injection strip electrodes and the red dots representing
the impedance measurement strip electrodes.
important waveform is that of dZ
dt
from which the systolic times and SV can be
calculated.
Figure 4.5: The waveforms measured and recorded from an ICG system [12].
Three variables measured from the impedance waveform are used to calculate
SV.
• The baseline impedance of the thorax Z0, also known as the Thoracic Fluid
Index (TFI)
• The maximum rate of change occurring in the ∆Z waveform,
(
dZ
dt
)
max
,
identified as the peak value in the dZ
dt
signal.
• The Left Ventricle Ejection Time (LVET)
Development of a Novel PTT Based
Algorithm
88
4.3 The Impedance Cardiograph
The relevant waveforms that are extracted from ICG measurements are shown
in Figure 4.5. ECG is also required as part of the ICG system to calculate the
Heart Rate (HR) but more importantly it is also used to identify the onset of
electromechanical systole, which is required to measure Pre-Ejection Period. This
onset occurs at the Q point of the ECG waveform. It can be difficult to identify
the Q wave and so the R-wave can be used as an approximation of the onset of
the electromechanical systole.
The B point is used to indicate the onset of the rapid up slope of the dZ
dt
as it
rises to the peak value
(
dZ
dt
)
max
. The B point is used to indicate the time of onset
of LVET and the end of the PEP. Finally the X point represents the lowest point
in the dZ
dt
waveform. It is seen as the sharp notch which represents the closure of
the aortic valve at the end of the left ventricle ejection.
4.3.2 Calculation of Stroke Volume
As mentioned in section 4.3, Kubicek presented the original ICG in 1966 [138]
and presented the results of correlation with other invasive methods using the
formula:
SV = ρb
L2
Z20
∆Z (4.1)
measured in [ml] and where ρb is the resistivity of the blood [Ω/cm], L is the
distance between the electrodes [m], Z0 is the basal impedance (or impedance of
the body between the electrodes) [Ω] and ∆Z [Ω] is the impedance change as a
function of time. In 1974, this formula was modified using the first derivative of
the impedance signal and incorporating LVET [s].
SV = ρb
L2
Z20
LV ET
(
dZ
dt
)
max
(4.2)
Since impedance Z0 of a uniform volume conductor, is directly proportional to ρb
and L and inversely proportional to the cross sectional area A [cm2].
Z0 = ρb
L
A
(4.3)
Rearranging and incorporating (4.3) into (4.2):
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SV = Z0 × A
L
· L
2
Z20
LV ET
(
dZ
dt
)
max
(4.4)
SV = A× L× LV ET
(
dZ
dt
)
max
Z0
(4.5)
SV = V EPT × LV ET
(
dZ
dt
)
max
Z0
(4.6)
Where VEPT is the Volume of Electrically Participating Tissue of the thorax
[m3]. Absolute values of SV depend on a good estimation of VEPT and this is
the primary difference between existing formulae [145]. Sramek and Bernstein
estimate VEPT by modeling the thorax as a cylinder [146] and that the circum-
ference C [m] of the lower part of the body at the xiphoid is roughly three times
the measured linear distance between the electrodes regardless of age and sex
[147].
C = 3L = 2pir (4.7)
r = 3L2pi (4.8)
V EPT = r2 × pi × L (4.9)
V EPT =
(3L
2pi
)2
piL = 9L
3
4pi ≈
L3
1.4 (4.10)
SV = L
3
1.4 × LV ET
(
dZ
dt
)
max
Z0
(4.11)
Sramek reported that SV is overestimated in (4.11), and therefore changed the
cylindrical model to that of a frustum and determined this volume to be one third
of the cylinder.
SV = 13 ×
L3
1.4 × LV ET
(
dZ
dt
)
max
Z0
(4.12)
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SV = L
3
4.2 × LV ET
(
dZ
dt
)
max
Z0
(4.13)
Finally Sramek determined that in a large normal adult population, the distance
between electrodes L should be 17% of body height H [m].
SV = (0.17H)
3
4.2 × LV ET
(
dZ
dt
)
max
Z0
(4.14)
In 1986 Bernstein [148] modified (4.14) by introducing the term δ (the actual
weight divided by the ideal weight) which accounted for deviations from ideal
body weight as established by Metropolitan Life insurance tables. The reason
for this was to more accurately determine the volume of the thorax [139]. This
resulted in the equation for SV:
SV = δ × (0.17H)
3
4.2 × LV ET
(
dZ
dt
)
max
Z0
(4.15)
Once SV has been determined, the calculation of CO [l/min] can be performed
easily by comparison and is given by:
CO = SV ×HR (4.16)
4.4 Choice of Acquisition Methodology
The ICG is, in theory, the ideal system to be used for this application. Each
of the relevant parts of the ICG has been identified and designed as described
in Appendix C, as part of this project, while the investigation of the PhysioNet
database was taking place. However, during the design process the complexity
of the system became apparent. It also became evident that the implementation
of such a system was outside the scope of the project, which was to develop an
algorithm to enable a continuous BP monitoring system, rather than developing
a full system to do the same. Once the algorithm was developed, it was clear that
the ICG was the system that could be used to measure the required parameters
as part of a non-invasive and wearable continuous BP monitor, but the algorithm
was the primary focus of the work described in this thesis.
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Since the PhysioNet Database had been shown to contain all the required param-
eters, it was considered to be a valid alternative to the use of the ICG system.
Although using the PhysioNet Resource meant that PEP could not be included in
the evaluation and development of a new algorithm, the major advantage of the
PhysioNet Resource was that it contained beat to beat invasive measurements of
ABP. This parameter is of significant importance when evaluating beat to beat
and continuous based algorithms and when designing or deriving new algorithms,
this parameter would also be of vital importance.
Therefore, the PhysioNet Resource was chosen as the tool to acquire all the pa-
rameters of interest for this application. Once the algorithm had been developed,
it would then be possible to return to the ICG board to continue the development
and implementation that were required for it to become operational and the en-
tire system (the ICG and PTT systems) could be further tested on volunteers as
the wearable system that was original envisaged.
To verify the database and identify its usefulness, it was decided that the algo-
rithms discussed in Chapter 3 i.e. Chen and Poon, should be re-evaluated using
the PhysioNet data. An added benefit of doing this would be that it would further
emphasise the usefulness and accuracy of the algorithms used to convert PTT to
BP using the existing algorithms.
4.5 Evaluation of Existing Algorithms using the
PhysioNet Database
4.5.1 Testing Methodology
As discussed in Chapter 3, various authors have reported the benefits of the
PTT method and there is no consensus as to which approach is best. Following
the results discussed in chapter 3, a better understanding of the strengths and
weaknesses of two of the existing algorithms i.e. those of Chen’s and Poon’s
algorithms had been established. Since this new data resource was available, it
was possible to re-examine these algorithms using a more comprehensive database
to verify the results obtained previously. To this end, 15 subjects/records were
chosen to examine this relationship and these algorithms. Three tests, each having
a duration of 30 minutes were taken from each record, in a similar fashion to the
original tests [128].
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Although it was originally hoped that 15 records could be chosen at random
(once the record had the required signals), it was quickly discovered that some
records did not have sufficient signal quality, due to artifacts or noise. From the
16 complete records that were available, 15 records were found to have sufficient
signal quality and continuous data over the 30 minutes required for the same
analysis that had been performed in the original test.
4.5.2 Characteristic Point Extraction Algorithms
Although the specifics for extracting the characteristic points from each of the
signals had been previously developed, new code and algorithms had to be devel-
oped so that the various peaks and points of interest could be extracted because
of the change of quality of the signals. Most of the peak extraction algorithms
that had been previously developed were equally applicable here i.e. the ECG R
wave identification algorithm worked very well for this database, as it had when
used on the original data. However, the most significant change was required
when extracting data from the PPG signal.
Figure 4.6: When the peak of the PPG wave was used to measure the PTT of
some patients in this test, it was found that the peak occurred after the R wave
of next cardiac cycle.
Upon initial investigation, it became apparent that using the peak of the PPG
data was no longer valid as it was found that in some cases the PPG peak occurred
after the subsequent ECG peak, as illustrated in Figure 4.6. In this figure, it is
evident that the peak point of the PPG wave occurs after the ECG R wave
of the next cardiac cycle. Due to the lack of information available for each
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patient, it could not be established exactly why this was but from the records
that were available, the only significant commonality was that the patients from
the database were significantly older than the volunteers that had been tested in-
house in Tyndall, which may have been a factor. However, in order to overcome
this from an analytical perspective, various other characteristic points of the
PPG wave were examined as alternatives to measure PTT. It has been previously
established that other points of the PPG wave can be used to measure PTT and
there is some debate as to which point is best. The points normally used to define
the PTT are:
• The peak of the PPG wave
• The point of maximum inflection
• The onset of the PPG wave
The point of maximum inflection of the PPG wave is found by taking the first
derivative of the PPG wave. The peak of this wave is the point of maximum
inflection of the PPG wave. The peak (of the first derivative wave) was detected in
a similar fashion to that described in the description of peak PPG wave detection,
discussed previously in chapter 3 i.e. by using a combination of a threshold based
technique and a minimum specific distance between points, as shown in Figure
4.7
Figure 4.7: The use of the first derivative of the PPG wave to find the point of
maximum inflection.
The onset of the PPG wave was detected using the second derivative of the PPG
wave. However, it was found that the 2nd derivative of this wave was quite noisy,
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as can be seen in green in Figure 4.8. So, the second derivative was filtered using
a 30 point Moving Average Filter, and this helped to reduce noise and artifacts.
It was found that the filtered 2nd derivative waveform, plotted in magenta in
Figure 4.8, had similar characteristics to that of the ECG wave. In this signal
there are numerous other peaks that could be misinterpreted as the point of
interest which a thresholding based system could not differentiate from the point
of interest. Similar to the ECG R peak, in this signal there was a sudden drop
in amplitude after the peak of interest, similar to the S wave in the ECG signal,
marked by a red star in Figure 4.8. It was decided that this characteristic "S"
wave could be used to identify the point of interest and was identified by using
a modified version of the ECG R wave detection algorithm, using a combination
of a threshold and minimum distance approach to the inverted, second derivative
filtered waveform.
The peak of this second derivative wave, which marked the onset point (blue
star) was then identified by using the minimum distance and threshold approach,
as well as specifying a maximum distance between it and the characteristic "S"
point. Using all of these characteristics the location of the onset point of the
PPG wave was identified, marked by a blue star in Figure 4.8 .
Figure 4.8: The characteristic points and waveforms used to identify the onset of
the PPG wave.
It was noted that the quality of the signals was generally better than those that
had been recorded from volunteers in the previous tests. The reason for the
improvement in signal quality was because these new signals were recorded in a
clinical setting, from much more expensive and precise pieces of equipment. This
type of equipment generally employs various filters and technology that are not
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generally available. However, some motion artifacts were still present throughout
the test data. These artifacts were primarily with regard to either the ECG or
the PPG sensor but the previously developed peak detection algorithms managed
to deal with the minor artifacts. All other artifacts were found to be either too
large to compensate for or the data quality around them was too poor to be of
any use; an example of a large artefact can be seen in Figure 4.9. In this figure,
a large artefact can be seen on the PPG signal, which affects the signal and foot
detection algorithm for a few seconds before returning to a more typical signal.
There is also a minor artefact present in the ECG signal; however, this does not
adversely affect the peak detection algorithm.
Figure 4.9: An example of both large artifacts (PPG signal in black with foot
points in magenta) and minor artifacts (ECG signal in blue with R peaks in green)
that were occasionally present among patients from the PhysioNet Database.
4.5.3 Systolic & Diastolic BP Determination from the Ar-
terial Blood Pressure Wave
Both the Diastolic BP (DBP) and the Systolic BP (SBP) were derived from the
Arterial BP (ABP) wave, the peak of the wave being the SBP and the trough
being the DBP. The SBP was determined using the threshold and minimum
distance based algorithm described earlier. The DBP was found in the same
manner, but by using the inverse of the ABP wave. The method that had been
developed for R peak detection was also found to be effective for extracting both
of these values.
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Figure 4.10: The steps required for calculating ABP.
4.5.4 Evaluating the Database
Table 4.1 shows the results of using Chen’s algorithm to track BP over each
calibration interval, presented in the format used in the AAMI standard and
Table 4.2 uses the BHS standard to evaluate Chen’s algorithm.
On examination of both Table 4.1 and Table 4.2, the point at which the filter
becomes dominant is obvious. Up to and including the 6 minute calibration
interval, a combination of the low frequency component and the filter that Chen
uses, which seems to be tuned to a 5 minute interval, ensures the error always
remains low and the effect of the filter is seen by the fact that all the errors occur
in one direction only in Figure 4.11a and Figure 4.11b. However, the longer the
calibration interval, the more dominant the filter becomes and the error becomes
greater. This is further emphasised using the Bland Altman graphs (explained
previously in section 3.10), Figure 4.11, where the standard deviation steadily
increases over the 2 - 6 minute calibration intervals before dramatically increasing
after each subsequent calibration interval.
In all of these graph, from Figure 4.11a through to Figure 4.11f, the number
of outliers only slightly increases as the calibration interval grows. The reason
for the growth in outliers is strongly linked with the growth of the error that
is due to the characteristics of the HFC and the LFC in Chen’s algorithm. If
there is a large change in BPs between measurements, the LFC is capable of
accounting for these changes at lower calibration intervals. However, at higher
calibration intervals, the error is completely dependent on the effect of the filter.
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Table 4.1: A summary of the results overall and from each volunteer. Each
result represents the mean error ± the standard deviation of error between the
Estimated BP, given by the PTT method, and Measured BP given by the ABP
Volunteer 2 Minute
Interval
4 Minute
Interval
6 Minute
Interval
8 Minute
Interval
10
Minute
Interval
12
Minute
Interval
pat 1 0.01±0.02 0.01±0.01 0.43±0.40 10.90±11.77 19.91±2.84 −27.43±5.96
pat 2 0.02±0.04 0.02±0.02 0.30±0.07 6.04±2.25 17.54±4.58 −22.56±11.13
pat 3 0.00±0.01 0.00±0.01 0.32±0.75 6.64±14.10 11.28±8.38 −5.20±19.80
pat 4 0.04±0.06 0.02±0.03 0.32±0.06 7.21±0.91 18.83±2.16 −30.39±5.54
pat 5 0.01±0.02 0.01±0.01 0.35±0.02 7.70±0.25 18.54±0.53 −34.63±1.18
pat 6 0.01±0.03 0.01±0.02 0.42±0.49 7.58±0.36 18.94±1.04 −33.45±2.15
pat 7 0.02±0.03 0.01±0.02 0.26±0.09 5.92±2.09 17.94±3.28 −21.76±16.58
pat 8 0.01±0.02 0.01±0.01 0.23±0.02 5.48±0.32 15.13±0.48 −23.90±2.20
pat 9 0.04±0.06 0.03±0.04 0.35±0.17 7.93±4.57 22.27±13.82 −30.27±3.84
pat 10 0.03±0.05 0.02±0.03 0.26±0.07 6.15±1.25 19.51±2.28 −13.55±15.58
pat 11 0.01±0.02 0.01±0.01 0.35±0.02 7.67±0.22 18.62±0.30 −34.37±1.16
pat 12 0.03±0.04 0.02±0.02 0.35±0.05 7.56±0.69 19.02±1.25 −32.44±4.74
pat 13 0.03±0.04 0.01±0.02 0.29±0.07 6.73±1.14 19.23±2.25 −27.38±8.33
pat 14 0.01±0.01 0.01±0.01 0.36±0.52 6.08±1.00 19.72±1.35 −21.34±8.74
pat 15 0.01±0.02 0.01±0.01 0.30±0.04 6.95±0.58 19.11±0.66 −28.24±6.60
All −0.02±0.04 −0.01±0.02 −0.33±0.30 −7.08±5.10 −18.26±4.62 25.65±12.27
Table 4.2: A summary of the results using percentage predicted values falling
within 5, 10 and 15 mmHg, based on the system for assessing BP measurement
accuracy. Each calibration interval is assessed using this method and the asso-
ciated BHS standard is provided in the last column. A rating of “B” is deemed
acceptable, while a rating of “C” or “D” is deemed a fail.
Volunteer 2 Minute Interval 4 Minute Interval 6 Minute Interval
5 mmHg 10 mmHg 15 mmHg Grade 5 mmHg 10 mmHg 15 mmHg Grade 5 mmHg 10 mmHg 15 mmHg Grade
pat 1 100% 100% 100% A 100% 100 % 100% A 100% 100 % 100% A
pat 2 100% 100% 100% A 100% 100 % 100% A 100% 100 % 100% A
pat 3 100% 100% 100% A 100% 100 % 100% A 100% 100 % 100% A
pat 4 100% 100% 100% A 100% 100 % 100% A 100% 100 % 100% A
pat 5 100% 100% 100% A 100% 100 % 100% A 100% 100 % 100% A
pat 6 100% 100% 100% A 100% 100 % 100% A 100% 100 % 100% A
pat 7 100% 100% 100% A 100% 100 % 100% A 100% 100 % 100% A
pat 8 100% 100% 100% A 100% 100 % 100% A 100% 100 % 100% A
pat 9 100% 100% 100% A 100% 100 % 100% A 100% 100 % 100% A
pat 10 100% 100% 100% A 100% 100 % 100% A 100% 100 % 100% A
pat 11 100% 100% 100% A 100% 100 % 100% A 100% 100 % 100% A
pat 12 100% 100% 100% A 100% 100 % 100% A 100% 100 % 100% A
pat 13 100% 100% 100% A 100% 100 % 100% A 100% 100 % 100% A
pat 14 100% 100% 100% A 100% 100 % 100% A 100% 100 % 100% A
pat 15 100% 100% 100% A 100% 100 % 100% A 100% 100 % 100% A
All 100% 100% 100% A 100% 100 % 100% A 100% 100 % 100% A
Volunteer 8 Minute Interval 10 Minute Interval 12 Minute Interval
5 mmHg 10 mmHg 15 mmHg Grade 5 mmHg 10 mmHg 15 mmHg Grade 5 mmHg 10 mmHg 15 mmHg Grade
pat 1 0.00 % 84.62% 89.74 % D 0.00 % 0.00 % 0.00 % D 0.00 % 0.00 % 0.00 D
pat 2 12.82% 100 % 100 % D 5.56 % 11.11% 11.11 % D 15.15% 15.15 % 15.15 A
pat 3 74.36% 89.74 % 89.74 % C 33.33 % 33.33 % 50.00 % D 48.48 % 57.58% 66.67 D
pat 4 2.56 % 97.44 % 100 % D 0.00 % 0.00 % 2.78 % D 0.00 % 0.00 % 0.00 D
pat 5 0.00 % 100 % 100 % D 0.00 % 0.00 % 0.00 % D 0.00 % 0.00 % 0.00 D
pat 6 0.00 % 100 % 100 % D 0.00 % 0.00 % 0.00 % D 0.00 % 0.00 % 0.00 D
pat 7 25.64 % 100 % 100 % D 2.78 % 2.78 % 8.33 % D 6.06 % 6.06 % 9.09 D
pat 8 10.26 % 100 % 100 % D 0.00 % 0.00 % 0.00 % D 0.00 % 0.00 % 0.00 D
pat 9 0.00% 95.83 % 95.83 % D 0.00% 0.00% 0.00% D 0.00 % 0.00 % 0.00 D
pat 10 23.08 % 100 % 100 % D 0.00 % 0.00 % 2.78 % D 0.00 % 6.06 % 33.33 D
pat 11 0.00 % 100% 100 % D 0.00 % 0.00 % 0.00 % D 0.00 % 0.00 % 0.00 D
pat 12 0.00 % 97.44 % 100 % D 0.00 % 0.00 % 0.00 % D 0.00 % 0.00 % 0.00 D
pat 13 10.26 % 100 % 100 % D 0.00 % 0.00 % 2.78 % D 3.03 % 6.06 % 12.12 D
pat 14 17.95 % 97.44 % 97.44 % D 0.00 % 0.00 % 0.00 % D 0.00 % 6.06 % 24.24 D
pat 15 0.00 % 100 % 100 % D 0.00 % 0.00 % 0.00 % D 3.03 % 3.03 % 3.03 D
All 12.11 % 97.72 % 98.42 % D 2.86 % 3.24 % 8.19 % D 5.21 % 6.88 % 11.25 D
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Although the general shape of the HFC is always the same, it has been observed
that sometimes the magnitude of the change due to the HFC can be dramatically
different. This can be seen in Figure 3.16a where there is very little change due
to the HFC in the second interval (in red), while the change is much greater
during the third interval (in magenta) and in Figure 3.16c where the change in
magnitude of the HFC in the first interval (in blue) is much greater than the
second interval (in red). It is these large changes that occur even within the
same tests that are responsible for the outliers. As can be seen from Figure 3.16a
and Figure 3.16c, the magnitude of the change, increases with the calibration
interval. When there is a particularly large (inter-test) change in magnitude due
to the HFC in the larger calibration intervals, the outlier is more prominent. For
example, in Figure 4.11d the maximum outlier has an error of -60 mmHg, whereas
in Figure 4.11f, the maximum outlier has an error of 120 mmHg.
Conversely, the results from Poon show a slight, albeit insignificant, improvement
in results. In Chapter 3, it was established that Poon failed even when using the
lowest calibration interval of 2 minutes. This was found to be the case again
when the AAMI standard is used. However, when using this new database and
the BHS standard, the results showed a slight improvement since the algorithm
passes when a two minute calibration interval is used, but fails when a four
minute calibration interval is applied. In the original test, one of the primary
criticisms of Poon’s algorithm was that it was quite noisy compared to the cuff
measurements that were being used to evaluate it. In this test, the arterial
systolic BP was available on a beat-to-beat basis and a more detailed analysis was
possible. Comparing Poon’s prediction to the ABP on a beat to beat analysis,
it was found that the algorithm was capable of tracking BP to a much higher
degree than the original results would suggest. Comparing Poon’s algorithm to
Chen’s it can be seen that Poon’s algorithm actually tracks changes in BP quite
well, as shown in Figure 4.12.
The use of the foot of the PPG wave to define PTT, rather than using the peak
of the PPG wave, as was the case in the previous chapter made no difference,
because Poon’s algorithm divides the beat to beat PTT value by its base value
i.e. a normalised PTT value is used.
Tables 4.3 and 4.4 present the results of using Poon’s algorithm on the data from
the PhysioNet Resource. A noteworthy set of results was obtained from patients
1 and 4 where the standard deviations were found to be quite high throughout.
This is highlighted by examining both Table 4.3 and Table 4.4, even at the lower
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(a) 2 Minute Calibration Interval (b) 4 Minute Calibration Interval
(c) 6 Minute Calibration Interval (d) 8 Minute Calibration Interval
(e) 10 Minute Calibration Interval (f) 12 Minute Calibration Interval
Figure 4.11: The Bland Altman graphs for Chen’s algorithm accumulated across
13 individuals for the six intervals (a - f). The deterioration of the results is
seen by the increase in magnitude of the outliers and the growing errors at each
interval.
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Figure 4.12: Poon’s algorithm (in cyan) is able to track the actual changes in
ABP (blue) quite well, especially when compared to Chen’s prediction (in green)
Table 4.3: Evaluation of Poon’s algorithm with respect to the AAMI standard.
Each result represents the mean error± the standard deviation of error between
the Estimated BP, given by the PTT method, and Measured BP, given by the
ABP.
Volunteer 2 Minute
Interval
4 Minute
Interval
6 Minute
Interval
8 Minute
Interval
10
Minute
Interval
12
Minute
Interval
pat 1 3.78±17.02 2.39±16.98 3.82±16.09 6.32±14.23 −0.15±14.34 −2.67±14.10
pat 2 0.32±6.65 0.82±8.64 1.17±9.70 2.25±11.54 2.68±12.53 4.15±11.29
pat 3 3.11±8.77 2.08±8.64 2.01±8.52 1.73±9.74 1.76±9.17 0.26±7.99
pat 4 −0.98±12.62 −0.68±11.78 −0.35±12.31 −1.27±12.76 −2.31±13.47 0.16±15.12
pat 5 −0.37±4.64 −0.75±5.03 −0.84±5.85 −1.43±6.19 −2.28±5.69 −2.28±6.05
pat 6 0.81±10.22 1.42±9.35 1.55±9.73 1.40±11.27 0.88±10.10 3.12±10.10
pat 7 −0.53±10.02 −1.07±11.18 0.16±11.67 0.19±9.95 0.00±7.05 1.78±8.57
pat 8 0.37±3.37 0.74±3.81 0.81±4.11 0.97±4.33 1.71±4.70 2.27±5.08
pat 9 0.48±9.60 1.40±14.42 2.71±16.18 4.04±16.25 2.93±14.59 1.05±12.77
pat 10 −1.34±8.01 −1.51±8.46 −1.87±6.78 −1.78±8.53 −1.92±8.62 −2.30±8.37
pat 11 −0.75±3.93 −1.09±6.04 −0.88±6.25 −0.57±6.22 −0.60±6.16 −0.70±5.99
pat 12 −0.34±10.11 −0.36±11.86 0.18±10.44 0.25±9.93 0.59±10.80 1.42±10.54
pat 13 −0.61±9.79 −0.66±9.03 −1.09±9.97 −1.98±11.95 −1.87±12.40 −1.67±9.81
pat 14 1.13±7.93 0.46±8.70 0.31±9.65 0.89±6.75 0.38±7.57 0.86±8.21
pat 15 0.43±3.23 0.72±3.77 0.93±4.28 1.25±4.75 0.94±4.04 1.10±6.68
All −0.36±9.14 −0.24±9.69 −0.52±9.88 −0.73±10.09 −0.10±9.85 −0.42±9.77
calibration intervals. The reasons for this are unclear for Patient 4, but a possible
explanation exists for Patient 1 and this will be expanded below.
Examining Figure 4.13, a slight growth of outliers and growth of the standard
deviation can be seen. Examining the “All” values of Table 4.4, in particular
for the 4 minute calibration interval, it can be seen that the level of failure is
very slight, the key number being the third percentages. A “B” rating or pass is
awarded if the third percentage is greater than 90%. In the 4 minute calibration
interval the algorithm fails by 0.61%. This shows the level of failure is quite
slight and so observing this failure is not practical, especially by comparing the 2
and 4 minute calibration intervals, shown in Figure 4.13a and Figure 4.13b. The
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Table 4.4: A summary of the results of Poon’s algorithm using the BHS standard.
A rating of “B” is deemed acceptable, while a rating of “C” is deemed a fail.
Volunteer 2 Minute Interval 4 Minute Interval 6 Minute Interval
5 mmHg 10 mmHg 15 mmHg Grade 5 mmHg 10 mmHg 15 mmHg Grade 5 mmHg 10 mmHg 15 mmHg Grade
pat 1 50.00% 66.67% 68.75% C 31.11% 62.22 % 71.11 % D 47.62% 71.43% 73.81 % C
pat 2 70.83% 87.50% 95.83% A 53.33% 84.44 % 93.33% B 50.00% 76.19% 88.10% C
pat 3 83.33% 87.50% 87.50% C 84.44% 88.89 % 88.89 % C 76.19% 88.10% 88.10 % C
pat 4 25.00% 56.25 % 75.00 % D 20.00% 64.44 % 75.56 % D 28.57% 54.76% 78.57 % D
pat 5 81.25% 95.83% 97.92% A 73.33% 93.33 % 100 % A 69.05% 90.48% 97.62 % A
pat 6 58.33% 79.17 % 89.58% C 46.67% 84.44 % 91.11 % C 54.76% 80.95% 92.86 % B
pat 7 58.33% 79.17 % 87.50% C 46.67% 71.11 % 80.00 % C 40.48% 69.05% 76.19% B
pat 8 87.50% 100% 100% A 84.44% 97.78 % 100 % A 78.57% 97.62% 100% A
pat 9 66.67% 78.79% 90.91% A 43.33% 66.67 % 76.67 % D 37.04% 55.56% 62.96% D
pat 10 50.00% 75.00% 93.75% A 51.11% 71.11 % 91.11 % A 50.00% 80.95% 100% A
pat 11 89.58% 95.83 % 100% C 68.89% 88.89 % 95.56% A 71.43% 92.86% 95.24% D
pat 12 50.00% 77.08% 85.42% C 48.89% 71.11 % 86.67 % C 33.33% 71.43% 85.71% C
pat 13 43.75% 79.17% 91.67% B 55.56% 77.78% 91.11 % B 52.38% 83.33% 92.86% B
pat 14 66.67% 93.75 % 95.83% A 71.11% 91.11 % 95.56 % A 64.29% 88.10% 92.86% A
pat 15 89.58% 100% 100 % A 84.44% 100 % 100 % A 80.95% 97.62% 100% A
All 64.68% 83.55% 90.64% B 57.88% 81.21% 89.39 % C 56.10% 80.49 % 88.94% C
Volunteer 8 Minute Interval 10 Minute Interval 12 Minute Interval
5 mmHg 10 mmHg 15 mmHg Grade 5 mmHg 10 mmHg 15 mmHg Grade 5 mmHg 10 mmHg 15 mmHg Grade
pat 1 23.08 % 51.28% 71.79% D 41.67% 58.33% 75.00% D 27.27 % 54.55% 75.76% D
pat 2 43.59 % 74.36% 82.05% D 38.89% 63.89% 80.56% D 39.39 % 66.67% 75.76% D
pat 3 58.97 % 82.05% 84.62% C 58.33% 83.33% 83.33% C 60.61 % 87.88% 87.88% C
pat 4 35.90 % 64.10% 79.49% D 22.22% 52.78% 63.89% D 30.30 % 51.52% 69.70% D
pat 5 53.85 % 92.31% 94.87% B 66.67% 83.33% 100 % B 54.55% 87.88% 96.97% B
pat 6 43.59 % 71.79% 84.62% C 44.44% 75.00% 88.89% C 54.55 % 75.76% 87.88% C
pat 7 41.03 % 82.05% 87.18% C 50.00% 86.11% 97.22% C 39.39 % 81.82% 93.94% C
pat 8 74.36% 97.44% 100 % A 80.56% 91.67% 100 % A 66.67 % 90.91% 100 % A
pat 9 25.00% 50.00% 58.33% D 33.33% 47.62% 76.19% D 27.78 % 55.56% 77.78% C
pat 10 33.33% 74.36% 94.87 % A 44.44% 75.00% 86.11% A 42.42 % 72.73% 87.88 % A
pat 11 66.67% 87.18% 97.44% D 69.44% 86.11% 97.22% D 69.70 % 87.88% 100% D
pat 12 41.03% 64.10% 82.05% B 38.89% 66.67% 83.33% B 33.33 % 72.73% 84.85% D
pat 13 58.97% 84.62% 94.87% D 44.44% 75.00% 91.67% C 36.36 % 69.70% 84.85% C
pat 14 69.23% 92.31% 97.44% A 61.11% 91.67% 97.22% A 60.61 % 87.88% 96.97% B
pat 15 74.36% 94.87% 97.44% A 77.78% 97.22% 100 % A 78.79 % 93.94% 96.97% A
All 50.18% 78.25% 87.89% C 52.00% 76.38% 88.38% C 48.75 % 76.46% 88.13% C
expansion of the cluster is more apparent in Figure 4.13e and Figure 4.13f, as are
the growing number of outliers, but part of this is due to fewer data points being
recorded for these intervals.
Examining both the AAMI and BHS evaluation tables, it can be seen that if
Patients 1 and 4 were omitted from the examination a clear improvement in
Poon’s results would be observed. Although the SV recorded from Patient 1 is
quite high, which could be an indicator of some other illness which may affect
these results, there is no other information available about their health nor is
there any information available from Patient 4, whose physiological signals are
well within the normal distribution. Therefore, without a reasonable explanation,
neither of these patients and their associated results can be nor should be omitted
from the tests and thus the results must be included.
In the original examination of Poon’s algorithm, described in Chapter 3, the
greatest criticism of Poon’s algorithm was that it provided a very “noisy” esti-
mation when compared to the intermittent cuff measurements. However, when
Poon’s estimation is compared to ABP, it can be seen that it frequently does not
track changes in the BP by a large enough degree. An example of this can be
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4.5 Evaluation of Existing Algorithms using the PhysioNet Database
(a) 2 Minute Calibration Interval (b) 4 Minute Calibration Interval
(c) 6 Minute Calibration Interval (d) 8 Minute Calibration Interval
(e) 10 Minute Calibration Interval (f) 12 Minute Calibration Interval
Figure 4.13: The Bland Altman graphs for Poon’s algorithm accumulated across
13 patients for the six intervals (a - f). The deterioration at the 4 minute calibra-
tion interval is practically unobservable but is more apparent for longer calibration
intervals
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Figure 4.14: Poon’s algorithm (in cyan) and its ability to track the measured ABP
(in blue). The problem of Poon’s algorithm occasionally not tracking changes in
BP by a large enough amplitude
seen in Figure 4.15 where although Poon’s algorithm increases and decreases as
the BP does, the amplitude of the prediction is only a fraction of the amplitude
of the actual change in BP.
Unfortunately, this is not the only criticism of the algorithm. It has been noticed
that there is frequently a poor initial estimation that is greater than 5 mmHg, a
critical value in both standards, as can be seen in Figure 4.14. This estimation is
usually corrected after the calibration interval has elapsed. When the calibration
interval is short, these errors, due to poor initial estimations, are not very notice-
able because there are a lot of other data points that are within the standards
i.e. when using a 2 minute calibration interval for each patient, 15 measurements
are taken over 30 minutes and a poor initial estimation could mean only one of
the 15 measurements is outside the standards. However, as the calibration inter-
val increases, the error due to a poor initial estimation becomes more significant
and noticeable because fewer data points are being measured i.e. at a 12 minute
calibration interval, only 10 intervals can be examined (i.e. 0 - 12 minutes, 2 - 14
minutes, 4 - 16 minutes, 6 - 18 minutes, 8 - 20 minutes, 10 - 22 minutes, 12 - 24
minutes, 14 - 26 minutes 16 - 28 minutes and 18 - 30 minutes), and a large error
due to a poor initial estimation has a much greater influence on the results.
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Figure 4.15: Poon’s algorithm (in cyan) and the large offset that is prominent in
many of its predictions of ABP (in blue).
4.6 Conclusions
The purpose of the work described in this chapter was to a find a method to mea-
sure Stroke Volume and associated parameters so that they could be included in
a new algorithm that would improve the existing PTT algorithms. Two methods
of doing this were investigated, the use of an ICG and the use of the PhysioNet
Resource.
The PhysioNet Resource and its associated database provided most of the physi-
ological signals that were required for this investigation. Using selected databases
of all those that were available, namely the MIMIC database and the Challenge
Sets from 2009, it was possible to find 15 records with all the required signals, over
the required duration, that would allow PTT along with SV and all associated
parameters to be measured.
Although the objective of this project is to develop an algorithm, an important
feature is that any algorithm that is developed must originate from calculating
signals that can be recorded using a non-invasive method and ideally that could be
part of a wearable system. One technique that would allow this would be through
the use of an ICG because it can measure all the relevant parameters and it only
requires an extra few electrodes. However, during the design of the ICG system
outlined in Appendix C, it became apparent that the implementation of the ICG
board was outside the scope of the project and it was far more important to
develop the algorithm. In this regard, the PhysioNet Resource has more benefits
for investigating and developing a new algorithm. The primary advantage of the
PhysioNet Resource was that the ABP was readily available. This ensured that
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any algorithm that was evaluated could be studied on a beat to beat basis, rather
than the intermittent cuff measurements that would need to be used if the ICG
and PTT systems were used.
In an attempt to confirm the value of the database, the tests from Chapter 3
were re-run using this database. Although the results from Chen’s algorithm were
almost identical to those that had been found previously, the results from Poon’s
algorithm were significantly different. In a similar fashion to the original test
where Poon’s algorithm failed even when using the shortest calibration interval
of 2 minutes, when using the PhsyioNet database the algorithm was found to also
fail using a 2 minute calibration interval.
In the original test, Poon’s algorithm was compared to cuff measurements of BP
once every two minutes. In this database, continuous ABP was available and a
beat to beat comparison could be made between Poon and the actual changes in
BP. It was noted in Chapter 3 that when compared to the cuff measurements,
Poon’s prediction was quite noisy but showed some potential. When it was com-
pared to ABP though, it was found that in many cases the prediction was actually
quite good. However, as good as the improvement was in some cases, there were
still a number of problems among the other tests and records. Two common and
frequent problems were identified where either the prediction gave a large offset
or its amplitude didn’t change enough when compared to changes in the actual
BP. Depending on the severity of either of these, it is possible that Poon’s algo-
rithm could have been deemed to be acceptable, but since these problems arose
frequently and since the algorithm performed poorly for two patients in partic-
ular, the maximum calibration was found to be only 2 minutes. This further
emphasises the case that neither Poon’s nor Chen’s algorithms could be deemed
to be useful or practical for clinical use or any other practical applications.
Although there has been a slight change in the results due to the use of direct
beat to beat measurements, especially with Poon’s calibration interval increasing
from 0 to 2 minutes, the overall findings of Chapter 3 remain valid and neither
of these algorithms are capable of tracking BP for enough time to be usable in
a practical setting. This suggests that an improvement in the PTT method is
still required. Now that the PhysioNet database has been shown to be even more
useful than originally hoped, due to its access to ABP and the fact that it can
provide SV along with other parameters of interest, it is possible to develop and
test a new algorithm that can improve on the PTT method through the inclusion
of new parameters which could ultimately be measured by ICG.
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Chapter 5
Deriving a Novel Blood Pressure
Tracking Algorithm
5.1 Introduction
The various approaches that were adopted during the development of an algo-
rithm that would improve on the existing PTT algorithms that are needed to
track BP are discussed in this chapter. The goal of this thesis was clear: to
improve on the state of the art in blood pressure monitoring through the devel-
opment of a new algorithm. The algorithm developed in this work is based on
the premise that the inclusion of additional parameters into existing equations
would allow better tracking of BP, for a longer duration, so that it would make
the algorithm practically and clinically useful.
Using the PhysioNet database, a number of new parameters was available and had
been identified from the outset and the first section deals with identifying which
of the available parameters would have the greatest significance. The interaction
between these parameters was identified by using a combination of a number
of different methods: Correlations, Draftsman Graphs and Semblance Analysis.
Each of these had certain advantages, which are discussed in section 5.2.
Section 5.3 describes how Multiple Linear Regression was used in an attempt to
initially derive the algorithm. Multiple Linear Regression (MLR) uses a constant
set of variables and a corresponding set of weights to predict a known output. By
examining multiple sets of inputs and outputs and the weights associated with
them, a general set of weights can be derived that would provide an algorithm
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for a good prediction of BP, regardless of the inputs. This will be explained in
more detail during this section. The evolution of the MLR equations, starting
with the most general equation and then using the results from this evaluation,
along with the results from the first section to narrow down the variables and get
better results, is also discussed. Although this method proved to be ultimately
unsuccessful, due to statistical and mathematical concerns, it was an important
part of the development process. Each of the MLR algorithms that performed
well was found to have two parameters in common, and despite the mathematical
concerns due to the derivation of an algorithm using MLR, the identification of
these critical parameters via MLR allowed alternative methods of derivation to
focus on the inclusion of these parameters in one algorithm.
The final derivation of the new BP monitoring algorithm is described in Section
5.4. Due to concerns and limitations with regard to the MLR derived equations,
it was felt that a more universally applicable algorithm should be possible. By
examining existing PTT equations, the variables that were identified via the use
of the MLR and through other statistical methods from the previous sections,
a new algorithm was derived by the use of some fundamental fluid dynamics
relationships. This new algorithm was then evaluated and compared to the other
approaches, all of which are discussed in detail in this chapter.
5.2 Identifying Parameters of Interest
The first step in deriving a new algorithm is to identify the most relevant vari-
ables that should be included. Although a number of parameters that should be
investigated [90, 149, 150] had been identified in the literature, these were only
suggestions and it was not clear if any previous work had been carried out to
see if including these parameters would make an improvement. Therefore, it was
necessary to investigate each variable and examine its relationship to BP.
The most fundamental way to identify the relationship is to plot the variable of
interest e.g. PTT over a certain period side-by-side against the desired outcome
e.g. Systolic BP. Figure 5.1 shows two examples of such a plot, comparing PTT
and measured BP from two different patients. In Figure 5.1a, the relationship
between this patient’s BP and PTT is not immediately apparent, whereas in Fig-
ure 5.1b, it is clear there is an inverse relationship between the parameters. This
is confirmed in the literature [57]. Although this method is easy to implement,
its limitations are quite obvious when Figure 5.1a is examined for a relation-
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(a) Sometimes a relationship is unclear (b) Sometimes the relationship is more trans-
parent
Figure 5.1: Identifying relationships between variables is not always apparent
ship. Furthermore, identifying relationships by eye is not a scientifically sound
approach and it has no underlying mathematical rigour associated with it and so
a more scientific method was sought.
5.2.1 Direct Correlations
A more mathematical approach was taken to examine the correlation between the
two variables. One way to do this is to sample each of the continuous signals at
certain intervals e.g. once a minute over 30 minutes, and plot the results against
each other. Then, by finding the line of best fit between them, it is possible
to find the correlation between the two variables. This is a very simple method
and provides an easily identifiable quantification factor, so that the relationships
between factors are very easily established.
To this end, an expansion of the correlation graphs was implemented using what
is known as a Draftsman’s Chart [151]. Figure 5.2 shows one of these Draftsman’s
Charts for one particular patient. In this example, five parameters were investi-
gated to determine the relationships between them, and to identify which param-
eters show the strongest relationship with the other parameters. In a Draftsman
Chart each parameter is plotted against each other in an n × n matrix. There-
fore, the centre spine of the graph plots the first variable versus itself, the second
variable versus itself etc. The correlation of each graph is then also plotted in
a matrix and using this method it is easy to get a summary of the relationships
between the selected variables. This tool is frequently used with Principle Com-
ponent Analysis [151], and, as long as representative data is used and analysed, it
can quickly be used to identify the strongest relationships of the variables being
examined.
109 Brian M McCarthy
5. Deriving a Novel Blood Pressure Tracking Algorithm
Figure
5.2:
A
n
exam
ple
ofa
D
raftsm
an’s
G
raph
for
one
patient
exam
ining
T
im
e,BP,SV
,H
R
and
PT
T
.
Development of a Novel PTT Based
Algorithm
110
5.2 Identifying Parameters of Interest
5.2.2 Semblance Analysis
Although using Draftsman Charts can provide a good indication of expected
values and relationships, it relies on sampled data and, because of this, it can be
difficult to ensure that all the data being examined is representative in that the
sampled data does not contain outliers or motion artifacts for example. Therefore,
other approaches were also investigated to find a quantification method that
would work for continuous data, rather than sampled data, and would allow a
rapid identification of well or badly correlated relationships (where continuous
refers to the “continuous signals” taken from the PhysioNet database).
One way to do this is by using semblance analysis. Semblance analysis is primarily
used for the analysis and study of seismic data, but has recently been adapted to
examine the correlation between two time series signals, which do not need to be
measured using the same units [152]. With this adaptation, semblance analysis
can now be used as a graphical tool that examines the correlation between two
continuous signals. Each continuous signal is transformed using a Continuous
Wavelet Transform (CWT), a mathematical tool. Then, a correlation analysis is
performed between the two transformed signals, the results being plotted using
coloured graphs where red indicates a strong correlation (r=1), blue indicates a
strong negative correlation (r=-1) and green indicates no correlation (r=0). It
is important that when examining the graphs, the correct scale/wavelength is
examined, as determined by the sampling rate of the signals.
From Figure 5.3, the relationships between different signals can be immediately
identified. Many of these relationships had been identified previously using the
sampled data in the Draftsman charts, but by using semblance analysis it is
possible to confirm that these relationships are also valid on a continuous ba-
sis. Examining 5.3b, it is also evident that semblance analysis is relatively noise
resistant in so far as there is a little noise associated with both signals but the
anti-correlation is still evident, not only in the time series graph, but also and
more importantly in the semblance graph. Figure 5.3a however, shows the limits
of the noise tolerance, where an artefact is apparent in the SV data at around 2100
seconds. At this point in the semblance graph, there is a sudden anti-correlation
which is not representative of the data on either side of the artefact. Figure
5.3c, shows the final scenario where there is no consistency with regard to the
semblance analysis. This is also representative of previously examined HR analy-
sis, that had been recorded when direct correlations had been examined using
Draftsman Charts, where correlations seemed to vary from patient to patient.
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(a) Semblance Analysis of SV vs. BP with a strong positive correlation
(b) Semblance Analysis of PTT vs. BP with a strong anti-correlation
(c) Semblance Analysis of HR vs. BP. A mixed correlation is seen throughout
and is repetition of what was seen previously
Figure 5.3: Examining the semblance analysis of various parameters. A quick
glance is enough to reveal what type of relationship exists between signals
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Table 5.1: A summary of the results from the semblance analysis comparing
various parameters and combinations of them to BP.
Parameter
Under Test r ≈ 1 r ≈ -1
Mostly
Strong
Mostly
Weak
More
Analysis
PTT X Yes
SV X Yes
HR X Yes
CO X No
SV × PTT X Yes
SV
PTT
X Yes
SV 2× PTT X No
SV 2
PTT
X Yes
SV × PTT 2 X No
SV
PTT 2 X Yes
(SV × PTT )2 X Yes
( SV
PTT
)2 X Yes
Using this technique it was possible to investigate multiple parameters across each
of the patients and each of the respective 45 tests very quickly. Each parameter
was compared to BP and if a semblance graph was found to be mostly red or
mostly blue, the parameter under test was classified as being of potential use and
a parameter of interest to the extent that more analysis should be carried out.
These parameters and combinations thereof were investigated and depending on
their results, were categorised as outlined in table 5.1.
5.3 Multiple Linear Regression
In Multiple Linear Regression (MLR), the objective is to build a probabilistic
model that relates a dependant variable Y to more than one independent or
predictor variables [153]. If k is the number of independent variables, and x
represents these variables, the general expression is
Y = β0 + β1x1 + β2x2 + β3x3 + · · ·+ βkxk +  (5.1)
Where  is the error term of the prediction and has an important role when using
MLR for certain situations in statistics e.g. finding which of the input variables
has most influence in the outcome of a prediction. In most situations,  must
also adhere to certain assumptions, such as having a normal distribution, but
due to the particular application described in this work,  does not have a major
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statistical impact or role in the following sections. In this application MLR is
only being used to derive an algorithm rather than identify or infer statistical
meanings or relationships.
For the most general and simple application in this work, Y would be the BP,
x1 would be PTT, x2 would be SV, x3 would be HR etc. Using Matlab [122]
or similar, it is possible to calculate β for each respective x value. β0 provides
what is essentially an offset and each subsequent β value represents a weighting
factor which determines which variables are most strongly related to BP and
which can be used to predict the BP at any particular point. From section 5.2,
it is expected that certain parameters will dominate any MLR equation that is
derived and certain combinations of those parameters, especially those identified
in Table 5.1, should also provide good predictors for BP. A description of how
the β values were derived is firstly discussed and applied, while the following
subsections describe the evolution of the MLR algorithm starting with its most
basic form as seen in equation 5.1 and proceeding to its most complex form, based
on the parameters identified previously, such as SV, PTT and to a lesser extent
HR.
5.3.1 Deriving β values and Testing Algorithm 1-x
The first equation that was analysed was
BP = β0 + β1 × PTT + β2 × SV + β3 ×HR +  (5.2)
Since this was the first attempt at deriving an algorithm, it was called Algorithm
1. It was realised at this stage that this first attempt would not be the solution to
relate BP to the various other parameters being investigated and a few iterations
would be necessary to find such a solution. For this reason, it was decided that
each different algorithm would be named using the following convention:
A major change to the method by which the algorithm was derived would be
denoted by an increase of the letter M in Algorithm M, whereas minor changes
would be denoted by a change in the letter x in Algorithm M - x. An example
of a minor change in the algorithm can be seen across equations 5.2 to equation
5.4, where the inverse of each of the parameters is sequentially chosen and each
equation is investigated as a potential solution i.e.
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BP = β0 + β1 × 1
PTT
+ β2 × SV + β3 ×HR +  (5.3)
was denoted Alg. 1-2,
BP = β0 + β1 × PTT + β2 × 1
SV
+ β3 ×HR +  (5.4)
was denoted Alg 1-3, and so on. As the tests progressed, the number of differ-
ent “x” tests were reduced since a pattern emerged on which configurations of
parameters worked best. When the correlation tests and semblance tests from
the previous section were considered as part of the evolution of the MLR tests,
the reason for these patterns became obvious. It was found that any algorithm
which contained the parameters with the strongest linear relationship to BP
performed the best, i.e. any algorithm that contained BP = · · · + 1
PTT
· · · or
BP = · · ·+ SV · · · was shown to perform much better than algorithms that did
not have these parameters, in this configuration.
If there was any major change to the form of the algorithm, the Algorithm number
increased e.g. from Algorithm 1, to Algorithm 2. An example of a major change
would be an elimination of one of the parameters of interest or another change
which would have a major impact on how the algorithm was derived or applied.
From the most fundamental point of view, the β values of equation 5.2 were
derived by using Matlab or a similar type of program from the independent
variables. As described in Chapter 4, all of the data described was taken from
15 patients over three half hour periods, which were known as tests, taken from
each patient. The independent variables, as previously discussed, were HR, SV
and PTT, and were derived from the continuous beat to beat data, from each of
the 45 tests.
Each MLR equation that was derived would provide different β values, each one
providing very specific β values for each of the 45 tests. An important point
to note is that because of the variance of the parameters from each test, it was
necessary to find a way that a general β could be derived and applied in such
a way that would satisfy every test. The most obvious way to do this would be
to take an average β for each of the independent variables, i.e an average β0,
an average β1 for PTT, an average β2 for SV etc. The problem with this was
that, due to the nature of physiological signals, the BP’s and other parameters
of each patient could be vastly different and if, for example, one patient had a
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particularly low BP, by only taking an average value of β0, the resulting β0 could
be skewed by that one patient (with a low BP). Therefore the median of each β
value was also calculated. The median is the centre value of all available data
points and is used to compensate for outliers. For completeness, the mode of
each β value was also examined. This extracts the most commonly used value;
however, after a brief investigation the mode value was omitted because it was
found that, in general, the β values were rarely repeated.
Two other values were also examined. From examining the median values, it was
found that the median value was quite often not the centre value. The reason
for this was not clear but one possible reason was that in most tests, at least
one large outlier was observed. While Excel would include this outlier when
calculating the median value, it was found that by omitting it, a more accurate
median value could be calculated. In an attempt to determine the actual centre
value two new values were examined. These values were derived by creating a
histogram of all the available data points, divided into twenty groups or bins,
going from the minimum value to the maximum value in equal jumps, shown in
Figure 5.4. A second histogram was then created which focused on the centre
of the first histogram, or the values of the first histogram that would give a
normal distribution, if the outliers were ignored, in this scenario −10 to 215.
This histogram was divided into ten bins, as shown in Figure 5.5. Finally, the
three or four bins with the most data points were then examined and all values
that fell into these three of four bins were examined for the median and average
values, i.e. all values between −10 and 65. These two values were simply known
as the histogram_average and the histogram_median. In the example shown here,
the median calculated by Excel was found to be 32.65 but the histogram_median
was found to be 1.34.
During this initial test, one final β derivation was investigated via the use of
standardisation, also known as calculating the standard scores or the z scores of
the variables. The z score of a variable x is calculated by:
z = x− µ
σ
(5.5)
where µ is the average of all the x values and σ is the standard deviation of the
x values.
In this test, each of the variables was standardised before the β values were de-
rived. This was investigated to determine which variables were the most dominant
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Bin Value
1 -10
2 65
3 140
4 215
5 290
6 365
7 440
8 515
9 590
10 665
11 740
12 815
13 890
14 965
15 1040
16 1115
17 1190
18 1265
19 1340
20 1415
Figure 5.4: A histogram of all the β1 values calculated for one of the first tests.
Bin Value
1 -10
2 15
3 40
4 65
5 90
6 115
7 140
8 165
9 190
10 215
Figure 5.5: A more focused histogram concentrating on the centre values of the
β1 values that had been calculated for the same tests.
when correctly predicting changes in BP. These “β” values were denoted with a
z to differentiate them from the non-standardised derived values. i.e. βz.
Therefore, β0, β1, β2 and β3 values were derived from the 45 tests. Each respective
β value varied depending on the equation from which it was derived i.e. β1 derived
from Test 1 and Equation 5.2 would be different to β1 derived from Test 1 and
Equation 5.3. To find a set of β values that would form a general equation that
would equally describe each of the 45 tests, the following eight calculations were
applied to each respective β value
• The average βav
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• The median βmed
• The histogram average βhist−av
• The histogram median βhist−med
• The average of the standarised tests βz−av
• The median of the standarised tests βz−med
• The histogram average of the standarised tests βz−hist−av
• The histogram median of the standarised tests βz−hist−med
Therefore, when Equation 5.2 was being examined, 45 β0’s, 45 β1’s, 45 β2’s and
45 β3’s were derived, i.e. one set of β values from each test. Instead of taking one
set of β values, that had been derived from one test and applying it to the other
44 tests (and repeating), the average β0, β1, β2 and β3 values were calculated
from the 45 tests, and then applied and evaluated for each of the 45 tests. Once
the average had been evaluated, the median was then calculated and evaluated
and so on until each of the eight β values had been tested. Once each of the eight
had been calculated and evaluated for Equation 5.2, the β values for Equation
5.3 were calculated and the procedure repeated.
5.3.2 Evaluating Algorithm 1-x
After testing various algorithms such as equations 5.2 - 5.4, using the procedure
outlined in Section 5.3.1, it became evident that including HR was having a
detrimental effect on the results from the algorithms. The reason for this was
that, for some patients, there was a positive correlation between HR and BP but
for others there was a negative correlation. No matter which type of correlation
existed, the correlation was also found to be weak in the majority of cases. This
is highlighted in Figure 5.6. This had been identified previously in Section 5.2,
in particular in Table 5.1 but HR was included to examine the effect for the first
round of testing of the MLR derivations.
Therefore, it was decided that HR should be omitted from subsequent equations
and a new set of algorithms, denoted Algorithm 2 -x was derived.
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(a) BP and HR showing a weak positive corre-
lation
(b) BP and HR showing a weak negative corre-
lation
Figure 5.6: The variability of the relationship between BP and HR
5.3.3 Algorithm 2-x
The weighting factors i.e. the β values, were derived and applied for each of the
"new" algorithms, based on equation 5.6, using all the knowledge that had been
discussed in previous sections.
BP = β0 + β1 × PTT + β2 × SV +  (5.6)
Each time an algorithm performed well i.e. tracked a number of tests well and
provided a low error for the majority of tests, extra time was spent examining
the β values in an attempt to maximise the effectiveness and minimise the error
of the algorithm. This was primarily done, by investigating the use of median βs,
mode βs and histogram derived βs. For example, if it was found that β_average
performed well when applied to some of the 45 tests, but an offset existed for
other tests, the use β_median was examined to see if an improvement could be
observed. However, it was found that if one set of β values performed well, on
a set of M tests and poorly on the other N tests, examining a different set of β
values would mean that an improvement would be noted on the N tests, but the
original M tests would then perform less well.
An example of this can be seen in Figure 5.7. In Figure 5.7a, one particular
algorithm Algorithm 2-g is being tested on the first half hour test extracted from
patient 2 i.e. Pat 2a. In Figure 5.7b, Algorithm 2-g is also being tested on Pat
3a. When Algorithm 2-g is applied to Pat 3a, it can be seen that there is a
low offset and the prediction (in red) tracks the actual BP (in blue) quite well.
However, Algorithm 2-g does not suit Pat 2a where there is quite a large offset,
even though the tracking still seems to be quite good. By applying a different
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algorithm, Algorithm 2-h, as seen in 5.7c, a large improvement is evident for Pat
2a; however Algorithm 2-h has negatively affected Pat 3a, which now has a large
negative offset between the predicted and actual BP shown in Figure 5.7d.
(a) Algorithm 2-g for Test 2a (b) Algorithm 2-g for Test 3a
(c) Algorithm 2-h for Test 2a (d) Algorithm 2-h for Test 3a
Figure 5.7: The variability of the algorithms; Improvements in one test usually
meant another became worse
The reason for the differences between Algorithm 2-g and Algorithm 2-h can be
explained by examining the β values in Table 5.2. The first eight rows of this
table show the result of deriving the β values for one particular equation. The
final two rows of the table show the Mean and Median β values of this data, either
of these could be used to form the general application that would be applied to
all tests. Taking β0 as an example and using the mean value of β0 , there is a
chance that test Pat 17a could give good results, but the other tests would not.
If the median value was used, tests Pat 3b, Pat 6a and Pat 13c could potentially
give good results, whereas the remaining tests would not.
Although Table 5.2 only shows β derived results for one algorithm, the same trend
appeared no matter which algorithm, parameters or combinations of parameters
were being examined. If some β values suited a number of tests, they were also
unsuited to other tests. This was due to the variability of each parameter that
was being examined i.e. some patients had a high BP whereas others had a
low BP. However, taking this type of variability into account is important when
developing an algorithm, so that any algorithm that is developed can be as robust
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Table 5.2: A sample of the β values calculated for one of the MLR tests. Even
in this example, a large variance between tests can be observed
Test β0 β1 β2
Pat 1a 100.7082 0.213505 -0.0451
Pat 2a 196.5665 235.3745 -1.46948
Pat 3b 69.9847 984.3945 0.259159
Pat 6a 69.64046 0.202034 0.632133
Pat 6b -198.077 -0.00714 2.897617
Pat 6c -56.7137 38.85773 1.67875
Pat 13c 65.95029 777.5987 0.291707
Pat 17a 44.30602 828.9337 0.002577
Mean 36.54568 358.1959 0.53092
Median 67.79538 137.1161 0.275433
Standard Deviation 117.4775919 429.5013481 1.291324619
and universally applicable as possible. However, from the perspective of MLR
based algorithms, it was clear that this approach would not yield an equation
that was sufficiently general for all tests, and therefore, for our purposes, a new
approach was required.
5.3.4 Algorithm 3-x
One solution that could accommodate the variability of the parameters was to
implement a categorisation process. For example, if the weighting factor of PTT
(β1), had been derived for a particularly low PTT value, using the categorisation
process, this β1 value would only be applied to other similarly low PTT values.
By using this method and by implementing a number of different categories, each
respective β value would then only be applied to an appropriate PTT or SV value.
To implement this, a two minute sample of PTT and SV was taken from the
beat to beat data from each of the 45 tests. The mean of this sample was then
calculated for SV and PTT and was tabulated as shown in Table 5.3, along with
the respective β1 and β2 values that had been derived for each test in section
5.3.3.
Initially, it had been hoped that specific bounds would exist for each variable
and their corresponding β value and clear categories could be observed e.g. all
PTT between 200ms and 250ms would have a β1 value between 1.5 and 2.0. On
examination of Table 5.3, it can be seen that in some cases there are clear bounds
and thus categories could be observed. For example, examining Pat 5a in Table
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5.3 shows a mean PTT of 195.6 ms, with a corresponding β1 value of 1.06. Tests
Pat 5b and Pat 5c also show similar mean and β values, so grouping these values
into one category, indicated in blue, makes sense. Applying the same logic to
Pat 6, it can be observed that all mean PTT values and β1 for this patient have
similar and unique values and so belong in a new category of their own, marked
orange.
For the remaining PTT and associated β1 values in Table 5.3, it can be seen that
the categories aren’t as clear or well defined as those of Patients 5 and 6. At
first, a similar categorisation process, as that applied to Patients 5 and 6 was
strictly followed, but too many categories were created, and most categories only
contained one or two tests. Therefore, for the remaining tests, it was necessary
to create categories based primarily on the mean PTT. Although the associated
β1 values were considered in each case, they were of less importance. Examining
the category indicated in purple, it can be seen that all PTT values are between
215ms and 226ms. However, the associated β1 values are between 1.09 and 1.84.
Examining other β1 values in the table, it can be seen that many other β1 values
are between these two bounds, but the associated PTT are greater or less than
those defined here.
This process was repeated for the SV and the associated β2 values. Again, some
categories were clear and well defined; for example it can be seen that Pat 5a, 5b,
5c and Pat 7b all have similar β2 values and similar SV values and therefore belong
in the same (brown) category. As was the case with the purple category when
PTT values were considered, the green category is primarily based on the SV
value, with the β2 value being of less importance in the categorisation procedure.
Although all SV values are between 38 and 47 ml, most β2 values are greater
than 18,000. However, since Pat 12c and Pat 13a, also have a SV value within
the specified SV range, their β2 values of approximately 12,000 are also included
into this category.
Once the categories had been defined, the mean values of all the β values in that
category were calculated e.g. from Table 5.3, for the purple PTT based category,
the mean of all the associated β1 values in this category was found. Therefore,
when the algorithm was being applied to data, if the mean PTT value over the
2 minute sampling period was found to be in the range of the purple category, a
β1 value of 1.44 (the mean of all the purple β1 values) was applied.
During the initial testing of the categorisation, it was noted that no major im-
provement was apparent, when the averaged β values of the categorisation process
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Table 5.3: An example from selected tests of the categorisation process for Al-
gorithm 3-x. Each colour represents a different category as defined by either the
mean SV or mean PTT value and its associated β value.
Test Mean PTT (ms) Mean SV (ml) β1 β2
pat 3a 225 46.8 1.84 11989.01
pat 3b 266 43.5 1.43 21739.36
pat 3c 275.2 44.4 1.52 18915.61
pat 4a 184.4 40 1.21 20343.56
pat 4b 188.5 38.9 0.81 22937.39
pat 4c 203.4 34.2 0.81 24271.42
pat 5a 195.6 61.1 1.06 9262.23
pat 5b 198 61.8 1.07 7136.96
pat 5c 191.9 63 1.02 7100.5
pat 6a 140.7 42.7 0.68 23000.22
pat 6b 145.5 40 0.56 19505.31
pat 6c 141.6 39.3 0.68 24202.56
pat 7b 694.2 67.1 2.62 7663.25
pat 9b 246.2 46.8 1.14 11715.76
pat 9c 257.4 51.8 2.07 133.4
pat 12a 226 45.1 1.11 7370.87
pat 12b 215.2 40.9 1.09 19601.59
pat 12c 220.1 43.2 1.66 12831.74
pat 13a 216.5 43.4 1.5 12618.3
pat 13b 256.3 39.6 1.14 20258.14
pat 13c 234.4 42.6 1.05 18646.66
were applied to each of the tests. After a detailed investigation, it was frequently
found that by using a large β0 value, the remaining parameter contributions of
the algorithm could not provide a large enough reaction, if the BP changed sud-
denly during any given test. Figure 5.8 shows an example of the effect of having
a large β0. In this example, the algorithm being applied is
BP = 78.99 + 1.146× 1
PTT 2
+ 3801.19× SV 2 +  (5.7)
where, β0 =78.99, β1 =1.146 and β2 =3801.19. Figure 5.8a shows the prediction
provided by Equation 5.7 when compared to the actual BP. To highlight the effect
of β0, its value was subtracted from the actual BP in Figure 5.8b, i.e. 78.99 was
subtracted from the actual BP in this figure. In this figure, the PTT component
i.e. 1.146 × 1
PTT 2 (green) and SV component (3801.19 × SV 2 , magenta) are
shown individually. The sum of the PTT component and the SV component is
shown in red. Although, the BP here does not change dramatically, because β0
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has been relied on to provide such a large offset, the PTT and SV components
are not capable of tracking large changes in BP throughout the test.
(a) Predicted BP in red generated from Equation 5.7 vs the Actual BP in blue
(b) The PTT component (green) and the SV component (magenta) when added (red) are not
capable of tracking the changes of BP when the offset of β0 is subtracted
Figure 5.8: Once the offset provided by β0 is subtracted, it can be seen that the
PTT and SV components are not large enough to compensate for large changes
in BP
For this reason, it was decided that instead of deriving a value for β0, it should be
fixed to a percentage of the first BP measurement. Using this method, a constant
offset was still being applied and the PTT and SV contributions should be able
to track larger changes in the actual BP. Figure 5.9 shows an example of this
methodology and the values in Table 5.3 were derived using this premise. The
algorithm thus becomes:
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BP = 0.6×BP (1) + 0.81× 1
PTT 2
+ 24271.42× SV 2 +  (5.8)
where 0.6 is the percentage chosen for this derivation, 0.81 is β1 and 24271.42 is
β2. In Figure 5.9a, there is a clear improvement in the algorithm’s ability to track
BP over the course of the measurement. Figure 5.9b shows the components of the
algorithm. For most of the test duration, the tracking is quite good, especially
when compared to Figure 5.8b. However, towards the end of test, large spikes can
be seen, the source of which originates from the SV contribution. The magnitude
of these spikes is quite large and exceed 200 mmHg, but are not shown so that
a more detailed comparison of the tracking ability of the new algorithm can be
made.
Overall, the various algorithms investigated using this method provided a signif-
icant improvement over the MLR procedure studied, since the β values applied
to any given test were usually much closer to the β values that would optimise
that test. However, as can be seen in Table 5.3, in particular Pat 4a, not all
categorisation suited every test. In these cases, graphs such as those shown in
Figure 5.7 were not uncommon. However, the frequency of the occurrence of these
types of offset was dramatically reduced compared to the previously implemented
algorithms.
Although this categorisation method made a significant improvement over the
previously implemented algorithm, one of the most common problems with regard
to this type of categorisation was that due to averaging there were some occasions
where one of either the PTT or SV contributions was much larger than the other
(as has already been illustrated in Figure 5.9b). Usually, this would cause a
slightly larger offset than was desired, but when there was one variable that
was dominant, it was not a major issue, since the overall offset (or error) would
remain low (demonstrated by Figure 5.9a). However, the problem was amplified,
if both the SV and PTT contributions became very large or very small due to
the averaging process. For example, in the case of Figure 5.9a, the β2 value is
quite large and therefore the SV contribution is also quite large. However, the β1
value is quite small and as a consequence the resulting PTT contribution is also
quite small. When the two are added together, even though the SV contribution
dominates that of PTT, the final prediction is acceptable. However, if a case
existed where both β values were quite large, each of the contributions would
also be quite large and therefore the sum of each would result in a large offset.
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(a) Predicted BP in red generated from Equation 5.8 vs the Actual BP in blue
(b) The PTT component (green) and the SV component (magenta) when added (red) are now
capable of tracking the changes of BP when the offset of β0 is subtracted
Figure 5.9: Once the offset provided by β0 is subtracted, it can be seen that the
PTT and SV components are now large enough to compensate for large changes
in BP
From an analysis of these results, it became obvious that for a categorisation
method to be effective, the numerical value of both the SV and PTT contributions
had to be taken into account. This would help to ensure that one contribution
wouldn’t erroneously dominate the other and two large β values would not be
applied to the same test and create an error. This lead to the implementation of
Algorithm 4-x.
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5.3.5 Algorithm 4-x
Despite the progress made over the previous number of algorithms, the statistical
justification, from what had been studied to date, was questionable. Perhaps the
biggest problem was the use of a constant in the MLR calculation, instead of
calculating β0. Although it is possible to perform regression without calculating
β0 (or the intercept, as it is also known) and this can be justified in some cases, the
use of a constant times the base BP has no statistical or physical basis. However,
it has been established that MLR components can be calculated without the need
to calculate β0 in certain circumstances, in particular:
“In rare cases you may wish to exclude the constant from the model...
Usually, this will be done only if (i) it is possible to imagine the in-
dependent variables all assuming the value zero simultaneously, and
you feel that in this case it should logically follow that the depen-
dent variable will also be equal to zero; or else (ii) the constant is
redundant with the set of independent variables you wish to use. An
example of case (i) would be a model in which all variables–dependent
and independent–represented first differences of other time series e.g.
if you are regressing DIFF(Y) on DIFF(X), you are essentially pre-
dicting changes in Y as a linear function of changes in X. In this case
it might be reasonable to assume that Y should be unchanged, on
the average, whenever X is unchanged i.e., that Y should not have an
upward or downward trend in the absence of any change in the level
of X [154]”
Furthermore, it is said that β0 can only be omitted if all the independent variables
are zero when the dependant variable is zero [155], i.e. if the PTT and SV are
zero, then the BP must also be zero, because the heart would not be pumping.
Therefore in an attempt to create a better model, the premise of omitting the
constant/intercept was investigated. All regression coefficients were recalculated
and a general model was generated.
As discussed in Section 5.3.4, it has been shown that much better results were
attained by categorising each of the parameters. However, this approach was not
without its flaws, the biggest of which are those occasions when one contribution
erroneously dominates the other due to the categorisation process. It was thus
decided that both SV and PTT contributions should be considered before the
respective β values were applied to each. Therefore, an average of SV and PTT
127 Brian M McCarthy
5. Deriving a Novel Blood Pressure Tracking Algorithm
Table 5.4: The β values for both the PTT and SV contributions of Algorithm
4-x. .
Ratio β1 β2
ratio < 3.0 3.285 3371.315
3.0 ≤ ratio < 3.3 3.615 5000.845
3.3 ≤ ratio < 4.0 3.5 6405.413
4.0 ≤ ratio < 5.0 3.765 13726.9
5.0 ≤ ratio <5.5 3.695 16287.79
5.5 ≤ ratio <7.0 4.35 17847.27
7.0 ≤ ratio <10 3.2 5266.515
ratio > 10 3.615 500.845
was initially calculated and then the PTT:SV
(
ms
ml
)
ratio was found. Depending
on the results of this ratio, different β values could then be applied to each
contribution.
Although not previously discussed, there were a few “outliers” among the dataset.
These “outliers” occurred in some tests or, sometimes across every test of a pa-
tient, who had excessively high or low PTT and SV values respectively i.e. a
PTT of 0.54 s or a SV of 106 ml. Examining each of these tests manually, it
was found that these values were real measurements and not errors due to, for
example, peaks not being correctly identified or motion artifacts. Up until this
algorithm, these “outliers” were not considered to be major factors, because there
were only 13 cases of them out of 45 tests and although they did adversely af-
fect the results, the results were never significant enough for them to matter or
they had all been categorised together and would not affect the results. However,
now that the ratio between PTT and SV was being considered, these outliers
were now frequently in the same category as other tests and had to be separated.
For this reason, two tables of ratio values are shown here: one for the “normal”
tests (Table 5.4) and another for these “outliers” (Table 5.5). These tables were
derived from the algorithm described by equation 5.9
BP = β1 × 1
PTT 2
+ β2 × SV 2 +  (5.9)
This method provided good results with an improvement over the previous algo-
rithm and examples of this are shown in Figure 5.10. Using this technique, the
algorithm tracked BP very well over each test. However, in many of the tests,
the prediction had quite a large offset, meaning there was still a significant error
associated with this approach.
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Table 5.5: The β values for both the PTT and SV contributions for the outliers
of Algorithm 4-x. An outlier was defined as being less than 0.16 s or greater than
0.5 s for PTT and less than 20 ml and greater than 80 ml
Ratio β1 β2
ratio < 2.9 5.25 1736.16
2.9 ≤ ratio < 3.0 8.31 1207.25
3.0 ≤ ratio < 5.5 1.09 47041.82
5.5 ≤ ratio < 10.0 23.835 5530.87
10.0 ≤ ratio < 15.0 1.24 27105.74
ratio > 15 21.14 27135.22
(a) An example of Algorithm 4-x applied to Pat 14b
(b) An example of Algorithm 4-x applied to Pat 17a
Figure 5.10: Algorithm 4-x proved to be very effective for certain tests as shown
here
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Upon detailed analysis, it was decided that two patients should be excluded since
one was found to have a highly variable BP and was found to be suffering from
sepsis and thus was an unsuitable patient for this kind of test. Another patient
was found to have a CO of 9.5 l/min, approximately twice the normal. Thus
of the remaining 39 tests, 15 of the predictions were found to track the BP well
and have a low and acceptable error, for an interval in excess of 10 minutes.
The remaining tests either had a large or small offset associated with them due
to a poor initial estimation. This remained throughout the test and ultimately
resulted in a poor overall estimate.
Even though this algorithm only performs well over the stated period in 15 of
the 39 tests, this result was considerably better than either of the Chen or Poon
offerings, and also better than the previous algorithms. When repeating the tests
that had been performed for Chen and Poon [128], this algorithm was found to
be inside the BHS standard when using a 10 minute calibration interval, a signif-
icant improvement over those previously reported. Unfortunately, the algorithm
failed the AAMI standard when using a 4 minute calibration interval by having a
standard deviation greater than 8 mmHg; however, the standard deviation never
exceeded 9 mmHg. This result was repeated for all subsequent calibration inter-
vals up to and including a 10 minute calibration interval. Considering how close
this algorithm is to passing the AAMI standard and how convincingly it passes
the BHS standard, it is clear that this algorithm is an improvement over both
the Chen and Poon algorithms.
Although this algorithm provides better results than those previously seen in this
work as well as the work of others there are still a few concerns. The first of
these is the use of categorisation for applying the MLR results. Although not
expanded on in this section, a similar procedure as outlined in section 5.3.4 was
followed i.e. the β values were examined in conjunction with the ratio and the
categories were thus decided. Categorisation can be used in some cases, if there
is a strong justification and clear definition of the categories. Given the process
defined here, it is possible that the use of categorisation could be reasonable.
However, using a posteriori knowledge to create the categories clearly cannot be
justified, especially since there is no clear definition or reasonable explanation
between one category and another i.e. what is the reason for a different category
between a ratio of 3.2 and that of 3.5 as is apparent from Table 5.4?
The other major concern was that although the algorithm gave good results, it
had no real obvious physiological meaning. In the case of Chen and Poon, each
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algorithm corresponded to a physiological event and was derived from cardiolog-
ical knowledge. In this derivation, the algorithm was derived mathematically,
with knowledge of correlations but with no concern for physiological or biological
parameters. Initially, it had been envisaged that the final algorithm would be a
combination of parameters that could also be derived from physiologically known
equations and would be universally applicable. In this algorithm, there was no
known explanation for the categories or the β values and no indication of how
the β values could be derived.
Therefore, it was decided that an alternative algorithm should be created that
could be derived from known physiological parameters or equations and that
would be universally applicable. From the work described in sections 5.2 through
to section 5.2.2, a number of key parameters had been identified. When these key
parameters had been applied using the various MLR algorithms, PTT and SV
were found to provide the algorithms which performed the best at tracking the
ABP, regardless of which variation of MLR was under investigation. Therefore,
although MLR is not used in the derivation of the final algorithm, the use of
MLR has allowed SV to be identified as the additional, critical parameter that
should be incorporated into PTT algorithms to allow them surpass their current
limits.
5.4 Derivation and Evaluation of a New Algo-
rithm Based on Physiological Parameters
A considerable amount was learned from the process that was undertaken during
the development of the preceding algorithms described in section 5.3. One of the
most important outcomes was that, no matter what equation was derived, HR
should not be a feature because it was so variable between patients and would
adversely affect the results from some patients at the very least. It also empha-
sised how effective PTT and SV were at tracking BP. However, after examining
the results and findings from Chapter 3, it was clear that any future equations
should include both PTT and SV. Therefore the key to the development of a new
algorithm was how SV could be integrated into the existing PTT equations.
It should be noted that many equations, physical and physiological laws, theories
and combinations of these were investigated before the solution outlined here was
found. This included examining various combinations of existing PTT equations
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such as the Bramwell-Hill equation [156] and Moens-Korteweg equation [157],
to investigating the Navier-Stokes equations [158], the Darcy-Weisbach equation
[159], the Bernoulli equation[160], the Reynolds Number [161] among others.
5.4.1 Quantifying the Performance
One of the most important points in evaluating a new algorithm is its quantifica-
tion process. Elements of this have already been outlined in Chapter 3 where the
performance of Chen and Poon were quantified using the BHS and AAMI stan-
dards. However, Chapter 4 revealed a shortcoming in this quantification process
when Poon was compared to Arterial BP instead of intermittent cuff measure-
ments. Whereas in Chapter 3, Poon’s algorithm had been found to be noisy
when compared to these point representations of BP, when Poon’s estimation
was compared to continuous beat to beat ABP it was found to perform consider-
ably better although it frequently didn’t have a great enough amplitude to track
the BP accurately.
Throughout the examination of various MLR based algorithms, it had been noted
that the Systolic Arterial BP could be considered as being quite noisy, with
a variation of 10 mmHg not being unusual over 3 - 4 beats. Therefore when
evaluating a new algorithm, it was necessary to average the Arterial BP over at
least 3 -4 beats so that a representative Arterial BP would be compared against
the predicted value of the new algorithm.
In essence, this type of sampling could be seen as applying a moving average
filter. As has been highlighted by Chen’s use of a bandpass filter, it is vital that
the choice of filter is analysed carefully so that it doesn’t dramatically change
either the value or shape of the signal. If a moving average filter is applied, the
window size is the most important factor to examine. If the window is too small,
it will not have any effect but if it is too large it will remove all the valuable
information. Therefore, in this type of application, the filter should remove any
artifacts and follow the trend line of the signal, but not destroy any information
the signal contains.
It was found that a Savitzky-Golay FIR filter [162] would provide the necessary
filtering without destroying any information. This filter is widely used, especially
in the area of ECG signal filtering [163], but also in other biomedical filtering
applications [164] because it is known for preserving peaks and other points of
interest while also smoothing and removing noise from data. Both the PTT and
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SV signals were filtered using this technique before any algorithm was applied.
5.4.2 Derivation of the New Algorithm
As has been previously outlined, the main focus of the new algorithm was to
incorporate SV into the PTT equations. Naturally, the Moens-Korteweg equation
[157], seen in equation 5.10, is at the core of this derivation as it has proven to
be the most important equation for each of the previously investigated PTT
equations:
PWV = K
PTT
=
√
tE0eγP
ρd
(5.10)
where PWV is the Pulse Wave Velocity [m/s], K is the length of the blood vessel
[m], t is the thickness of the vessel wall [m], E0 is the elasticity at time zero
[m−1kgs−2], γ is a derived constant [mmHg−1], ρ is the density of blood [kg/m3],
d is the diameter of the blood vessel [m] and P is the blood pressure [mmHg].
An alternative equation, that has been used in the development of other PTT
equations is known as the Bramwell-Hill equation [156], seen in equation 5.11,
which is also related to the Moens-Korteweg equation
PWV =
√
V ×∆P
ρ×∆V (5.11)
where V is the volume [m3], ∆P is the change in Pressure [mmHg], and ∆V is
the change in volume [m3].
While investigating various principles of fluid dynamics and equations concerning
the flow of fluids through a pipe, the following relation was identified:
∆P = Q×R (5.12)
where Q is the flow of blood [l/s]and R is the resistance to the flow of blood.
This is a simplification of another equation, known as the Poiseuille equation
[165], which explicitly states the origin of the resistance to the flow of blood, as
shown in Equation 5.13.
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∆P = Q× 8µK
pir4
(5.13)
where µ is the viscosity of blood [kg/sm]and r is the radius of the blood vessel
[m].
However, it should be noted that when the Poiseuille equation is applied to ar-
teries, where pulsatile flow exists, the value of the resistance is more complex and
more factors must be taken into account to calculate its exact value. Specifically,
the Womersley Equation [166, 167] is more appropriate, which can be seen in
equation 5.14.
Q = P × pir
4
µ
× M
′
10(α)
α2
× sin[ωt− φ+ ′10(α)] (5.14)
where µ is the coefficient of viscosity [kg/sm], α is a non-dimensional parameter
r
√
ω
v
, where ω = 2pi × frequency and M ′10(α) and 10(α) are functions of α
tabulated by Womersley for α = 0to10. It should be noted that this equation is
per unit length.
Comparing equation 5.14 to Poiseuille equation 5.13, a clear relationship is evi-
dent, the difference coming from the α related parameters.
Therefore, the primary difference between both equations is due to the com-
plex relationship derived by Womersley, that defines the actual resistance to flow
through the artery. However, in the algorithm that has been derived, the specific
value of the resistance is not used and from Womersley’s tables the difference
becomes a matter of a scaling factor. Since it provides a good estimation of the
resistance and for the sake of simplicity, the Poiseuille equation was used as a
substitute. Combining Equation 5.11 and 5.13 gives:
PWV =
√√√√V × 8µKQpir4
ρ×∆V =
√
8µQKV
ρpit4∆V (5.15)
Equating 5.10 and 5.15 √
tE0eγP
ρd
=
√
8µQKV
ρpir4∆V (5.16)
It is well known that
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Q = ∆V∆t ; d = 2r (5.17)
and so using these basic substitutions
tE0e
γP
ρ2r =
8µKV∆V
ρpir4∆V∆t (5.18)
Re-arranging
eγP = 16µKV
tE0pir3∆t
(5.19)
Taking the natural log of both sides yields:
P = 1
γ
[
ln
( 16µK
tE0pir3
)
+ ln
(
V
∆t
)]
(5.20)
where V is the Stroke Volume and ∆t is the Pulse Transit Time
P = 1
γ
[
ln
( 16µK
tE0pir3
)
+ ln
(
SV
PTT
)]
(5.21)
using the natural log theorems, this can be re-written as
P = 1
γ
[
ln
( 16µK
tE0pir3
)
+ ln(SV )− ln(PTT )
]
(5.22)
Using partial differentiation on both sides with respect to PTT and SV
∂(P )
∂(PTT )∂(SV ) =
1
γ
∂
∂(PTT )∂(SV )



:0(
ln
( 16µK
tE0pir3
))
+ (ln (SV )− ln (PTT )

(5.23)
which yields
∂
∂(PTT )∂(SV ) (P ) =
1
γ
[ 1
SV
− 1
PTT
]
(5.24)
rearranging and updating the notation:
∆P = 1
γ
[
∆(SV )
SV
− ∆(PTT )
PTT
]
(5.25)
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Equation 5.25 will track changes in BP, much in a similar fashion way that Chen’s
basic equation would. Therefore
PE = PB +
1
γ
[
SV
SVB
− PTT
PTTB
]
(5.26)
will provide a BP [mmHg] estimate at any given time (PE), once a base or initial
BP (PB) has been provided and SV and PTT has been monitored continuously
since the initial measurement.
This derivation bears some similarities to the procedure followed by Chen. How-
ever the main and important differences are that a bandpass filter, as described
by Chen, is not applied and this equation incorporates SV as well. This equation
is also significantly different to those derived from the various MLR equations
that had been previously examined. The following sections evaluate and quan-
tify the performance of this new algorithm when compared to both the existing
equations and the standards.
5.4.3 Evaluation of the New Algorithm
Overall, this new algorithm performs very well, especially in comparison to the
algorithms described in this work and all previously examined algorithms, includ-
ing Chen and Poon. One of the most instantly identifiable features of the new
algorithm is that the tracking ability of this new algorithm exceeds that of the
MLR algorithms and it is universally applicable, with at least one test from each
patient performing very well.
The new algorithm provided a very low error for 24 of the 45 tests over short
periods. More specifically, the algorithm provided an acceptable error for 20 of
the 45 tests over half an hour, without the need for recalibration, an example
of which is shown in Figure 5.11. This is a stark difference to that found from
examining Chen and Poon, who could typically only manage 6 minutes before
a recalibration was required. Furthermore, 9 tests were able to track BP for
45 minutes without the need for calibration. It should be noted the biggest
limitation with regard to these tests was identifying tests which had 45 minutes
of continuous data that was of sufficiently high quality for tracking, rather than
the quality of the algorithm.
In terms of standards, the algorithm was found to achieve a B grade (pass) when
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Figure 5.11: An example of the tracking ability of the new algorithm over 30
minutes. In this figure the estimation is being compared to the raw Systolic
Arterial BP, rather than the ABP filtered signal
using a 12 minute calibration interval when the BHS standard was applied. It
was not possible to apply a longer calibration interval when using this calibra-
tion interval, because only 9 points from each test were available and it was felt
that this may not be statistically valid. When the AAMI standard was applied,
the algorithm passed when using a 2 minute calibration interval, at which point
the standard deviation exceeded the 8mmHg required to pass. However, for the
remaining tests, the standard deviation of all the tests together never exceeded
9.33 mmHg, an improvement to that seen in both Chen’s and Poon’s algorithms.
Table 5.6 shows the mean and standard deviation of each patient over 2 minute
intervals, in a similar approach to that previously shown for Poon and Chen and
shows the AAMI ratings of each individual patient. Although the new algorithm
suits some patients extremely well, there are others where the algorithm con-
sistently fails the AAMI standard by a significant amount. Referring back to
Table 4.4, where Poon’s algorithm was investigated on the same dataset, it can
be seen that Patients 1 and 4 fail both algorithms by a significant amount across
all calibration intervals.
It had been previously noted in section 5.3.5, that there were a number of tests and
patients that were noted to have average results that were greater than the other
patients tested i.e the outliers that were discussed previously. Patient 1 was one
of the notable patients here, having a mean PTT of about 500 ms. Unfortunately,
the specifics of this patient are unavailable, but this PTT is approximately twice
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the normal and so may not be well suited to a PTT tracking algorithm and this
is reflected by the fact that the algorithm performs poorly when either standard
is applied. It is interesting to note that Poon’s algorithm also performed poorly
when it was applied to Patient 1 which adds weight to this statement.
The majority of tests where the algorithm doesn’t do well stems from a poor
initial estimation. However, even in these situations, the algorithm tracks very
well over the entire test, as can be seen in Figure 5.12. It is unclear why this
poor estimation only exists in some cases, despite numerous tests, but if it were
possible to improve this initial estimation, possibly by a short initial calibration,
a marked improvement would be observed in the results.
Patient 4 is an example of this feature, but compared to Patient 1 the mean
values are well inside the normal distribution, and has no discernible differences
when compared to the other patients. In Figure 5.12 one of Patient 4’s tests is
used as an example of a poor initial estimation but the test itself, and the values
derived from it, exhibit no obvious problems.
Figure 5.12: A typical example of a poor initial estimation of the new algorithm
meaning a poor overall estimation of BP throughout the 30 minute duration
of a test. Despite the poor initial estimation, the tracking remains accurate
throughout. Again the estimation is being compared to the raw ABP rather than
the filtered one.
One other patient, Patient 2, gave some interesting results. Throughout each
test, it was found that the new algorithm predicted almost the exact opposite of
the ABP. This was found to be the case for each test and only occurred for the
tests from Patient 2. Examining the contributions from the SV and PTT, the
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origin appears to be from the SV. Since this peculiarity did not appear in Poon’s
prediction, this would further strengthen this view. It should also be noted that
the mean SV throughout Patient 2’s tests is abnormally high and this may be
the reason why this feature is not observed in any other test.
(a) 2 Minute Calibration Interval (b) 4 Minute Calibration Interval
(c) 6 Minute Calibration Interval (d) 8 Minute Calibration Interval
(e) 10 Minute Calibration Interval (f) 12 Minute Calibration Interval
Figure 5.13: The Bland Altman graphs for the new algorithm accumulated across
13 individuals for the six intervals (a – f).
The Bland Altman graphs, shown in Figure 5.13 are an extension of both of the
standards used to a certain degree. Each Bland Altman graph shows the mean
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Table 5.6: A summary of the results overall and from each volunteer. Each
result represents the mean error ± the standard deviation of error between the
Estimated BP, given by the PTT method, and Measured BP given by the ABP
Volunteer 2 Minute
Interval
4 Minute
Interval
6 Minute
Interval
8 Minute
Interval
10
Minute
Interval
12
Minute
Interval
pat 1 0.46±10.81 −0.29±11.09 1.71±13.72 4.39±10.55 1.17±11.36 −0.50±8.00
pat 2 1.90±12.01 2.91±14.16 3.70±15.06 4.74±16.70 5.25±17.40 7.05±16.30
pat 3 2.54±7.89 2.70±10.25 1.55±7.17 2.48±11.80 3.32±12.07 1.20±10.25
pat 4 −2.56±13.20 −2.43±11.79 −1.00±10.87 −1.34±10.16 −1.86±12.97 −1.19±13.98
pat 5 0.60±3.78 0.40±4.06 0.04±3.85 −0.15±3.92 −0.41±4.30 −0.24±4.21
pat 6 0.29±7.27 0.00±6.46 0.16±6.49 0.90±9.26 −0.25±7.34 1.92±7.65
pat 7 −0.85±8.94 −0.72±9.57 0.06±9.77 0.03±8.55 −0.60±7.43 1.30±8.03
pat 8 0.80±3.03 1.07±3.68 1.25±4.17 1.57±4.67 2.32±4.03 2.97±4.74
pat 9 −0.35±7.08 0.49±11.12 0.96±11.73 1.99±12.21 1.30±11.18 −0.11±10.90
pat 10 −3.29±7.26 −3.14±9.05 −2.63±9.43 −1.63±8.98 −1.29±8.73 −0.53±10.07
pat 11 −0.73±5.84 −0.78±6.12 −0.51±6.69 −0.35±6.64 0.18±6.68 −0.34±6.84
pat 12 −1.30±7.15 −1.04±8.36 −1.38±8.44 −1.30±9.63 0.97±10.10 −0.32±8.60
pat 13 1.25±8.29 1.23±8.90 1.42±10.13 −0.84±9.34 1.75±11.55 1.18±11.59
pat 14 0.26±5.16 −0.08±6.61 0.04±7.52 0.69±7.39 −0.59±6.58 0.12±8.76
pat 15 −0.67±3.58 −0.39±4.33 −0.29±4.33 0.12±5.80 0.57±6.09 2.18±8.81
All 0.11±8.04 0.02±8.88 −0.32±9.16 −0.84±9.54 −0.64±9.84 −1.01±9.77
and standard deviation and the AAMI standard is apparent. Examining the
Bland Altman graphs more carefully can also provide an indication of the BHS
standard, because it is most desirable to have an error less than ±5mmHg and all
points less than ±15mmHg with the exception of a few outliers. Comparing the
Bland Altman graphs of Figure 5.13 to Table 5.7, show that the vast majority of
points are less than ±15mmHg and quite a large cluster are also with ±5mmHg.
This is emphasised by examining the BHS results of the individual patients in
Table 5.7. Again, Patients 1 and 4 perform poorly throughout, but many patients
also achieve an A or B rating throughout giving an overall improvement over
Poon’s results discussed in Chapter 4.
As discussed in Section 5.4.1, the value of this new algorithm is not always imme-
diately apparent due to the high variability of the Systolic Arterial BP. For this
reason, it can be useful to filter this signal and then compare the new algorithm
to the filtered signal. Figure 5.14 shows two examples where, although the esti-
mation looks reasonable at first, when the prediction is compared to the filtered
signal, the quality of the prediction becomes much more apparent.
5.4.4 Relative Performance
Although the previous section provides some insight into the value of the new
algorithm, it is only when it is compared to the algorithms suggested by Chen
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Table 5.7: A summary of the results of the newly developed algorithm from the
perspective of the BHS standard.
Volunteer 2 Minute Interval 4 Minute Interval 6 Minute Interval
5 mmHg 10 mmHg 15 mmHg Grade 5 mmHg 10 mmHg 15 mmHg Grade 5 mmHg 10 mmHg 15 mmHg Grade
pat 1 47.92% 77.08% 83.33% C 57.78% 75.56% 82.22% C 57.14% 69.05% 80.95% C
pat 2 54.17% 81.25% 87.50% C 51.11% 68.89% 80.00% C 38.10% 64.29% 73.81% D
pat 3 85.42% 85.42% 89.58% C 84.44% 86.67% 88.89% C 88.10% 88.10% 90.48% A
pat 4 29.17% 54.17% 72.92% D 35.56% 55.56% 80.0% D 30.95% 69.05% 83.33% D
pat 5 79.17% 97.92% 100% A 77.78% 100% 100% A 80.95% 97.62% 100% A
pat 6 56.25% 91.67% 93.75% B 62.22% 88.89% 95.56% A 54.76% 90.48% 97.62% B
pat 7 66.67% 85.42% 91.67% B 53.33% 68.89% 84.44% C 40.48% 71.43% 85.71% B
pat 8 83.33% 100% 100% A 80.00 100% 100% A 73.81% 97.62% 100% A
pat 9 63.64% 90.91% 93.94% A 33.33% 83.33% 93.33% D 48.15% 74.07% 77.78% C
pat 10 39.58% 77.08% 95.83% D 42.22% 66.67% 88.89% A 40.48% 69.05% 85.71% B
pat 11 83.33% 97.92% 97.92% B 71.11% 91.11% 97.78% B 73.81% 88.10% 97.62% D
pat 12 54.17% 83.33% 93.75% D 51.11% 82.22% 91.11% C 38.10% 78.57% 95.24% D
pat 13 43.75% 75.00% 93.75% A 44.44% 77.78% 88.89% A 33.33% 66.67% 85.71% A
pat 14 68.75% 95.83% 100% A 57.78 88.89% 95.56% A 59.52% 85.71% 92.86% A
pat 15 85.42% 100% 100% D 71.11% 100% 100% C 73.81% 100% 100% C
All 62.70% 86.10% 92.91% A 58.79% 82.27% 91.06% B 55.61% 80.81% 90.08% B
Volunteer 8 Minute Interval 10 Minute Interval 12 Minute Interval
5 mmHg 10 mmHg 15 mmHg Grade 5 mmHg 10 mmHg 15 mmHg Grade 5 mmHg 10 mmHg 15 mmHg Grade
pat 1 71.79% 76.92 % 79.49% C 50.00 % 80.56% 83.33% C 66.67% 78.79% 96.97 % A
pat 2 25.64% 56.41% 76.92% D 27.78 % 58.33% 69.44% D 33.33% 45.45% 75.76% D
pat 3 74.36% 84.62% 84.62% C 75.00 % 83.33% 83.33% C 63.64% 87.88% 90.91% A
pat 4 38.46% 61.54% 89.74% D 19.44 % 55.56% 80.56% C 33.33% 63.64% 81.82% D
pat 5 76.92% 100% 100% A 75.00 % 100% 100% A 72.73% 100% 100% A
pat 6 43.59% 71.79% 89.74% C 55.56 % 80.56% 97.22% B 54.55% 81.82% 93.94% B
pat 7 41.03% 82.05% 92.31% C 50.00 % 80.56% 91.67% B 45.45% 81.82% 90.91% B
pat 8 76.92% 94.87% 100% A 69.44 % 97.22% 100% A 69.70% 96.97% 96.97% A
pat 9 50.00% 70.83% 79.17% C 42.86 % 71.43% 90.48% A 50.00% 61.11% 94.44% B
pat 10 43.59% 71.79% 84.62% A 52.78% 77.78% 88.89% C 39.39% 57.58% 90.91% C
pat 11 74.36% 84.62% 97.44% C 69.44 % 88.89% 94.44% C 60.61% 87.88% 94.44% C
pat 12 46.15% 79.49% 89.74% C 41.67 % 66.67% 91.67% D 51.52% 81.82% 90.91% D
pat 13 33.33% 71.79% 89.74% B 47.22 % 69.44% 88.89% B 36.36% 63.64% 81.82% B
pat 14 56.41% 89.74% 97.44% A 55.56% 91.67% 97.22% B 51.52% 90.91% 97.22% B
pat 15 61.54% 92.31% 100% C 58.33 % 91.67% 97.22% C 51.52% 90.91% 96.97% D
All 54.39% 79.47% 90.35% B 52.95 % 79.81% 90.29% B 52.08% 78.54% 91.25% B
(a) Unfiltered BP vs new algorithm (b) Filtered BP vs new algorithm
(c) Unfiltered BP vs new algorithm (d) Filtered BP vs new algorithm
Figure 5.14: By filtering the Systolic ABP, the true value of the new algorithm
becomes much more apparent
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and Poon that the real value becomes evident. As has been well documented at
this stage, Chen’s estimation is always poor over any extended period of time,
because the shape seems to be the same, regardless of what actually happens
to the BP over the duration of the tests. This is shown in Figure 5.15 and this
exemplifies a poor filter choice, because it not only clearly changes the PTT
values, but also the shape of the signal. Comparatively, it can be easily seen
that Poon’s prediction and the new algorithm far exceed predictions from Chen’s
algorithm, especially over longer periods of time.
Figure 5.15: This figure shows Chen’s prediction, compared to the new algorithm
and Poon’s prediction. Again the use of an improper filter as designed by Chen
is apparent, with the prediction bearing no resemblance to actual changes to the
BP
As previously examined in Chapter 4, Poon’s prediction is known to provide re-
sults within the BHS standard at 2 minutes but fails thereafter. Accordingly,
Poon’s estimation provides some very good predictions of BP and this can be
seen in Figure 5.16, where both Poon’s algorithm and the new algorithm per-
form quite well. As has been previously noted, Poon’s algorithm does not often
react significantly to changes in BP to ensure a low error within the standards.
However, as can be seen in Figure 5.17, the new algorithm has improved on this
shortcoming and is capable of tracking BP more accurately than Poon’s.
The new algorithm sometimes suffers from the same criticism as Poon where it
doesn’t react to large changes in BP, and this is exemplified in Figure 5.18a. In
these cases, neither Chen’s nor Poon’s algorithms were capable of tracking these
large changes and the new algorithm does track the subsequent changes in BP
quite well. The occurrences of this behaviour are also significantly fewer than
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Figure 5.16: This figure shows Poon’s prediction, compared to the new algorithm.
Here both algorithms perform quite well, tracking BP and providing a low error
throughout.
Figure 5.17: The biggest criticism of Poon’s algorithm previously is that it fre-
quently did not react enough to changes in BP. This is apparent in this figure but
unlike Poon’s prediction the new algorithm is capable of tracking changes such
as these
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(a) Looking at this figure shows that although the new algorithm doesn’t react enough to the
change in BP, it is a significant improvement over Poon’s estimation
(b) Although the new algorithm has an acceptable error in this test after the large change in
BP, it is on the limit of the acceptable error. Poon’s estimation doesn’t react enough again and
so an improvement between the two is clear
Figure 5.18: One of the main criticisms of Poon’s algorithm was that it did
not react adequately to actual changes in BP. On occasion the new algorithm is
susceptible to the same criticism, but to a far lesser extent than Poon’s algorithm.
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the other algorithms but it does still exist, as is apparent in Figure 5.18b. In the
tests where this type of large change in BP has been noted, the details of the
patient are usually unavailable and therefore it is not possible to identify why
these sudden changes occurred. Given the nature of the patients under test, it is
quite possible that these reactions are not naturally occurring and could be due
to measurement artifacts or a reaction to drugs or surgery. These may also be
legitimate, naturally occurring changes in BP but without further information
this cannot be verified.
5.5 An Investigation of the Algorithm as Part
of a Wearable System
Throughout this thesis, it has been suggested that an Impedance Cardiograph
could potentially be used to measure SV. In the later chapters it has also been
suggested that when an Impedance Cardiograph is combined with a PTT mea-
surement system and a BP cuff, it would be possible to measure BP on a contin-
uous basis and by non-invasive means. In an attempt to verify these hypotheses
an ICG was acquired and a number of tests were done to verify that firstly, it is
practical to measure SV using an ICG and secondly, when all three systems were
combined a continuous BP measurement was possible for the duration that had
been found in the PhysioNet Tests.
Although it would have been most desirable to perform these tests on sick or
elderly patients, it was not practical to do so. Instead three subjects that had
been used in the tests in section 3.10 were sought to repeat those tests using
the new system. In line with all the tests that have been performed throughout
the thesis, each subject was tested three times, each test lasting 30 minutes. BP
was measured using the Omron M6 oscillometric monitor at two minute intervals.
ECG was measured continuously using the PHALs board and PPG was measured
continuously using the Tyndall developed system. SV was measured continuously
using the Bio-Pac MP36 [168] and the SS31L non-invasive cardiac output sensor
[169].
The Bio-Pac system measures Z and ∆Z continuously for the duration of the
tests. These signals were then post-processed using Matlab to extract the various
parameters required to calculate SV. Three points need to be extracted from the
∆Z signal to calculate SV: the C Point, the B point and the X Point [147]. The
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C Point is the maximum of the ∆Z signal during a heart beat, the equivalent
of an R wave in an ECG signal. The B Point is the point prior to the C Point
which initialises the upstroke of the signal. The X point is the minimum point
after the C Point. The difference between the X Point and the B Point gives the
Left Ventricle Ejection Time (LVET).
In general, it was found that it was relatively easy to extract the C Point con-
sidering it was so prominent in the signal. However, the extraction of the B and
X Points were found to be much more difficult. Figure 5.19 shows a typical ∆Z
recording and highlights many of the possible locations where each the B or X
point could have been erroneously identified and the correct location on each
beat. This type of signal is not unusual and these alternative possible B and X
point locations have been previously noted by Sherwood [131].
Figure 5.19: Examining the ∆Z signal it is easy to see that identifying the correct
location (represented by circles) for each the B (in red) and X points (in green)
from a continuous signal is quite difficult and that there are many alternative
locations which could be misinterpreted (shown in by crosses) as being a B or X
point.
A number of different methods were investigated to extract these points including
the use of Continuous Wavelet Transforms [170, 171] and higher order differenti-
ations. However, the solution to extracting these points was found via the use of
Ensemble Averaging [172] and the use of a 4th order differentiation of the signal.
Using the ECG R waves as a reference, the ∆Z signal is divided into sections
defined by R-R intervals. A mean or average ∆Z signal is then formed by taking
one minute’s worth of R-R interval based segments and averaging each point of
the signal across the one minute (usually 60-70) worth of beats as noted by Riese
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[173]. An example of the resulting waveform is shown in Figure 5.20.
Figure 5.20: The Ensemble Averaged ∆Z signal, showing the B, C and X points
Using the ensemble averaged ∆Z signal, it becomes much easier to identify the
C and X points. The C point is defined as the largest peak in the window. The
X point is then defined as the lowest point after the C point. However, it is
much more difficult to identify the B point. In some cases, the B point could be
identified as the first minimum peak prior to the C Point. However, a feature
of the ensemble averaging has been noted as a flattening of the signal and this
was most prominent around the B point. An alternative and reliable method to
identify the B point was found by taking the fourth derivative of the signal and
searching for the first peak that occurred prior to the C Point, as shown in Figure
5.21.
Once a successful and reliable method had been found to identify each of the
characteristic points, testing of the algorithm could begin on real patients and
the results can be seen in Tables 5.8 and 5.9 showing the results from the BHS
and AAMI standards respectively. Examining the last row and overall results of
the BHS results in Table 5.9 it can be seen that the new algorithm passes the
standard for the 2, 4, 6, 8 and 12 minutes intervals. The algorithm is outside the
BHS standard at the 10 minute interval by 0.1%. In terms of the AAMI standard,
the algorithm is inside the standard for the 2, 4, 6 and 8 minute intervals, while
each of the remaining intervals are outside the standard, even though it is only
by a marginal amount.
On closer examination of these results, it can be seen that the results from Vol-
unteer 3 were significantly worse than either of the other two volunteers. In an
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Figure 5.21: Although it is quite easy to identify the C and X Points via thresh-
olding, identification of the B point was much more difficult and required using
the 4th derivative of the signal.
Table 5.8: A summary of the results overall and from each volunteer, presented
in the form of the AAMI standard. Each result represents the mean error ±
the standard deviation of error between the Estimated BP, given by the new
algorithm, and the measured BP given by the cuff measurement
Volunteer 2 Minute
Interval
4 Minute
Interval
6 Minute
Interval
8 Minute
Interval
10
Minute
Interval
12
Minute
Interval
Volunteer 1 0.50±4.50 −1.26±4.06 −1.46±4.74 −1.75±4.50 −0.97±5.01 −0.77±5.05
Volunteer 2 2.74±5.65 2.72±6.06 2.91±7.20 3.51±6.28 3.39±6.58 3.29±6.78
Volunteer 3 1.17±9.65 0.27±9.61 −0.44±9.57 −0.46±10.87 −0.46±11.15 −1.96±10.60
All 1.13±7.07 0.56±7.23 0.30±7.58 0.45±8.00 0.64±8.22 0.17±8.23
Table 5.9: A summary of the results of the newly developed algorithm from the
perspective of the BHS standard, using data recorded from the ICG.
Volunteer 2 Minute Interval 4 Minute Interval 6 Minute Interval
5 mmHg 10 mmHg 15 mmHg Grade 5 mmHg 10 mmHg 15 mmHg Grade 5 mmHg 10 mmHg 15 mmHg Grade
Volunteer 1 73.33% 97.78% 100% A 80.95% 97.62% 100% A 74.36% 92.31% 100% A
Volunteer 2 62.22% 84.44% 97.78% B 61.90% 83.33% 92.86% A 48.72% 79.49% 97.44% C
Volunteer 3 42.22% 57.78% 86.67% D 35.71% 71.43% 88.10% D 38.46% 71.79% 87.18% D
All 59.26% 80.00% 94.81% B 59.52% 84.13% 93.65% B 55.56% 80.34% 94.02% B
Volunteer 8 Minute Interval 10 Minute Interval 12 Minute Interval
5 mmHg 10 mmHg 15 mmHg Grade 5 mmHg 10 mmHg 15 mmHg Grade 5 mmHg 10 mmHg 15 mmHg Grade
Volunteer 1 63.89% 97.22 % 100% A 69.70 % 96.97% 100% A 66.67% 90.00% 100 % A
Volunteer 2 50.00% 86.11% 88.89% B 48.48 % 84.85% 93.34% C 53.33% 83.33% 96.67% B
Volunteer 3 33.33% 63.89% 83.33% D 45.45 % 57.58% 75.76% D 43.33% 70.00% 86.67% C
All 50.00% 82.41% 91.67% B 54.55 % 79.80% 89.90% C 53.33% 78.89% 94.44% B
Development of a Novel PTT Based
Algorithm
148
5.5 An Investigation of the Algorithm as Part of a Wearable System
Table 5.10: A summary of the results overall and from each volunteer, presented
in the form of the AAMI standard. Each result represents the mean error ±
the standard deviation of error between the estimated BP, given by the new
algorithm, and the measured BP given by the cuff measurement
Volunteer 2 Minute
Interval
4 Minute
Interval
6 Minute
Interval
8 Minute
Interval
10
Minute
Interval
12
Minute
Interval
Volunteer 1 0.50±4.50 −1.26±4.06 −1.46±4.74 −1.75±4.50 −0.97±5.01 −0.77±5.05
Volunteer 2 2.74±5.65 2.72±6.06 2.91±7.20 3.51±6.28 3.39±6.58 3.29±6.78
Volunteer 3 1.56±8.31 1.27±8.47 0.99±7.80 1.07±8.70 0.68±9.35 −0.15±9.01
All 1.27±6.45 0.91±6.61 0.81±6.89 0.95±6.99 1.03±7.36 0.79±7.28
attempt to understand why these results were so bad, a more comprehensive
examination of the results of Volunteer 3 was completed. Although the signals
recorded from this volunteer were acceptable, when the volunteer was questioned,
a possible reason for the poor results was identified. During the first of the three
tests carried out on Volunteer 3, it appears that the volunteer was able to see
the results of the BPs and Pulse rate from the cuff measurements. Throughout
the test, it emerged that the volunteer was performing “deep breath exercises” in
an attempt to lower either their BP or pulse rate. The volunteer said that they
would begin the deep breath exercises leading up to a cuff measurement and stop
immediately afterwards. Examining the results of this first test, it was observed
that the results recorded from it were worse than the other two tests.
It was therefore decided to test this volunteer once more, this time ensuring
that they could not see the results from the BP monitor and with an assurance
from them that they would not practice their deep breath exercise during the
measurements. The results from this test are shown in Table 5.10 and Table 5.11
and show a significant improvement over the initial tests. In Table 5.10, it can
now be seen that when all the results are accumulated, the results are within
the AAMI standard at every interval. In a similar fashion, in Table 5.11, the
accumulated results are within the BHS standard at every interval.
Once again, each of these tables highlights and reiterates results that have been
seen throughout the testing of various algorithms. The first point is that no
matter what the algorithm, some people are more suited to certain algorithms
than others. As previously outlined, in both Table 5.11 and Table 5.10, Volunteer
1 seems to be very suited to the algorithm where as Volunteer 3 consistently
exhibits much poorer results, while Volunteer 2 lies somewhere in between these
two extremes. The second point is that a large number of volunteers are required
to get a good picture of the value of an algorithm since one extreme set of results
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Table 5.11: A summary of the results of the newly developed algorithm from
the perspective of the BHS standard, using data recorded from the ICG and the
re-test of Volunteer 3.
Volunteer 2 Minute Interval 4 Minute Interval 6 Minute Interval
5 mmHg 10 mmHg 15 mmHg Grade 5 mmHg 10 mmHg 15 mmHg Grade 5 mmHg 10 mmHg 15 mmHg Grade
Volunteer 1 73.33% 97.78% 100% A 80.95% 97.62% 100% A 74.36% 92.31% 100% A
Volunteer 2 62.22% 84.44% 97.78% B 61.90% 83.33% 92.86% A 48.72% 79.49% 97.44% C
Volunteer 3 46.67% 71.11% 93.33% C 35.71% 80.95% 92.86% C 43.59% 84.62% 94.87% C
All 60.74% 84.44% 97.78% B 59.52% 87.30% 96.30% B 55.56% 85.47% 97.44% B
Volunteer 8 Minute Interval 10 Minute Interval 12 Minute Interval
5 mmHg 10 mmHg 15 mmHg Grade 5 mmHg 10 mmHg 15 mmHg Grade 5 mmHg 10 mmHg 15 mmHg Grade
Volunteer 1 63.89% 97.22 % 100% A 69.70 % 96.97% 100% A 66.67% 90.00% 100 % A
Volunteer 2 50.00% 86.11% 88.89% B 48.48 % 84.85% 93.34% C 53.33% 83.33% 96.67% B
Volunteer 3 50.00% 77.78% 91.67% B 57.78 % 69.70% 84.85% D 50.00% 80.00% 93.33% B
All 54.63% 87.96% 96.30% B 58.59 % 83.84% 92.93% B 56.67% 84.44% 96.67% B
from either Volunteer 1 or Volunteer 3 can significantly skew the results, as has
been exhibited by the need for a retest of Volunteer 3.
This test has established that the algorithm that has been developed can not
only be used on data that has been measured invasively i.e. via the PhysioNet
database, but can accurately predict and track BP using non-invasive measure-
ments. It is clear that to be fully validated, a much larger number of volunteers
would be required, but this test has validated the concept that by using the al-
gorithm, an ICG, a PTT system and a cuff monitor, BP can now be measured
continuously and non-invasively simply by taking one cuff measurement every 12
minutes. Not only does this double the calibration interval of the previously in-
vestigated algorithms, but it makes the algorithm and system practical for both
users and clinicians and provides a potential breakthrough in BP measurement.
5.6 Summary
This chapter presented the key focus for this thesis, namely deriving a new algo-
rithm that would improve existing algorithms for the calculation of BP using a
PTT based method by including other parameters such as HR and SV.
The first step of this process was to identify the key parameters that had the most
potential to improve the algorithms. Using methods such as including correlations
and Draftsman graphs, it was possible to confirm that both SV and PTT had
strong correlations to BP and should be the key parameters in any calculation.
Initially, HR was also included in the investigation, despite having poor or mixed
correlations with BP. This was especially highlighted when semblance analysis
was included. Using semblance analysis, it also became much easier to identify
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some combinations of parameters that could help provide a solution.
Once the key parameters had been established and some other combinations
of these parameters were also determined, the process of deriving an algorithm
began by investigating the use of Multiple Linear Regression for a solution. The β
values derived by the MLR process were derived from the continuous beat to beat
independent variables. During the initial tests of the various equations, it was
established that using HR was having a detrimental effect on the algorithms and
it was omitted from subsequent versions. Another problem that was identified
was that there was a large variability in the PTT, SV and respective β values
that were being derived and this was causing large offsets and errors among the
estimations.
Therefore, the next evolution of the MLR equations examined the use of cate-
gorisation to compensate for the large differences that were observed across the
datasets. By categorising SV and PTT according to their values and the β val-
ues that had been derived for each variable, many of the large offsets and errors
were eliminated depending on which combination of parameters was being in-
vestigated. However, some offsets still existed and under further examination it
became evident that the PTT and SV contributions were interlinked and so both
values had to be taken into consideration when categorising the data.
The next algorithm took a ratio of PTT:SV and used the results of this ratio,
along with the β values to categorise the data. It was also established that the
β0 value that was being used in the derivation could be omitted. This yielded
much better results and the algorithm is now able to perform for 10 minutes
without needing calibration. However, upon review, it was found that although
categorisation of data can be used if a strong justification exists, the categori-
sation process for this process was limited and not easily justifiable. The other
main concern was that although it gave good results, the algorithm had no obvi-
ous physiological meaning or derivation. In an attempt to fulfil this self imposed
restriction, alternative methods and derivations were examined. From examin-
ing the correlations, the semblance analysis and each of the MLR algorithms that
had been derived, it was clear that the primary components of any new algorithm
should be both PTT and SV. For this reason, a further investigation was under-
taken to develop a new, physiological based, algorithm that would incorporate
these parameters.
Since the MLR equations that only used SV and PTT had proven to perform so
well, these parameters became the focus of a more rigorous investigation. Since
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Moens-Korteweg is used as a basis for nearly all PTT based algorithms, this
was chosen as the basic equation that described the system and it was decided
that SV should be incorporated into an algorithm derived from this equation.
Another equation, the Bramwell - Hill equation, which is also frequently used in
PTT algorithms has a volume component and this was also used as part of the
basis of the new algorithm. Finally, after an investigation into fluid dynamics,
physiological and cardiological relationships, the key component, the Poiseuille
equation, was incorporated into the derivation and a new algorithm was created.
This new algorithm was evaluated using both the BHS and AAMI standard.
Although the algorithm failed the AAMI standard at every calibration interval
other than two minutes due to an excessive standard deviation, this excess was
never greater than 1.3 mmHg, an improvement when compared to Chen and
Poon. Unlike the AAMI standard, when the BHS standard was applied, the
new algorithm passed at every calibration interval that was examined, up to a
maximum of 12 minutes. This is twice the previously recorded best from Chen and
Poon, although Chen’s shortcoming has been previously identified and discussed.
It has also been noted that the algorithm suited some patients better than others
and it is interesting to note that the two patients who provided the worst results
are those who also gave poor results when Poon was applied. For one of these
patients, it had been noted that their PTT is quite high at 500 ms and so may not
be suited for this type of algorithm. However, for the second patient, their mean
values are not remarkable and so it is unclear why they consistently performed
so poorly.
The biggest limitation to further testing was due to the lack of datasets that had
continuous good quality data for greater than half an hour. As previously noted,
in 9 tests the algorithm was capable of tracking changes over 45 minutes, without
the need for recalibration, but since there were so few of these tests it was not
possible to do a complete statistical analysis of these occasions. The next chapter
discusses acquiring data for longer periods of time so a complete analysis of long
term tracking of blood pressure by this new algorithm can be done.
Although the results of the new algorithm were really good, the algorithm had
only been tested using data that had been gathered clinically and invasively using
the PhysioNet database. Although it had been suggested throughout the thesis,
there was no indication that the algorithm could be implemented in a practical
system. To test this concept, an Impedance Cardiograph was purchased and
together with the PTT system that had been previously used, the Omron M6
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BP monitor and the new algorithm three volunteers were tested using the same
procedure as before. The results of these tests were as good as had been found by
using the PhysioNet database. Furthermore, this validates that the algorithm can
be implemented in a practical system and has validated the conceptual system
which had been previously suggested. By implementing this system it is now
possible to track BP continuously and non-invasively, with high accuracy when a
12 minute calibration interval is used. Although further testing will be required
as will be discussed in Chapter 6, this new algorithm and system provides a
significant and important improvement, not only over existing PTT equations,
but to the area of BP monitoring in general.
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6.1 Summary
Initially, it had been envisaged that this project would create a new BP monitor-
ing system that would allow continuous BP to be monitored using a non-invasive
technique. This system would be unobtrusive, wearable and comfortable for the
user, while being accurate and reliable. During the literature review described
in Chapter 2, a number of systems that were identified suited certain require-
ments of this project, but none completely satisfied all of them. After the PTT
method had been identified as a suitable candidate, it became clear that it could
potentially satisfy all the requirements. It also became evident, from examining
this method, that the key to the project would not necessarily be the creation
of the system but the development of the algorithm that would facilitate the
measurement and monitoring functions.
The first step of the project was to identify the state of the art algorithms and
to test their performance with calculations of PTT from ECG and PPG in an
unbiased manner. During the literature review, it was established that many tests
of the algorithms were only performed over very short periods of time (usually less
than a minute) and their value was unclear. Other algorithms, such as Chen’s had
been tested over longer periods of time, and their accuracy had been established
but the interval between measurements that required calibration was not stated.
Two of these algorithms were thus chosen to test the hypothesis of the PTT
method, namely Chen’s and Poon’s algorithms. The test was performed on 15
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young, healthy individuals, with each individual being tested three times and
each test lasting 30 minutes. A PTT system was built for this test and an Omron
M6 BP monitor was used for calibrating and benchmarking the system. Each
algorithm was tested to determine which could monitor and track BP changes the
most accurately and which would provide the longest calibration interval. After
analysing the results, it became clear that although Chen’s algorithm provided a
much longer calibration interval of 6 minutes, it was virtually useless at tracking
BP changes due to the presence of a filter used in its design. Although Poon’s
algorithm failed even when a two minute calibration interval was used, it did
provide some tracking of BP and if some improvements could be made to it, it
was predicted that it would perform much better.
Overall, this set of tests established that neither of the PTT algorithms that
were tested could be used in any practical implementation and that a significant
improvement was necessary. After examining the results of others, it was noted
that a number of authors had suggested that an improvement could only be
made by including more cardiac parameters to develop the necessary algorithm.
Parameters suggested included pre-ejection period, HR and SV [90, 149, 150].
Two methods of obtaining this data were identified: the PhysioNet Resource, a
large database of physiological signals that had been recorded from patients in a
hospital; and the use of an Impedance Cardiograph system that could be used to
record new data in real life experiments.
The PhysioNet Resource contains many databases of physiological signals and
some of these databases contained records from patients where SV, HR, ECG and
PPG signals were being monitored directly. The benefit of using this database
was that many of the signals, especially the BP, was an invasive beat to beat
measurement and was much more accurate than the cuff measurements taken to
date. On examination it was found that only 15 records existed that contained
all the necessary signals of SV, ECG, PPG and ABP.
The alternative was to measure these parameters by using an ICG, one of the only
methods by which the parameters could be measured by a non-invasive technique.
However, it was also found that very little information was available about ICGs,
despite the many investigations into their use in the past. A measurement using
ICGs is covered by Medicare in the USA and this led to a number of ICG products
being manufactured. However, most of these were found to be quite expensive and
in the same price range of other medical systems, such as ECG bedside monitors,
used in hospitals. Therefore, if an ICG system were to be used, it would need to
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be designed and developed.
After some consideration, it was realised that since it was possible to acquire these
parameters from the PhysioNet Resource, this acquisition method was preferable
since the key to the project was to develop an algorithm and not an ICG system.
To test its value, the algorithms identified in Chapter 3 were retested based on
the signals taken from the PhysioNet database such as ABP, ECG and PPG. The
outcomes of these tests showed that using Chen’s algorithm gave a similar result
to that found in Chapter 3, but that using Poon’s algorithm gave an improved
result due to the use of the continuous invasive ABP measurements instead of the
use of intermittent BP cuff measurements. In this test Poon’s algorithm was able
to track BP for up to 2 minutes without needing a recalibration. Although this is
a significant improvement over the previous results, the calibration interval still
remains too low to be of practical use. However, the value of the database had
been established by this result and an approach that looked to incorporate the
SV and HR parameters into an equation was undertaken.
Although a number of these parameters had been identified from various papers,
it was not clear how strongly the parameters related to BP or how much value
could be gained from using them. The first step in the process of designing
the algorithm was to establish how strongly each parameter was related to BP
and whether it should be present in a new algorithm. The use of correlations and
Draftsman Charts were used to examine these parameters, but semblance analysis
was found to be the most useful technique because it enables comparisons of time
varying data streams. Using semblance analysis, a number of combinations were
identified which showed a strong relationship to BP and that could be useful in
a new algorithm.
The first method that was used to create a new algorithm was the use of Multiple
Linear Regression. When this technique was used, the beat to beat continu-
ous independent variables were used to derive the β values. The β values were
then averaged and applied to the same dataset. During the development of the
first MLR based algorithm i.e. Algorithm 1-x, it was noted that HR was having
a detrimental affect on the outcome of the algorithms and it was subsequently
omitted when the MLR tests were rerun giving Algorithm 2-x. While investigat-
ing Algorithm 2-x, the variance between patients became more prominent and
the dominating influence of the algorithm. Therefore, the equations derived from
this approach were found to be ineffective and an algorithm that was universally
applicable was not found and would not be found unless a fundamental change
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was applied. Algorithm 3-x used a categorisation process where PTT and SV
along with their respective β values were grouped into different categories and
β values were only applied to appropriate PTT values and SV values and most
of the large offsets that had been found in Algorithm 2-x were eliminated. Al-
though Algorithm 3-x brought a significant improvement, it was thought that the
algorithm could be improved by taking both SV and PTT into account when gen-
erating and applying β values. Therefore in Algorithm 4-x the ratio of PTT:SV
was examined and β values were categorised using this ratio. This process yielded
further improved results, and when this algorithm was tested it was found that
a 10 minute calibration interval could be achieved.
Although Algorithm 4-x was a significant improvement, not only over other MLR
equations but also over Chen and Poon’s algorithms. However, it had no obvi-
ous physiological basis or justification. For this reason it was decided that an
alternative method should be investigated, using existing PTT algorithms as a
foundation and using the lessons that had been learned from the MLR process,
fluid dynamics, physical relations and equations as well as physiological and car-
diological relationships. After a detailed investigation of these relationships, a
new algorithm was derived from a combination of the Bramwell Hill equation,
the Moens Korteweg equation and the Poiseuille equation. When this algorithm
was tested, it was found that not only did it track BP changes very well, and
that it was universally applicable but it also passed the BHS standard even when
a 12 minute calibration interval was used. This is a calibration interval 100%
and 600% greater than Chen’s and Poon’s algorithms, respectively. It is also sus-
pected that a longer calibration interval may be possible but due to limitations
of the database, it was neither possible to test larger calibration intervals nor to
have more statistically significant results.
6.2 Discussion and Conclusions
The original goal of this project was to develop an algorithm that could be used
as part of a new BP monitoring system that would monitor BP continuously
and non-invasively while being unobtrusive and comfortable to the user, some-
thing which no current system provides. The algorithm that has been developed
uses PTT and SV to continuously monitor BP, along with intermittent BP mea-
surement by other means. It has been shown that the PTT satisfies all the
requirements of a continuous and wearable system and that by using an ICG to
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measure SV, this system would also satisfy these requirements and therefore the
goal of the project has been successfully achieved.
This new algorithm is valid when using a 12 minute calibration interval, a 100%
improvement over existing approaches and it is suspected that a longer calibra-
tion interval is possible. However, due to the lack of continuous data for periods
greater than half an hour, it is not possible to test this theory using the Phys-
ioNet databases, since there would not be enough data to make statistically valid
conclusions. Even if it is found that 12 minutes is the limitation of this new al-
gorithm, this is a significant improvement over the current algorithms and brings
the method into the realm of being practically useful.
One of the primary methods that is used by cardiologists for “in home” moni-
toring and diagnosis of patients is the use of an oscillometric BP monitor that
inflates once every 15 minutes over a 24 hour period. As has been highlighted
throughout this thesis, the use of intermittent points to diagnose or assess a signal
can be fraught with difficulty and it is highly recommended that such situations
be avoided. If this new algorithm could be extended to have a calibration inter-
val of 15 minutes, and if it could be incorporated into the existing system that
is given to these patients, a cardiologist could then potentially have 24 hour con-
tinuous monitoring of BP. Even if the algorithm is ultimately found to only be
accurate using a 12 minute calibration interval, this would only mean one extra
measurement every hour for the patient to achieve continuous BP measurements.
Throughout this thesis, SBP has been the main focal point of all analysis and
discussion. However, in a clinical setting, both SBP and DBP are used in tan-
dem. The decision to focus on SBP comes from the fact that SBP is generally
considered to be more important, as it provides a much greater predictor of risk
and indicator of cardiovascular health [174, 78, 175]. More specifically, isolated
systolic hypertension (hypertension where only the SBP is raised, while the DBP
remains at a normal level) predicts risk better than isolated diastolic hyperten-
sion [176]. Epidemiologically, isolated systolic hypertension is the most common
form of hypertension and is present in approximately two thirds of hypertensive
individuals older than 60 years of age [177]. It was therefore felt that the ability
to track SBP on a continuous basis would provide far more vital information, in
far more cases. The deployment of this algorithm, which allows the beat to beat
tracking of SBP, could allow the early identification of CVD and to track and
monitor hypertensive patients with elevated SBPs.
Although not as important, the ability to track DBP would also be highly useful
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and beneficial. An initial evaluation of the newly developed algorithms to track
DBP has taken place using the PhysioNet database. These results show that
the algorithm is capable of tracking DBP, again using a 12 minute calibration
interval. However, these results also showed that the algorithm failed the BHS
standard when either an 8 or 10 minute calibration interval was used. The source
of this failure, in both cases, were due to the algorithm failing to have sufficient
datapoints less than 15 mmHg i.e. at both of these interval, less than 90% of the
points were less than 15 mmHg. Although the level of failure at both intervals
was marginal, 0.7% and 0.1% respectively, it is a cause of concern and indicates
that more volunteers/patients should be evaluated to confirm these findings. It
may also be the case that more work may be needed to adapt the algorithm for
DBP, or that a specific algorithm for DBP should be developed, similar to that of
Poon, who had two different algorithms; one for SBP and one for DBP. The first
step, in either case, should be the testing of more patients/volunteers, ideally via
a clinical trial.
It is also interesting to note the failure of both the new algorithm and Poon’s
algorithm over certain calibration intervals when the AAMI standard is used.
When both of these algorithms were analysed, no outliers were removed from
either test to ensure complete analysis. Examining the Bland Altman graphs
for Poon’s test in Chapter 4, a drift and expansion of the data points from the
zero error point (and even the 5mmHg error) can be observed as the calibration
interval increases and the reason for the failure of the AAMI standard becomes
more obvious than when the Bland Altman graphs for the new algorithm in
Chapter 5 are examined. In these graphs the cluster of data points around the
zero mark (and inside the 5mmHg error marks) does not seem to degrade as
significantly. The number of outliers seems to increase a little as the calibration
interval increases and certainly the numerical value of these outliers also seems
to increase. Examining the associated AAMI table and even the BHS table, it is
clear that there are a number of patients whose results perform poorly throughout.
The details of these Patients 1 and 4 are unknown, although the large PTT of
Patient 1 could indicate that the algorithm may be unsuitable for them.
Another patient who performs poorly throughout is Patient 14 whose specifics
are stated to be post - op cardiac bypass graft. Whether this patient should have
been excluded from the evaluation or not is questionable. However, examining
each of the three tests of this patient reveal that the new algorithm performs very
well in two of the tests and for the one that failed a large offset is apparent due
to a poor initial estimation.
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The major problem of using the PhysioNet database is highlighted by these three
patients. Due to the limited availability of all the required signals, it was necessary
that all patients where the signals were found had to be used. In the case of
Patient 14, it could be argued that this type of patient should not be included
when evaluating a new technique but their inclusion is probably of more value
than their exclusion. In the case of Patients 1 and 4, it is quite possible that
they should be excluded given how poorly they performed for both Poon and
the new algorithms. However, without knowing their specifics, they must be
included unless it was found they had abnormal signals. It is also quite possible
that some of the patients that were tested were on BP altering drugs and were
also not suitable for testing, but again given the limited knowledge and limited
availability of data every one of the patients had to be included.
In many ways, the value of the new algorithm can be appreciated because of the
test subjects that were used. It is more than likely that it is these types of people
on which the algorithm would be used, rather than fit, healthy individuals. How-
ever, in order for it to be properly evaluated, the ailments and specific treatment
regimes of each person under test must be fully known and a wide variety of
people such as those found in the database should be evaluated.
The use and assessment of the MLR equations that were used to develop a new
algorithm in this work, has emphasised the range of people and parameter values
that were available in the PhysioNet database. If any BP monitors are to be
evaluated, a range, such as those used in the PhysioNet database, should be
mandatory. The ESH standard goes some way to enforce this, saying that the
subjects used should have low, medium and high systolic and diastolic BPs in
order to pass the standard. It may also be appropriate to not only examine
people and categorise people (and their measurements) using a large range of
BPs, but also to examine other cardiovascular parameters that have an influence
on their health, such as PTT and SV.
If a large range of people is not used to evaluate BP monitors, it is possible that
these monitors may pass standards they would otherwise fail. An example of
this has been noted in relation to Poon’s algorithm in section 3.10.2, where it was
noted that the algorithm seems to be quite accurate between 100 and 130 mmHg.
Had the evaluation of Poon’s algorithm been limited to this range, it is possible
that it would have passed the standard at every calibration interval. However,
because the algorithm was evaluated using people with a much larger range, its
limitations were also identified.
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Although the ESH standard was not used to evaluate any algorithms in this
work, due to the various concerns outlined in Appendix A, it is worth some
discussion. Aside from the concerns outlined in Appendix A, it would not have
been possible to implement the ESH standard completely in this work since there
were not enough patients available in the PhysioNet database with the required
parameters nor were there (proportionally) enough patients from each of the
required ranges of BP. The ages and health of the patients that were used satisfy
the requirements of the standard, although more BP readings would have been
required by independent, blind observers. Since the ESH standard uses a similar
grading system of the BHS standard, it is anticipated that the new algorithm
would pass the ESH standard. To further emphasise this, by analysing the Bland
Altman graphs in section 5.4.3, it can be seen that there are no apparent trends
in the graphs that suggest the use of more patients, with either higher or lower
BP ranges, would have caused a fail if the standard had been applied.
The final test, where the algorithm was implemented using a practical system
and tested using volunteers, is an important validation of the work described in
this thesis. Although this test was a preliminary one to establish the value of
the ICG and the new algorithm, it has validated the concept of the system and
the algorithm. However, even in this test, the need for a much larger study can
be observed. One other factor that may influence the results, which is not im-
mediately apparent, is the impact of using the non-invasive, non-continuous BP
monitor as a reference. Since BP readings are not observable between the two
minute intervals, the tracking ability of the algorithm in between these intervals
is unknown whereas in section 5.4 using the ABP, the tracking ability was ob-
servable. The danger of using a non-continuous BP monitor has been established
in Section 4.5.4 where the value of Poon’s algorithm became more apparent when
it was compared to ABP, rather than when it had been compared to the non-
continuous measurement in Section 3.10 and consequently was within the BHS
standard at the two minute interval when compared to ABP. Therefore, it is also
possible that a further improvement could be observed if it were possible to com-
pare the new algorithm to ABP, something which has been suggested by the EHS
standard, but that would require a clinical trial.
The results of this test reflect those that had been established in section 5.4,
where a 12 minute calibration interval was achieved using the PhysioNet database.
However, the results of this test are even more significant as they show that it is
possible to implement this system using non-invasive methods. This means that
it is now possible to measure BP on a continuous basis, by non-invasive methods
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over calibration intervals that are practical from the perspective of both clinicians
and users. Although, this appears to only provide a 100% improvement to the
calibration interval for the PTT algorithms such as Chen and Poon, the practical
implications are much more momentous, providing a breakthrough in the area of
BP monitoring. Up until this point, to measure BP on a continuous basis required
either a catheter or a continuously inflating/inflated cuff i.e. via tonometers or
the Peñáz method. Using this system though, an inflation is required only once
every 12 minutes providing even less discomfort for the user but with the same
accuracy and reliability for the clinician. An extra bonus of this system is that
with the inclusion of the ICG and PPG sensor, it would be possible to incorporate
this suggested system into the existing 24 hour BP monitors that are currently
used by clinicians, the only difference being that a cuff measurement is required
every 12 minutes instead of 15 minutes. This is also a very important feature, as
it allows the new system to be used by clinicians without any risk, since the cuff
measurement will also be recorded, but could provide far more information since
every BP movement will also be recorded in the intervals.
6.3 Future Work
The next step for this project would be to confirm the findings of this thesis
in a clinical trial. This would establish the limitations of the new algorithm.
Any such test should be performed in a trial where ABP can be monitored as the
benchmarking tool on patients with known physiological parameters. During this
trial, the use of a pre-ejection period could be explored, because it has previously
been found to have a significant impact on PTT methods and by accounting for
it in this algorithm, a further improvement should be noted. It would also be
desirable, as part of this trial, to use an ICG to monitor all of the signals of
interest, as it can measure each of them on a continuous basis and its use as part
of a non-invasive BP monitor could be evaluated.
As previously mentioned, the specifics of each person being tested should be
known prior to any test but a wide a variety of people should be tested where
possible. To ensure a proper evaluation, a large number of people, in excess of
85, should also be tested in accordance with the AAMI and BHS standards. The
International protocol for BP measurements should also be used as a basis for
evaluating the algorithm. However, the use of ABP would complicate these tests
somewhat because all were designed for testing intermittent measurements such
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as those used by a cuff.
As has been already established the PTT system and ICG systems would suit the
requirements for a wearable and continuous BP monitoring system. It would also
be possible to reduce the size of each system significantly. In Qu’s design [178],
an ECG is part of the ICG design eliminating the need for two different boards,
and the ICG patches can be used to detect the ECG waveform, further reducing
any potential discomfort for the patient. Another improvement could be made
by incorporating the PPG sensor into a ring type device, as has been done by
Shaltis [86]. Both sensors could also use a Body Sensor Network to communicate
with each other or a base station as long as timing issues can be resolved. One
further step, which was envisaged when developing the ECG and ICG boards,
would be to use a mobile phone as a base station for these sensors via Bluetooth.
The phone could then process all the raw data captured from each sensor, store
the data or forward it to a GP or cardiologist on request and the other sensors
could be integrated into a t-shirt similar to the concept drawing shown in Figure
6.1. Other smart vests have been previously developed [179, 180, 181], primarily
for the area of AAL, and the development of such a shirt would allow the system
to be implemented in a variety of different settings be it for AAL or other home
monitoring systems and could allow the integration of other sensors for a complete
health monitor.
This project has provided a new algorithm which has been shown to exceed
the calibration intervals of two of the state of the art algorithms by 100% for
calculation of blood pressure. However, the ramifications of this system are far
greater, allowing BP to be measured on a continuous and non-invasive basis
with even less discomfort to the patient than has been previously possible. It
may perhaps even be possible to further improve the algorithm by taking pre-
ejection period into account and using ABP as a reference. By using an ICG
system as outlined in this section, along with a ring type PPG sensor, it would
be possible to create a wearable BP monitoring system that could integrate with
a person’s phone to provide a non-invasive, unobtrusive, wearable and continuous
BP monitor, something which does not currently exist.
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Figure 6.1: A conceptual image of a t-shirt that incorporates both the ECG and
ICG systems via patches built into the shirt. A BP cuff could also be incorporated
into the arm and a ring photoplethysmograph sensor could also be included.
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Appendix A
The Use of the Poiseuille
Equation in the New Algorithm
It is well documented that there are a number of assumptions that are necessary
so that the Poiseuille Equation can be used, namely where
• The fluid is incompressible and Newtonian
• The flow is laminar through the pipe
• There is no acceleration of fluid in the pipe
For the most part, it is recognised that blood is a non-Newtonian fluid. However,
it has been found that blood behaves as a Newtonian fluid only at high shear
stress rates δv
δy
≥ 100s−1 [182]. In large arteries [183], the shear rate is well
above this limit and so the blood flow through this artery can be deemed to be
a Newtonian fluid.
The primary problem with using the Poiseuille equation in large arteries, is that
the blood flow is pulsatile. Therefore, a modification of the Poiseuille equation
is necessary to account for this difference. This alternative equation is known as
Womersely’s equation [166].
The derivation of this equation begins with the Navier Stokes Equation [184]
and is outlined in Gabe’s paper [167]. From this paper, if an idealized model
of an artery as a long, straight, cylindrical, rigid tube of radius R, containing a
Newtonian viscous liquid is assumed, the Navier Stokes equation can be simplified
to
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(A.1)
where w is the velocity [m/s] along the tube at radius r [m], z is the distance
along the tube [m], ρ the density [kg/m3]and v the kinematic viscosity of the
liquid [kg/sm]. If the pressure gradient along the tube is Pcos(ωt − φ), it has
been shown by Womersely that the volume flow Q along the tube is
Q = P × piR
4
µ
× M
′
10(α)
α2
× sin[ωt− φ+ ′10(α)] (A.2)
where µ is the coefficient of viscosity, α is a non-dimensional parameter R
√
ω
v
,
where ω = 2pi × frequency and M ′10(α) and 10(α) are functions of α tabulated
by Womersely for α = 0to10. It should be noted that this equation is per unit
length.
Comparing A.2 to Poiseuille’s equation A.3, a clear relationship is evident.
Q = ∆P × pir
4
8µK (A.3)
Therefore, the primary difference between both equations is due to the com-
plex relationship derived by Womeresly, that defines the actual resistance to flow
through the artery.
However, in the algorithm that has been derived, the value of the resistance is
not critical or used because it is removed during the differentiation, and so for
the sake of simplicity, the Poiseuille equation was used as a more convenient
replacement.
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Appendix B
An Examination of the European
Society of Hypertension Standard
for Blood Pressure Monitoring
B.1 The Specifics of the Standard
The European Society of Hypertension (ESH) International Protocol for valida-
tion of BP measuring devices [18, 185] is the most complex of the three standards
for blood pressure monitoring and uses lessons and shortcomings learned from the
BHS and AAMI standards. The aim when creating this standard was to make it
more practical for smaller companies to be able to validate their devices because
both the BHS and AAMI standards require a large data set to be tested with
a large variance of BP across all the subjects, thus making any new device very
expensive to validate.
The ESH standard is very detailed on how the validation should be carried out.
It requires four people to be part of the validation team: two observers, one
supervisor (typically a nurse) and one expert (typically a doctor). The validation
itself uses a categorisation system similar to the BHS standard to evaluate the
device over two stages. The first stage requires fifteen subjects, with at least five
male and five female and the second requires an additional eighteen subjects, at
least ten male and ten female. Each subject should be at least 25 years of age.
The subjects should also have a wide range of Blood Pressures. In the initial
round of 15 subjects, 5 subjects should have a systolic blood pressures in the
range as outlined in Table B.1. In the second test, 11 subjects are required to
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Table B.1: The ranges of Blood Pressure of the subjects that are required for the
ESH Testing Procedure
SBP DBP
Low <90 <40
90-129 40-79
Medium 130-160 80-100
High 161-180 101-130
>180 >130
have blood pressures in each of these ranges.
The procedure for the measurement is as follows. The subject is initially intro-
duced to the validation team and allowed to rest for fifteen minutes prior to any
measurements being recorded. The following measurements are then recorded:
BPA
Observers 1 and 2 take a measurement with the mercury standard which is
used to categorize the subject
BPB
Observer 3 takes a blood pressure measurement with the test device. The
result from this measurement is not included in the results, but if a success-
ful measurement is not possible after three attempts, the subject is excused.
BP1
Observers 1 and 2 take a measurement using the mercury standard
BP2
The supervisor takes a measurement with the test device
BP3
Observers 1 and 2 take a measurement using the mercury standard
BP4
The supervisor takes a measurement with the test device
BP5
Observers 1 and 2 take a measurement using the mercury standard
BP6
The supervisor takes a measurement with the test device
BP7
Observers 1 and 2 take a measurement using the mercury standard
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In a similar method to the BHS standard, the differences (errors) are classified
into one of three ranges within 5mmHg, within 10mmHg or within 15mmHg. To
test the accuracy, only measurements BP1 to BP7 are used. The mean of each pair
of observer measurements is calculated, this is denoted as observer measurement
BP1, BP3, BP5 and BP7. Each test device measurement is flanked by two of these
measurements and one of these must be selected as the comparative measurement.
The following procedure is then followed:
1. The absolute differences of BP2−BP1, BP2−BP3, BP4−BP5, BP4−
BP3, BP6−BP5, BP6−BP7 are calculated.
2. These are paired according to device reading
3. If the values in the pairs are unequal, the observer measurement correspond-
ing to the smaller measurement is used
4. If the values in a pair are equal, the first of the two pairs is used
When this has been completed there are three device readings for SBP and three
device readings for DBP. This further means that there are 99 measurements in
the first phase of testing outlined in Table B.2. In this round there are 33 subjects
in total meaning a total of 99 results. There are two criteria for the device to
pass this round. The device must satisfy two of the criteria in the first row of
Table B.2 and all of the criteria from the second row of Table B.2. At this stage
the mean and standard deviation of the differences should be recorded.
Table B.2: A summary of the results required to pass phase 1 of the ESH Testing
Procedure
Measurements Within 5 mmHg Within 10 mmHg Within 15 mmHg
Two of 73 87 96
All of 65 81 93
If the device passes the first phase, it must pass one final test outlined in Table
B.3. This table analyses data in a per subject basis. It states that at least 22 of
the 33 subjects must have at least 2 of their 3 comparisons within 5 mmHg. At
most, three of the subjects can have all three of their comparisons over 5 mmHg
apart. If a device passes both the first and second phases of testing, it can be
said to have achieved a pass from the ESH standard.
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Table B.3: A summary of the results required to pass phase 2 of the ESH Testing
Procedure
Measurements 2/3 within 5 mmHg 0/3 within 5 mmHg
At least ≥ 22
At most ≤ 3
B.2 The Exclusion of the ESH standard in the
Evaluation of this Work
There are many reasons why it would have been preferable if this standard could
have been implemented in this work. The primary reason is that it is the most
complete and detailed of all the standards since it is based on the lessons learned
from both the AAMI and BHS standard.
However, there are many compelling reasons why the standard should not have
been used. The most simple and easiest to explain is that in one of the appendices
of the ESH standard, it states that any device that measures beat to beat blood
pressure should be tested and its results compared to those from an arterial
catheter, something which has been previously stated in this thesis.
Another reason for not using this standard is the amount of resources that are
necessary to implement the tests required for the standard i.e. the number of ob-
servers, supervisors and experts that would be required. A much larger restriction
was also found due to the subjects that are required since all the subjects used in
this work were volunteers and colleagues. Although the age requirements of the
standard would not have been a restriction, the primary concern was in getting
access to the wide range of blood pressures that would be required, especially in
the category of very high blood pressure.
The final reason for not implementing this standard was that the tests outlined
in the ESH standard did not fit with any of the tests that were required to
evaluate the devices under test. The vast majority of PTT based algorithms
that have been published attempt to pass the standards after long calibration
intervals. In the AAMI standard, it is quite easy to compare the differences of
many measurements at a specific calibration interval and check if the results are
within a certain mean and standard deviation. In a similar manner, it is possible
to test these differences and add them to the accumulated ranges specified in
the BHS standard. In this test seven measurements would be required at every
calibration interval, making it impractical.
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Design of an Impedance
Cardiograph
Examining the literature, it was found that there were not many designs available
for ICGs. However, many papers discussed the principles and basic concepts of
the technique [186, 187, 188]. From this literature it was clear that there were
two main components of the system: the current injection and the impedance
measurement. However, beyond this basic information not much else was avail-
able. It was found that only two papers and one book outlined the hardware
and components in any detail: Qu [178], Fortin [145] and Prutchi [189]. Qu’s
paper was first published in 1986 and gave very specific circuit information, but
some of the components were found to be obsolete. Fortin’s paper was much
more recent on the other hand, being published in 2006. However, it provided
less specific information, describing its components using block diagrams and text
rather than circuit diagrams. Prutchi’s book was published in 2005 and provided
a high level of detail and good descriptions of each component. However, it also
shared a common problem among all three sources: each circuit was powered
from the mains, whereas the application for this work was for a wearable system
that would be powered by batteries. To be more specific, many of the IC’s in
each of the designs were powered from ± 15V whereas a typical wearable system
would rarely exceed ± 5V. However, it was felt that by combining the technology
outlined in Fortin’s paper along with the specifics from Qu’s paper and Prutchi’s
book, a good compromise could be achieved along with full functionality. This
appendix will describe the resulting design and is divided into two main sections:
the “current injection hardware” section and the “impedance measurement hard-
ware” section.
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C.1 Current Injection Hardware
Figure C.1 shows a block diagram of the components required for the current
injection hardware. These consist of current generation block, where the current
that is to be injected is generated, a DC safety circuit, which ensures no DC
current is injected into the user and a precision rectifier, PI controller and two
summing amplifiers (represented by two plus signs) which provide a feedback loop
that monitors the leads for stray currents.
Figure C.1: A Block Diagram describing the implemented Current Injection Sys-
tem.
From reading the basic specifications of the current injection hardware from every
source in the literature identified in the previous sections, it was evident that an
oscillator was needed to generate the 100kHz sine wave that was required. Numer-
ous different oscillators were simulated, designed and built in the course of this
work, but only two basic configurations were finally considered: the Quadrature
Oscillator and the Wein Bridge Oscillator.
Examining the simulations of the circuits with practical capacitor and resistor
values and various implementations it was found that the circuit shown in Figure
C.2, a modified Wein Bridge Oscillator, provided the best sine wave at the desired
frequency of 100kHz.
Qu [178] and Prutchi [189] also used a type of Wein Bridge oscillator in their
design, but took advantage of the dual power supply, which means a reduction of
the component count due to the bipolar swing of the oscillator provided by the
dual power supply. In other words, by using a dual power supply it is much easier
for a sine wave to be generated that oscillates around 0V, whereas if the circuit
does not contain a positive and negative supply, extra components are required to
force the oscillation around 0V. Fortin, on the other hand, used a Direct Digital
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Figure C.2: A PSPICE circuit diagram of the modified Wein Bridge Oscillator
developed during this work.
Synthesis (DDS) chip, which is an IC capable of generating precise sine waves via
programming, usually used for modulation and demodulation of communication
signals. The advantage of using this kind of device is that both the frequency
and amplitude could (in theory) be changed simply by reprogramming the chip
via the 3-wire SPI. Given that this design was using a combination of sources
for design and that there was an understandable concern about injecting current
into the body, it was felt that a circuit which could easily adjust the amplitude
of the current and its frequency would be best rather than either of Wein Bridge
Oscillators that would require different components if either the amplitude or
frequency were to be adjusted.
An AD9834 DDS chip [190]was chosen as the basis for the current injection circuit.
A 75 MHz oscillator was paired with the DDS chip to provide the required clock
signal. The current was controlled by two parameters, the resistors RSET placed
on both of the output pins IOUT and IOUTB and the voltage on the input pin FS
ADJUST. Although FS ADJUST is nominally set to 1.15 V, by using a DAC
on its input, it is possible to have greater control over the input voltage and
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therefore the output current. A 12 bit DAC, the AD5620 [191], was used in this
application as recommended by the application note CN-0156 [192], because it
was also programmable using a 3-wire SPI.
In Fortin’s circuit diagram, a feedback loop is present which monitors the leads
that are connected to the subject in case of stray voltages, which could potentially
harm them. If a stray signal is detected, it is fed into a precision rectifier and
Proportional + Integral (PI) controller before being subtracted from the original
current "input" signal going to the body. The precision rectifier was included in
case some of the modulated signal was present on the ground signal, which the
rectifier would remove. The PI controller would then examine the stray signal
and provide an output that would compensate this offset.
Figure C.3: The standard configuration Proportional + Integral Controller used
in the feedback loop of the current injection system [193].
While the current was injected, it was constantly being monitored for DC compo-
nents by a safety circuit. The safety circuit was comprised of a transimpedance
amplifier, a comparator with a low reference voltage and a D flip flop with set
and reset as shown in the Figure C.4. If a DC current was detected and exceeded
the reference, set by resistors R155 and R156, the flip flop would toggle and
send a reset to the rest of the system that would disable the current injection
immediately.
C.2 Impedance Measurement Hardware
When an instrumentation amplifier is used along with a synchronous detector/
demodulator, the result is a lock in amplifier. A lock in amplifier [194] is basically
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a synchronous demodulator followed by a narrow band, low pass filter. This allows
very small signals to be detected in the presence of large amounts of uncorrelated
noise when the frequency and phase of the desired signal are known [189]. The
demodulator used in this design is the AD630 [195]. This is the recommended
demodulator in Prutchi’s design. When being used as a demodulator, the AD630
needs a reference signal that is 90° out of phase with the original input signal.
This reference signal is provided by using a second DDS chip, whose amplitude
is controlled by the same DAC as described earlier. This signal is then buffered
and phase shifted, as described by Prutchi’s design. A potentiometer is used in
the phase shifting circuit to (manually) adjust the phase shift as per Prutchi’s
design. Again, this is a relatively standard configuration for an adjustable phase
shifting circuit, [196].
Differential and common mode offset are also provided as part of the AD630
circuitry. Both of these parameters can be adjusted using potentiometers. The
output of the AD630 is then filtered using a low pass filter with cutoff frequency
of 0.72Hz. This LPF design is taken from Qu’s schematic. The resulting signal
is known as the Basal Impedance i.e. Z0. Impedance Cardiographs are very
sensitive to motion artifacts and baseline drift due to respiration. These artifacts
can cause saturation in the ICG system which could result in the loss of data for
up to 10 seconds. It is therefore desirable to incorporate an automatic adjustment
unit which is capable of accounting for these artifacts if they occur. There are
several ways to do this, such as the successive approximation register (SAR) based
method, as described by Qu but the components used in this method were found
to be obsolete. However, it was found that this type of motion artefact removal
can now easily be performed using a microcontroller and it was therefore omitted
from the design.
The final stage of the impedance measurement unit is the calculation of dZ/dt
from the ∆Z signal. This is done using a practical differentiator, as can be seen
in application note 31 from National Semiconductor [197].
C.2.1 Other Design Features
As mentioned in C.2, a microcontroller was also included in this design. The
microcontroller was responsible for controlling the DACs, which controlled the
amplitude of the DDS signals for both the current injection and demodulation
process. It was also responsible for reprogramming the DDS ICs, and the motion
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Figure C.6: A Block Diagram describing the implemented Impedance Measure-
ment System.
artefact reduction necessary for all ICGs. Since an ADC (that was capable of
sampling at 250 Kbit/s) would also be required to transmit the results of the
ICG to a PC, choosing a microcontroller that had one incorporated would have
been advantageous. Furthermore, the communication of the data to another
source also required a microcontroller to translate the analogue or digital signal.
With all these considerations in mind, the microcontroller that was chosen was the
Atmel Mega 1281 [105]. The most significant advantage of this microcontroller
was that it had already been used in the design of the PHALs board and so
most of the code written for that application could also be used in this one.
By including this microcontroller, all other Tyndall motes could be attached as
necessary at a later stage, e.g. for Zigbee communications or signal processing
via an FPGA.
It was also decided that a Bluetooth module and an SD card would be included
in the design, to allow for live and/or local recording respectively and to ensure
compatibility in a Body Area Network (BAN). Both of these features were copied
from the PHAL design where they had already been tested extensively. Unlike
the PHAL design however, no battery charging circuitry was included in the
design so that a subject under test would never be connected to a mains supply,
regardless of the safety features included in the design.
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Protocol for Recording Data
from Volunteers
Each of the tests described in this thesis follow essentially the same protocol when
volunteers are being tested. These procedures are based around the recommen-
dations outlined by Pickering [6] for taking BP measurements from patients. The
number of patients required, their genders and the ratio of genders was decided
after consulting with the clinical advisor for this project, Dr. Carl Vaughan. No
ethical approval was sought since none of the tests were invasive procedures.
D.1 Round 1 Testing
The procedure outlined below was followed for the first round of testing.
• Each subject was asked to refrain from ingesting anything for half an hour
prior to the test
• Once each subject arrived at the laboratory, they were seated for at least 5
minutes before any data was recorded
• The Pulse Oximeter was placed on the middle finger of the left hand
• The BP cuff was placed on the upper left arm, 2-3 cm above the bend in
the elbow
• The ECG electrodes were placed in the regular 3 electrode positions seen
in Figure 3.12 a)
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• Each volunteer was seated in an upright position, feet flat on the floor and
elbow (and arm) resting comfortably on the desk
• A BP measurement was taken every 5 minutes
• ECG and Pulse Oximeter data was recorded continuously over 15 minutes,
from which the PTT was later derived using Matlab [122]
Notes:
[1] Volunteers were sought from colleagues within Tyndall. No restrictions with
regard to health or age were imposed on the volunteers but all volunteers
that were tested were other students. The reason for this selection was that
it was felt that students had more availability and could be more flexible than
staff for initial and subsequent testing. Since all volunteers were students,
this meant that all volunteers were relatively young, the youngest being 22
years old and the oldest being 32 years old, and all volunteers were relatively
healthy.
[2] Each volunteer was asked to refrain from eating or drinking prior to the test,
but they were also asked not to smoke as it may have adversely affected the
results.
[3] Each volunteer was asked to remain seated for at least 5 minutes prior to the
test. This was to eliminate any elevated BP readings that may have occurred
due to exercise. If the volunteer seemed out of breath or if it seemed that
they had rushed to the laboratory, this rest period was extended until they
had recovered. A few BP readings were also taken during this period, to
allow the volunteer to get used to the feeling of the BP cuff. This allowed
the volunteer to relax and potentially identify white coat hypertension. If
there was either a very high initial BP reading or if there was a major change
in BP between the first and subsequent readings of BP, this initial testing
duration was extended until the BP was relatively consistent. This reduced
the chances of nervousness affecting the reading or of white coat hypertension.
[4] As previously mentioned in section 3.7.2.1, each volunteer was asked to refrain
from wearing nail polish during the testing as it had been noted that it would
distort the signal. Each volunteer was also asked not to move their hand or
finger during the test, to eliminate motion artifacts as much as possible.
[5] It was found that one volunteer had a very poor ECG signal, using the
electrode positions shown in Figure 3.12 a). After consulting the clinical
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advisor to the project, he suggested moving the electrodes to the positions
shown in Figure 3.12 b) for this volunteer only.
[6] Each volunteer was seated for the duration of the test. They were asked not
to slouch but to find a comfortable position that they could hold throughout
the test. It was also important that they kept their elbow and arm flat on
the desk and to have both in a natural position relative to the rest of the
body, essentially meaning that their lower arm was almost at 90° to their
upper arm, but in a slightly more relaxed position.
D.2 Round 2 Testing
A number of problems were identified when the data from the first round of testing
was analysed. The most important of these, from the perspective of the testing
procedure was that when the cuff inflated, the data from the Pulse Oximeter
disappeared (unsurprisingly). To ensure continuous data was being recorded the
Pulse Oximeter was then moved to the right hand. Another important change
was that the original BP monitor was replaced by a more expensive, clinically
validated one, the Omron M6 [26]. Other changes were also necessary to improve
the signal quality and the peak detection of the algorithms in Matlab, but these
did not have an impact on the procedure.
For the most part all other procedures that had been followed were found to be
adequate and so were kept in place. The following points were then added to the
procedure in an attempt to improve the overall testing procedure:
• A preliminary test of each volunteer was introduced, typically lasting less
than two minutes
• Each test was recorded the hours of 2.30pm and 4.00pm, in a quiet room
at a comfortable temperature
• Both the PHALs board and Pulse Oximeter were packaged so nothing could
interfere with the circuit or adversely affect the signal
• The Pulse Oximeter was placed on the middle finger of the right hand
• ECG and Pulse Oximeter data was recorded continuously over 30 minutes,
from which the PTT was later derived
Notes:
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[1] A preliminary test of every volunteer prior to every test they provided was
introduced. Initially, this was to ensure that any ECG abnormalities which
would lead to errors in the peak detection algorithm could be identified.
However, it was found that this became useful to ensure the signal quality
was sufficient and for example none of the wires of the ECG were loose or
that the person had mistakenly worn nail polish. Also, during the initial test,
one of the volunteers had a panic attack during the BP measurements and
had to be subsequently omitted from the tests. Therefore, it was found by
performing this initial test, white coat hypertension could be avoided.
[2] Each test was recorded was recorded at some time between 2.30pm and
4.00pm, depending on the availability of the volunteer.
[3] Packaging the two sensors ensured that the wires coming from both were
rigid and held in place and could not be accidentally moved or come loose
during the test.
D.3 Round 3 Testing
By the time the second round of testing had taken place, the procedure for test-
ing volunteers was satisfactory and was capable of producing high quality and
reproducible results. For the third round of testing, two changes were made. The
first of these was to increase the number of volunteers and the second was to
increase the frequency of BP measurements:
• The number of volunteers was increased to fifteen
• A BP measurement was taken every 2 minutes
Notes:
[1] Originally the number of volunteers was increased to ten; however, on sub-
mitting the results to the Journal of Human Hypertension, the reviewers
requested the number to be increased to fifteen. These fifteen consisted of
five females and ten males.
[2] By measuring the BP every two minutes, a more exact calibration interval
could be extracted from the data. The figure of two minutes was chosen
because although one BP measurement typically took about 45 seconds, on
occasion a second inflation was required by the BP monitor for an accurate
183 Brian M McCarthy
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reading. Although these were infrequent, extending the calibration interval
to two minutes ensured a reading could be taken at every interval.
Development of a Novel PTT Based
Algorithm
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